Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hypertension

  Free Subscription


Articles published in J Hypertens

Retrieve available abstracts of 999 articles:
HTML format
Text format



Single Articles


    May 2017

  1. Effect of estrogen on the change of GABA function in the vasopressin neurons of salt-dependent hypertension model rats: Retraction.
    J Hypertens. 2017;35:1129.
    PubMed     Text format    


  2. HAMDIDOUCHE I, Boutouyrie P
    Is renal denervation an alternative or a complement to aldosterone antagonists in treatment of resistant hypertension?
    J Hypertens. 2017;35:955-957.
    PubMed     Text format    


  3. DOUMAS M, Stavropoulos K, Imprialos K
    Obstructive sleep apnea, hypertension, and fibrin clot properties: a novel pathogenetic link with cardiovascular disease?
    J Hypertens. 2017;35:950-952.
    PubMed     Text format    


  4. HEAGERTY AM
    Changes in small artery structure in hypertension: ready for prognostic translation?
    J Hypertens. 2017;35:945-946.
    PubMed     Text format    


  5. LEE CJ, Hwang J, Oh J, Lee SH, et al
    Treatment of uncomplicated hypertension is associated with a reduction in cardiovascular mortality: a Korean national cohort study.
    J Hypertens. 2017;35 Suppl 1:S41-S49.
    PubMed     Text format     Abstract available


  6. TIMASHEVA Y, Nasibullin T, Imaeva E, Erdman V, et al
    Genetic determinants of essential hypertension in the population of Tatars from Russia.
    J Hypertens. 2017;35 Suppl 1:S16-S23.
    PubMed     Text format     Abstract available


    April 2017
  7. MENDEZ-LOPEZ I, Bomfim GH, Musial DC, Arranz-Tagarro JA, et al
    Altered mitochondrial function, capacitative calcium entry and contractions in the aorta of hypertensive rats.
    J Hypertens. 2017 Apr 11. doi: 10.1097/HJH.0000000000001360.
    PubMed     Text format     Abstract available


  8. RUBATTU S, Cotugno M, Bianchi F, Sironi L, et al
    A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines.
    J Hypertens. 2017 Apr 10. doi: 10.1097/HJH.0000000000001374.
    PubMed     Text format     Abstract available


  9. LEONE D, Tosello F, Faletti R, Schivazappa G, et al
    Accuracy of transthoracic echocardiography in the assessment of proximal aortic diameter in hypertensive patients: comparison with cardiac magnetic resonance.
    J Hypertens. 2017 Apr 10. doi: 10.1097/HJH.0000000000001381.
    PubMed     Text format     Abstract available


  10. PENG H, Yeh F, de Simone G, Best LG, et al
    Relationship between plasma plasminogen activator inhibitor-1 and hypertension in American Indians: findings from the Strong Heart Study.
    J Hypertens. 2017 Apr 4. doi: 10.1097/HJH.0000000000001375.
    PubMed     Text format     Abstract available


  11. WANG JG, Kario K, Park JB, Chen CH, et al
    Morning blood pressure monitoring in the management of hypertension.
    J Hypertens. 2017 Apr 4. doi: 10.1097/HJH.0000000000001379.
    PubMed     Text format     Abstract available


  12. RAVASSA S, Lopez B, Querejeta R, Echegaray K, et al
    Phenotyping of myocardial fibrosis in hypertensive patients with heart failure. Influence on clinical outcome.
    J Hypertens. 2017;35:853-861.
    PubMed     Text format     Abstract available


  13. FERNANDEZ-MENDOZA J, He F, Vgontzas AN, Liao D, et al
    Objective short sleep duration modifies the relationship between hypertension and all-cause mortality.
    J Hypertens. 2017;35:830-836.
    PubMed     Text format     Abstract available


  14. VELOUDI P, Blizzard CL, Srikanth VK, Breslin M, et al
    Age-dependent changes in blood pressure over consecutive office measurements: impact on hypertension diagnosis and implications for international guidelines.
    J Hypertens. 2017;35:753-760.
    PubMed     Text format     Abstract available


  15. RIM TH, Lee SY, Kim SH, Kim SS, et al
    Increased incidence of open-angle glaucoma among hypertensive patients: an 11-year nationwide retrospective cohort study.
    J Hypertens. 2017;35:729-736.
    PubMed     Text format     Abstract available


  16. HUANG Y, Huang W, Mai W, Cai X, et al
    White-coat hypertension is a risk factor for cardiovascular diseases and total mortality.
    J Hypertens. 2017;35:677-688.
    PubMed     Text format     Abstract available


  17. ZANCHETTI A
    Predisposing factors, accompanying diseases and complications of hypertension.
    J Hypertens. 2017;35:655-656.
    PubMed     Text format    


  18. BURNIER M
    Is there a place for a dual angiotensin receptor-neprilysin inhibitor in the treatment of hypertension?
    J Hypertens. 2017;35:726-728.
    PubMed     Text format    


  19. KOLLIAS A, Protogerou AD, Stergiou GS
    Antihypertensive treatment-induced changes in arterial stiffness: Which artery? Which method?
    J Hypertens. 2017;35:721-725.
    PubMed     Text format    


  20. PERSEGHIN G, Manzoni G, Grassi G
    Hypertension and hepatic triglycerides content: a two (multi)-faceted clinical challenge?
    J Hypertens. 2017;35:715-717.
    PubMed     Text format    


  21. MANCIA G
    White-coat hypertension: growing evidence in favour of its adverse prognostic significance.
    J Hypertens. 2017;35:710-712.
    PubMed     Text format    


    March 2017
  22. ZANCHETTI A
    Treatment adherence and hypertension in the elderly.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001351.
    PubMed     Text format    


  23. BAHADORAN Z, Mirmiran P, Momenan AA, Azizi F, et al
    Allium vegetable intakes and the incidence of cardiovascular disease, hypertension, chronic kidney disease, and type 2 diabetes in adults: a longitudinal follow-up study.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001356.
    PubMed     Text format     Abstract available


  24. CORRAO G, Rea F, Monzio Compagnoni M, Merlino L, et al
    Protective effects of antihypertensive treatment in patients aged 85 years or older.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001323.
    PubMed     Text format     Abstract available


  25. YAO QP, Xie ZW, Wang KX, Zhang P, et al
    Profiles of long noncoding RNAs in hypertensive rats: long noncoding RNA XR007793 regulates cyclic strain-induced proliferation and migration of vascular smooth muscle cells.
    J Hypertens. 2017 Mar 17. doi: 10.1097/HJH.0000000000001304.
    PubMed     Text format     Abstract available


  26. POULTER NR, Schutte AE, Tomaszewski M, Lackland DT, et al
    May Measurement Month: a new joint global initiative by the International Society of Hypertension and the World Hypertension League to raise awareness of raised blood pressure.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001346.
    PubMed     Text format     Abstract available


  27. MOURAD JJ, Amodeo C, de Champvallins M, Brzozowska-Villatte R, et al
    Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trial.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001359.
    PubMed     Text format     Abstract available


  28. MUIESAN ML, Salvetti M, Paini A, Riviera M, et al
    Ocular fundus photography with a smartphone device in acute hypertension.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001354.
    PubMed     Text format     Abstract available


  29. HAMDIDOUCHE I, Jullien V, Boutouyrie P, Billaud E, et al
    Drug adherence in hypertension: from methodological issues to cardiovascular outcomes.
    J Hypertens. 2017 Mar 16. doi: 10.1097/HJH.0000000000001299.
    PubMed     Text format     Abstract available


  30. KAZE AD, Schutte AE, Erqou S, Kengne AP, et al
    Prevalence of hypertension in older people in Africa: a systematic review and meta-analysis.
    J Hypertens. 2017 Mar 6. doi: 10.1097/HJH.0000000000001345.
    PubMed     Text format     Abstract available


  31. KAWADA T
    Thiazide diuretics and fracture in patients with hypertension.
    J Hypertens. 2017;35:645-646.
    PubMed     Text format    


  32. HERING D, Grassi G
    Prognostic significance of masked tachycardia in hypertension: evidence from a prospective international registry.
    J Hypertens. 2017;35:468-470.
    PubMed     Text format    


    February 2017
  33. ZANCHETTI A
    Problems of antihypertensive management: diabetes mellitus, ethnic differences, organ damage and resistance to treatment.
    J Hypertens. 2017 Feb 27. doi: 10.1097/HJH.0000000000001334.
    PubMed     Text format    


  34. PARK SK, Kim WJ, Lee DY, Lee SY, et al
    Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive urgency: a randomized, control trial.
    J Hypertens. 2017 Feb 27. doi: 10.1097/HJH.0000000000001340.
    PubMed     Text format     Abstract available


  35. ZHANG Z, Li Z, Cao K, Fang D, et al
    Adjunctive therapy with statins reduces residual albuminuria/proteinuria and provides further renoprotection by downregulating the angiotensin II-AT1 pathway in hypertensive nephropathy.
    J Hypertens. 2017 Feb 27. doi: 10.1097/HJH.0000000000001325.
    PubMed     Text format     Abstract available


  36. JIN L, Lin MQ, Piao ZH, Cho JY, et al
    Gallic acid attenuates hypertension, cardiac remodeling, and fibrosis in mice with NG-nitro-L-arginine methyl ester-induced hypertension via regulation of histone deacetylase 1 or histone deacetylase 2.
    J Hypertens. 2017 Feb 22. doi: 10.1097/HJH.0000000000001327.
    PubMed     Text format     Abstract available


  37. FRITH E, Loprinzi PD
    Physical activity and cognitive function among older adults with hypertension.
    J Hypertens. 2017 Feb 17. doi: 10.1097/HJH.0000000000001311.
    PubMed     Text format     Abstract available


  38. UITERWIJK R, Staals J, Huijts M, de Leeuw PW, et al
    MRI progression of cerebral small vessel disease and cognitive decline in patients with hypertension.
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001294.
    PubMed     Text format     Abstract available


  39. NAUMCZYK P, Sabisz A, Witkowska M, Graff B, et al
    Compensatory functional reorganization may precede hypertension-related brain damage and cognitive decline: a functional magnetic resonance imaging study.
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001293.
    PubMed     Text format     Abstract available


  40. XU T, Zhang Y, Bu X, Wang D, et al
    Blood pressure reduction in acute ischemic stroke according to time to treatment: a subgroup analysis of the China Antihypertensive Trial in Acute Ischemic Stroke trial.
    J Hypertens. 2017 Feb 6. doi: 10.1097/HJH.0000000000001288.
    PubMed     Text format     Abstract available


  41. SARAFIDIS PA, Persu A, Agarwal R, Burnier M, et al
    Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association - European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the
    J Hypertens. 2017 Feb 2. doi: 10.1097/HJH.0000000000001283.
    PubMed     Text format     Abstract available


  42. DE SOCIO GV, Ricci E, Maggi P, Parruti G, et al
    Time trend in hypertension prevalence, awareness, treatment, and control in a contemporary cohort of HIV-infected patients: the HIV and Hypertension Study.
    J Hypertens. 2017;35:409-416.
    PubMed     Text format     Abstract available


  43. SATOH A, Arima H, Ohkubo T, Nishi N, et al
    Associations of socioeconomic status with prevalence, awareness, treatment, and control of hypertension in a general Japanese population: NIPPON DATA2010.
    J Hypertens. 2017;35:401-408.
    PubMed     Text format     Abstract available


  44. PEKARSKIY SE, Baev AE, Mordovin VF, Semke GV, et al
    Denervation of the distal renal arterial branches vs. conventional main renal artery treatment: a randomized controlled trial for treatment of resistant hypertension.
    J Hypertens. 2017;35:369-375.
    PubMed     Text format     Abstract available


  45. GARCIA ML, Pontes RB, Nishi EE, Ibuki FK, et al
    The antioxidant effects of green tea reduces blood pressure and sympathoexcitation in an experimental model of hypertension.
    J Hypertens. 2017;35:348-354.
    PubMed     Text format     Abstract available


  46. MONNIER A, Garnier P, Quirie A, Pernet N, et al
    Effect of short-term exercise training on brain-derived neurotrophic factor signaling in spontaneously hypertensive rats.
    J Hypertens. 2017;35:279-290.
    PubMed     Text format     Abstract available


  47. PUCCI G, Battista F, Anastasio F, Schillaci G, et al
    Morning pressor surge, blood pressure variability, and arterial stiffness in essential hypertension.
    J Hypertens. 2017;35:272-278.
    PubMed     Text format     Abstract available


  48. XU SL, Trevathan E, Qian Z, Vivian E, et al
    Prenatal and postnatal exposure to pet ownership, blood pressure, and hypertension in children: the Seven Northeastern Cities study.
    J Hypertens. 2017;35:259-265.
    PubMed     Text format     Abstract available


  49. O'ROURKE MF, Adji A
    Managing hypertension in children and adolescents.
    J Hypertens. 2017;35:417.
    PubMed     Text format    


  50. LEYVRAZ M, Santschi V, Chiolero A
    What systematic reviews bring to the field of hypertension.
    J Hypertens. 2017;35:240-242.
    PubMed     Text format    


  51. AKBARI M, Moosazadeh M, Ghahramani S, Tabrizi R, et al
    High prevalence of hypertension among Iranian children and adolescents: a systematic review and meta-analysis.
    J Hypertens. 2017 Feb 1. doi: 10.1097/HJH.0000000000001261.
    PubMed     Text format     Abstract available


    January 2017
  52. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood-pressure-lowering treatment on outcome incidence in hypertension: 10 - Should blood pressure management differ in hypertensive patients with and without diabetes mellitus? Overview and meta-analyses of randomized trials.
    J Hypertens. 2017 Jan 30. doi: 10.1097/HJH.0000000000001276.
    PubMed     Text format     Abstract available


  53. JOZWIK-PLEBANEK K, Prejbisz A, Wypasek E, Pregowska-Chwala B, et al
    Altered plasma fibrin clot properties in hypertensive patients with obstructive sleep apnoea are improved by continuous positive airway pressure treatment.
    J Hypertens. 2017 Jan 30. doi: 10.1097/HJH.0000000000001269.
    PubMed     Text format     Abstract available


  54. DASGUPTA K, Rosenberg E, Joseph L, Trudeau L, et al
    Carotid femoral pulse wave velocity in type 2 diabetes and hypertension: capturing arterial health effects of step counts.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001277.
    PubMed     Text format     Abstract available


  55. LEE CJ, Oh J, Lee SH, Kang SM, et al
    Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants: a Korean national cohort study.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001279.
    PubMed     Text format     Abstract available


  56. WEIR MR, Mayo MR, Garza D, Arthur SA, et al
    Effectiveness of patiromer in the treatment of hyperkalemia in chronic kidney disease patients with hypertension on diuretics.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001278.
    PubMed     Text format     Abstract available


  57. DE SOUZA F, Muxfeldt ES, Margallo V, Cortez AF, et al
    Effects of continuous positive airway pressure treatment on aldosterone excretion in patients with obstructive sleep apnoea and resistant hypertension: a randomized controlled trial.
    J Hypertens. 2017 Jan 27. doi: 10.1097/HJH.0000000000001254.
    PubMed     Text format     Abstract available


  58. SALADINI F, Mos L, Fania C, Garavelli G, et al
    Regular physical activity prevents development of hypertension in young people with hyperuricemia.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001271.
    PubMed     Text format     Abstract available


  59. ROSA J, Widimsky P, Waldauf P, Zelinka T, et al
    Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001257.
    PubMed     Text format     Abstract available


  60. SCHNEIDER A, Schwab J, Karg MV, Kalizki T, et al
    Low-dose eplerenone decreases left ventricular mass in treatment-resistant hypertension.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001264.
    PubMed     Text format     Abstract available


  61. LI X, Wang W, Wang A, Li P, et al
    Vulnerability of the frontal and parietal regions in hypertensive patients during working memory task.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001250.
    PubMed     Text format     Abstract available


  62. VINYOLES E, de la Sierra A, Roso-Llorach A, Banegas JR, et al
    24-h pulse pressure cutoff point definition by office pulse pressure in a population of Spanish older hypertensive patients.
    J Hypertens. 2017 Jan 23. doi: 10.1097/HJH.0000000000001268.
    PubMed     Text format     Abstract available


  63. RUPPAR TM, Dunbar-Jacob JM, Mehr DR, Lewis L, et al
    Medication adherence interventions among hypertensive black adults: a systematic review and meta-analysis.
    J Hypertens. 2017 Jan 18. doi: 10.1097/HJH.0000000000001260.
    PubMed     Text format     Abstract available


  64. TEDLA YG, Gepner AD, Vaidya D, Colangelo L, et al
    Association between long-term blood pressure control and ten-year progression in carotid arterial stiffness among hypertensive individuals: the multiethnic study of atherosclerosis.
    J Hypertens. 2017 Jan 13. doi: 10.1097/HJH.0000000000001199.
    PubMed     Text format     Abstract available


  65. MYERS MG
    Statistical analysis as a cause of white-coat hypertension.
    J Hypertens. 2017 Jan 12. doi: 10.1097/HJH.0000000000001232.
    PubMed     Text format    


  66. CHU C, Dai Y, Mu J, Yang R, et al
    Associations of risk factors in childhood with arterial stiffness 26 years later: the Hanzhong adolescent hypertension cohort.
    J Hypertens. 2017 Jan 5. doi: 10.1097/HJH.0000000000001242.
    PubMed     Text format     Abstract available


  67. CHUANG YW, Yu MC, Huang ST, Yang CK, et al
    Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control study.
    J Hypertens. 2017;35:170-177.
    PubMed     Text format     Abstract available


  68. MALOBERTI A, Meani P, Vallerio P, Varrenti M, et al
    Annexin A5 in treated hypertensive patients and its association with target organ damage.
    J Hypertens. 2017;35:154-161.
    PubMed     Text format     Abstract available


  69. LINZ D, Mancia G, Mahfoud F, Narkiewicz K, et al
    Renal artery denervation for treatment of patients with self-reported obstructive sleep apnea and resistant hypertension: results from the Global SYMPLICITY Registry.
    J Hypertens. 2017;35:148-153.
    PubMed     Text format     Abstract available


  70. OH JY, Allison MA, Barrett-Connor E
    Different impacts of hypertension and diabetes mellitus on all-cause and cardiovascular mortality in community-dwelling older adults: the Rancho Bernardo Study.
    J Hypertens. 2017;35:55-62.
    PubMed     Text format     Abstract available


  71. ZANCHETTI A
    Factors and consequences of hypertension.
    J Hypertens. 2017;35:1-2.
    PubMed     Text format    


  72. TANEMOTO M
    Blood pressure reduction after renal denervation in obese hypertensive swine model.
    J Hypertens. 2017;35:199.
    PubMed     Text format    


  73. TEO KK
    Does spironolactone reduce the risk of urinary tract cancers in hypertensive patients?
    J Hypertens. 2017;35:36-38.
    PubMed     Text format    


  74. BANEGAS JR
    Mass starvation in early life and adult hypertension in China.
    J Hypertens. 2017;35:29-32.
    PubMed     Text format    


    December 2016
  75. BORGHI C, Paolillo S, Cicero AF, Gargiulo P, et al
    New oral anticoagulants and prevention of thromboembolic events in patients with hypertension and atrial fibrillation: an appraisal.
    J Hypertens. 2016 Dec 28. doi: 10.1097/HJH.0000000000001228.
    PubMed     Text format     Abstract available


  76. BAI YP, Xiao S, Tang YB, Tan Z, et al
    Shear stress-mediated upregulation of GTP cyclohydrolase/tetrahydrobiopterin pathway ameliorates hypertension-related decline in reendothelialization capacity of endothelial progenitor cells.
    J Hypertens. 2016 Dec 28. doi: 10.1097/HJH.0000000000001216.
    PubMed     Text format     Abstract available


  77. WANG JG, Yukisada K, Sibulo A Jr, Hafeez K, et al
    Efficacy and safety of sacubitril/valsartan (LCZ696) add-on to amlodipine in Asian patients with systolic hypertension uncontrolled with amlodipine monotherapy.
    J Hypertens. 2016 Dec 24. doi: 10.1097/HJH.0000000000001219.
    PubMed     Text format     Abstract available


  78. KOTON S, Tanne D, Grossman E
    Prestroke treatment with beta-blockers for hypertension is not associated with severity and poor outcome in patients with ischemic stroke: data from a national stroke registry.
    J Hypertens. 2016 Dec 24. doi: 10.1097/HJH.0000000000001218.
    PubMed     Text format     Abstract available


  79. CHOWDHURY EK, Nelson MR, Jennings GL, Wing LM, et al
    Pet ownership and survival in the elderly hypertensive population.
    J Hypertens. 2016 Dec 22. doi: 10.1097/HJH.0000000000001214.
    PubMed     Text format     Abstract available


  80. STEVENSON ER, Johns EM, Marques FZ, Jackson KL, et al
    Positive allosteric modulation of GABAA receptors attenuates high blood pressure in Schlager hypertensive mice.
    J Hypertens. 2016 Dec 22. doi: 10.1097/HJH.0000000000001210.
    PubMed     Text format     Abstract available


  81. CHEN CW, Kuo TB, Chen CY, Yang CC, et al
    Reduced capacity of autonomic and baroreflex control associated with sleep pattern in spontaneously hypertensive rats with a nondipping profile.
    J Hypertens. 2016 Dec 21. doi: 10.1097/HJH.0000000000001205.
    PubMed     Text format     Abstract available


  82. LIU X, Gu W, Li Z, Lei H, et al
    Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  83. KINTIS K, Tsioufis C, Kasiakogias A, Dimitriadis K, et al
    Noninvasive assessment of haemodynamics in resistant hypertension: the role of the renal resistive index.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  84. BONNET F, Gastaldelli A, Pihan-Le Bars F, Natali A, et al
    Gamma-glutamyltransferase, fatty liver index and hepatic insulin resistance are associated with incident hypertension in two longitudinal studies.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  85. WANG Z, Chen Z, Wang X, Hao G, et al
    Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  86. PALATINI P, Reboldi G, Beilin LJ, Casiglia E, et al
    Masked tachycardia. A predictor of adverse outcome in hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  87. CUSPIDI C, Facchetti R, Bombelli M, Sala C, et al
    Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: the PAMELA study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  88. FODOR JG, Baker P, Chen L, Leenen FH, et al
    On-treatment blood pressures of older hypertensive patients in Canada: implications for systolic blood pressure intervention trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  89. ZANCHETTI A
    From inflammation to renal denervation in hypertension research.
    J Hypertens. 2016;34:2301-2302.
    PubMed     Text format    


  90. TOMLINSON B, Sritara P, Lopez E, Dalal J, et al
    Hypertension and elevated heart rate: focus on the Asia Pacific region.
    J Hypertens. 2016;34:2330-2332.
    PubMed     Text format    


    November 2016
  91. MANCIA G, Rea F, Cuspidi C, Grassi G, et al
    Blood pressure control in hypertension. Pros and cons of available treatment strategies.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  92. BRUNSTROM M, Eliasson M, Nilsson PM, Carlberg B, et al
    Blood pressure treatment levels and choice of antihypertensive agent in people with diabetes mellitus: an overview of systematic reviews.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  93. ASH GI, Taylor BA, Thompson PD, MacDonald HV, et al
    The antihypertensive effects of aerobic versus isometric handgrip resistance exercise.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  94. WANG T, Li GQ, Zhang HP, Zhang Y, et al
    Overactivation of cannabinoid receptor type 1 in rostral ventrolateral medulla promotes cardiovascular responses in spontaneously hypertensive rats.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  95. YU EY, Wan EY, Wong CK, Chan AK, et al
    Effects of risk assessment and management programme for hypertension on clinical outcomes and cardiovascular disease risks after 12 months: a population-based matched cohort study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  96. DIEDERICHS C, Neuhauser H
    The incidence of hypertension and its risk factors in the German adult population: results from the German National Health Interview and Examination Survey 1998 and the German Health Interview and Examination Survey for Adults 2008-2011.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  97. RAYNER BL, Spence JD
    Hypertension in blacks: insights from Africa.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  98. BRUNO RM, Cartoni G, Stea F, Armenia S, et al
    Carotid and aortic stiffness in essential hypertension and their relation with target organ damage: the CATOD study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  99. GORDON RD
    The importance of not overlooking curable hypertension: primary aldosteronism rarely screened for reflecting poor uptake of Endocrine Society Guidelines.
    J Hypertens. 2016;34:2143-4.
    PubMed     Text format    


  100. SCHMITZ B, Brand SM
    Uric acid and essential hypertension: the endothelial connection.
    J Hypertens. 2016;34:2138-9.
    PubMed     Text format    


    October 2016
  101. SECCIA TM, Caroccia B, Calo LA
    Hypertensive nephropathy. Moving from classic to emerging pathogenetic mechanisms.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  102. CUNHA AR, D'El-Rei J, Medeiros F, Umbelino B, et al
    Oral magnesium supplementation improves endothelial function and attenuates subclinical atherosclerosis in thiazide-treated hypertensive women.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  103. MOSS JG, Belli AM, Coca A, Lee M, et al
    Executive summary of the joint position paper on renal denervation of the Cardiovascular and Interventional Radiological Society of Europe and the European Society of Hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  104. THOMSEN LC, Mccarthy NS, Melton PE, Cadby G, et al
    The antihypertensive MTHFR gene polymorphism rs17367504-G is a possible novel protective locus for preeclampsia.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  105. ROUSH GC, Amante B, Singh T, Ayele H, et al
    Quality of meta-analyses for randomized trials in the field of hypertension: a systematic review.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  106. BOHM M, Ukena C, Ewen S, Linz D, et al
    Renal denervation reduces office and ambulatory heart rate in patients with uncontrolled hypertension: 12-month outcomes from the global SYMPLICITY registry.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  107. MENDES M, Dubourg J, Blanchard A, Bergerot D, et al
    Copeptin is increased in resistant hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  108. JACKSON CA, Pathirana T, Gardiner PA
    Depression, anxiety and risk of hypertension in mid-aged women: a prospective longitudinal study.
    J Hypertens. 2016;34:1959-1966.
    PubMed     Text format     Abstract available


    September 2016
  109. KULCHAITANAROAJ P, Brooks JM, Chaiyakunapruk N, Goedken AM, et al
    Cost-utility analysis of physician-pharmacist collaborative intervention for treating hypertension compared with usual care.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  110. CAMACHO PA, Gomez-Arbelaez D, Molina DI, Sanchez G, et al
    Social disparities explain differences in hypertension prevalence, detection and control in Colombia.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  111. NAPOLI C, Omboni S, Borghi C
    Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  112. CARRARA D, Bruno RM, Bacca A, Taddei S, et al
    Cholecalciferol treatment downregulates renin-angiotensin system and improves endothelial function in essential hypertensive patients with hypovitaminosid D.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  113. YU C, Wang J, Li Y, Han X, et al
    Exposure to the Chinese famine in early life and hypertension prevalence risk in adults.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  114. SCHEEPERS LE, Wei FF, Stolarz-Skrzypek K, Malyutina S, et al
    Xanthine oxidase gene variants and their association with blood pressure and incident hypertension: a population study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  115. SVEDMYR S, Zou D, Sommermeyer D, Ficker JH, et al
    Vascular stiffness determined from a nocturnal digital pulse wave signal: association with sleep, sleep-disordered breathing, and hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  116. ZAMAMI R, Kohagura K, Miyagi T, Kinjyo T, et al
    Modification of the impact of hypertension on proteinuria by renal arteriolar hyalinosis in nonnephrotic chronic kidney disease.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  117. OTT C, Mahfoud F, Schmid A, Ewen S, et al
    The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherence.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  118. MAIDA KD, Vieira S, Gastaldi AC, Bezerra VB, et al
    Amlodipine and enalapril promote distinct effects on cardiovascular autonomic control in spontaneously hypertensive rats: the role of aerobic physical training.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  119. YAN W, Li X, Zhang Y, Niu D, et al
    Reevaluate secular trends of body size measurements and prevalence of hypertension among Chinese children and adolescents in past two decades.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  120. MARTINEZ-AGUAYO A, Campino C, Baudrand R, Carvajal CA, et al
    Cortisol/cortisone ratio and matrix metalloproteinase-9 activity are associated with pediatric primary hypertension.
    J Hypertens. 2016;34:1808-14.
    PubMed     Text format     Abstract available


  121. CALHOUN DA
    Spironolactone versus renal nerve denervation for treatment of uncontrolled resistant hypertension.
    J Hypertens. 2016;34:1701-3.
    PubMed     Text format    


  122. CUSPIDI C, Sala C, Grassi G
    ECG left atrial abnormality: a marker of stroke prediction in hypertension.
    J Hypertens. 2016;34:1698-700.
    PubMed     Text format    


  123. JORDAN J, Toplak H, Grassi G, Yumuk V, et al
    Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure.
    J Hypertens. 2016;34:1678-88.
    PubMed     Text format     Abstract available


  124. ZANCHETTI A
    Consensus documents and challenges in hypertension research.
    J Hypertens. 2016;34:1663-4.
    PubMed     Text format    


  125. PARREIRA LB, Jardim PC, Sousa AL, Jardim TS, et al
    [OP.8A.06] CARDIAC REHABILITATION IN HYPERTENSIVE PATIENTS: COMPARISON BETWEEN TWO PROTOCOLS.
    J Hypertens. 2016;34 Suppl 2:e99.
    PubMed     Text format     Abstract available


  126. MOS L, Fania C, Saladini F, Mazzer A, et al
    [OP.8A.05] REGULAR PHYSICAL ACTIVITY ATTENUATES THE ASSOCIATION BETWEEN COFFEE CONSUMPTION AND CARDIOVASCULAR EVENTS IN HYPERTENSION. THE HARVEST.
    J Hypertens. 2016;34 Suppl 2:e99.
    PubMed     Text format     Abstract available


  127. MILLEN A, Woodiwiss A, Norton GR
    [OP.8A.02] POST-EXERCISE EFFECTS ON AORTIC WAVE REFLECTION DERIVED FROM WAVE SEPARATION ANALYSIS IN PRE-HYPERTENSIVES AND HYPERTENSIVES: COMPARISON WITH CHANGES IN AUGMENTATION INDEXES.
    J Hypertens. 2016;34 Suppl 2:e98.
    PubMed     Text format     Abstract available


  128. MENDES P, Martinho R, Leite S, Leite-Moreira A, et al
    [OP.8A.01] EXERCISE-INDUCED HYPERTENSION AND CARDIAC HYPERTROPHY IN EPINEPHRINE-DEFICIENT MICE.
    J Hypertens. 2016;34 Suppl 2:e98.
    PubMed     Text format     Abstract available


  129. EIKELIS N, Hering D, Marusic P, Walton A, et al
    [OP.7D.10] THE EFFECT OF RENAL DENERVATION ON ADIPOKINES IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e97.
    PubMed     Text format     Abstract available


  130. ROSA J, Widimsky P, Waldauf P, Lambert L, et al
    [OP.7D.09] THE ROLE OF ADDING SPIRONOLACTONE AND RENAL DENERVATION IN TRUE RESISTANT HYPERTENSION. ONE-YEAR OUTCOMES OF RANDOMIZED PRAGUE-15 STUDY.
    J Hypertens. 2016;34 Suppl 2:e96-7.
    PubMed     Text format     Abstract available


  131. KASIAKOGIAS A, Tsioufis C, Kordalis A, Dimitriadis K, et al
    [OP.7D.08] SEVERE RESISTANT HYPERTENSION EXHIBITS THE GREATEST CARDIOVASCULAR RISK AMONG TREATED UNCONTROLLED HYPERTENSIVES: A 4-YEAR FOLLOW-UP STUDY.
    J Hypertens. 2016;34 Suppl 2:e96.
    PubMed     Text format     Abstract available


  132. MEGDICHE F, Vakilzadeh N, Maillard M, Grouzmann E, et al
    [OP.7D.04] CHANGES IN RENAL HEMODYNAMIC AND TUBULAR SODIUM HANDLING ONE YEAR AFTER TRANSCATHETER RENAL DENERVATION IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e95.
    PubMed     Text format     Abstract available


  133. SANDERS M, de Jager R, Bots M, Lobo M, et al
    [OP.7D.03] RENAL DENERVATION IN HYPERTENSIVE PATIENTS NOT ON BLOOD PRESSURE LOWERING DRUGS.
    J Hypertens. 2016;34 Suppl 2:e94-5.
    PubMed     Text format     Abstract available


  134. DUBOURG J, Mendes M, Blanchard A, Frank M, et al
    [OP.7D.02] INCREASE IN PLASMA COPEPTIN CONCENTRATION IN PATIENTS WITH CONFIRMED RESISTANT ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e94.
    PubMed     Text format     Abstract available


  135. RIMPELA J, Hiltunen TP, Fyhrquist F, Kontula KK, et al
    [OP.7C.10] IDENTIFICATION OF GENE VARIANTS ASSOCIATED WITH ANTIHYPERTENSIVE RESPONSES TO BETA BLOCKERS AND LOSARTAN.
    J Hypertens. 2016;34 Suppl 2:e92-3.
    PubMed     Text format     Abstract available


  136. SIEDLINSKI M, Szczepaniak P, Nosalski R, Ludwig-Galezowska A, et al
    [OP.7C.06] VASCULAR TRANSCRIPTOME PROFILING IDENTIFIES SPHINGOSINE KINASE 1 AS A KEY MODULATOR OF ANGIOTENSIN II-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e91.
    PubMed     Text format     Abstract available


  137. TENTORI S, Lanzani C, Citterio L, Brioni E, et al
    [OP.7C.03] KLOTHO GENE POLYMORPHISM INTERACTS WITH ADDUCIN-ENDOGENOUS OUABAIN-NA+-K+ ATPASE SYSTEM IN SALT SENSITIVE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e90-1.
    PubMed     Text format     Abstract available


  138. MULE G, Castiglia A, Schillaci MK, Luna C, et al
    [OP.7B.08] INFLUENCE OF GENDER ON THE RELATIONSHIPS BETWEEN NEW INDICES OF ADIPOSITY AND LEFT VENTRICULAR MASS AND HYPERTROPHY IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e88.
    PubMed     Text format     Abstract available


  139. BORDICCHIA M, Ceresiani M, Pavani M, Sarzani R, et al
    [OP.7B.04] UP-REGULATION OF THE NATRIURETIC PEPTIDE CLEARANCE RECEPTOR AND INHIBITION OF LIPOLYSIS BY INSULIN: FILLING THE GAP BETWEEN METABOLIC SYNDROME AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e86-7.
    PubMed     Text format     Abstract available


  140. DIMITRIADIS K, Tsioufis C, Andrikou E, Kasiakogias A, et al
    [OP.7B.02] METABOLIC SYNDROME IS ASSOCIATED WITH INCREASED SYMPATHETIC NERVOUS SYSTEM ACTIVITY AND ARTERIAL STIFFNESS IN RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e86.
    PubMed     Text format     Abstract available


  141. LIM K, Barzel B, Burke S, Head G, et al
    [OP.7B.01] NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY.
    J Hypertens. 2016;34 Suppl 2:e86.
    PubMed     Text format     Abstract available


  142. DARABONT R, Tautu O, Ardeleanu M, Dorobantu M, et al
    [OP.7A.10] COMMON AND EMERGENT FACTORS ASSOCIATED WITH HYPERTENSION CONTROL IN ROMANIA.
    J Hypertens. 2016;34 Suppl 2:e84-5.
    PubMed     Text format     Abstract available


  143. VAISSE B, Pannier B, Hanon O, Mourad JJ, et al
    [OP.7A.09] A NATIONWIDE EVALUATION OF BLOOD PRESSURE CONTROL IN FRANCE USING HOME BLOOD PRESSURE MONITORING: THE FRENCH LEAGUE AGAINST HYPERTENSION SURVEY (FLAHS 2015).
    J Hypertens. 2016;34 Suppl 2:e84.
    PubMed     Text format     Abstract available


  144. STERGIOU GS, Margetaki A, Boubouchairopoulou N, Haidich B, et al
    [OP.7A.08] AWARENESS, TREATMENT AND CONTROL OF HYPERTENSION IN GREECE: INTERIM ANALYSIS OF THE EMENO NATIONAL EPIDEMIOLOGICAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e84.
    PubMed     Text format     Abstract available


  145. CARRERE P, Halbert N, Helene-Pelage J, Lang T, et al
    [OP.7A.07] TRENDS IN HYPERTENSION AMONG POOR FRENCH CARIBBEAN, 2003 TO 2014: BETTER BUT STILL NOT GOOD ENOUGH.
    J Hypertens. 2016;34 Suppl 2:e83-4.
    PubMed     Text format     Abstract available


  146. GABBA M, Salinaro F, Mussinelli R, Boldrini M, et al
    [OP.7A.06] TREATING HYPERTENSIVE CRISES BETWEEN GUIDELINES AND REAL-WORLD: AN ANTI-HYPERTENSIVE ROLE OF ANTI-ANXIETY DRUGS?
    J Hypertens. 2016;34 Suppl 2:e83.
    PubMed     Text format     Abstract available


  147. VRDOLJAK A, Ivkovic V, Karanovic S, Dika Z, et al
    [OP.7A.05] TRENDS IN PREVALENCE, TREATMENT AND CONTROL OF HYPERTENSION IN CROATIAN CONTINENTAL RURAL POPULATION - ENAH STUDY.
    J Hypertens. 2016;34 Suppl 2:e83.
    PubMed     Text format     Abstract available


  148. BOKRANTZ T, Schioler L, Ljungman C, Kahan T, et al
    [OP.7A.04] ANTIHYPERTENSIVE DRUGS AND THE RISK OF FEMUR FRACTURE IN HYPERTENSIVE PATIENTS IN SWEDISH PRIMARY HEALTH CARE. RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE (SPCCD).
    J Hypertens. 2016;34 Suppl 2:e83.
    PubMed     Text format     Abstract available


  149. SAMJI S, Small HY, Coley S, Mischak H, et al
    [OP.LB.02: 06] INVESTIGATION OF URINARY PEPTIDOME OVER PREGNANCY IN RODENT MODEL OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e80.
    PubMed     Text format     Abstract available


  150. MARAIS L, Boutouyrie P, Khettab H, Boulanger C, et al
    [OP.1C.04] STRUCTURAL AND FUNCTIONAL ARTERIAL ABNORMALITIES IN FIBROMUSCULAR DYSPLASIA ARE IN THE CONTINUUM OF HYPERTENSION: AN IMAGING AND BIOMECHANICAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e8-9.
    PubMed     Text format     Abstract available


  151. MITCHELL A, Nokay B, Guberina H, Behlen-Wilm U, et al
    [OP.LB.02.05] A PATIENT WITH MALIGNANT HYPERTENSION SUCCESSFULLY TREATED WITH ECULIZUMAB AND BOSENTAN - SUGGESTIONS OF SIGNIFICANT INTERACTIONS OF COMPLEMENT AND THE ENDOTHELIN SYSTEM IN BLOOD PRESSURE CONTROL.
    J Hypertens. 2016;34 Suppl 2:e79-80.
    PubMed     Text format     Abstract available


  152. LOBO M, Saxena M, Sobotka PA, Ott C, et al
    [OP.LB.02.04] CENTRAL ILIAC ARTERIOVENOUS ANASTOMOSIS FOR UNCONTROLLED HYPERTENSION: 12 MONTH FOLLOW UP RESULTS OF THE ROX CONTROL HTN RANDOMISED CONTROLLED TRIAL.
    J Hypertens. 2016;34 Suppl 2:e78-9.
    PubMed     Text format     Abstract available


  153. NECHUTOVA H, Soucek M, Brabencova K, Stepanova R, et al
    [OP.LB.02.02] NEUROMODULATION IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e78.
    PubMed     Text format     Abstract available


  154. HMAZZOU R, Flahault A, Marc Y, Llorens-Cortes C, et al
    [OP.6D.03] MODE OF ACTION OF RB150, AN AMINOPEPTIDASE A INHIBITOR PRODRUG AS A CENTRALLY-ACTING ANTIHYPERTENSIVE AGENT IN DOCA-SALT HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 2:e75.
    PubMed     Text format     Abstract available


  155. BUESS D, Giezendanner S, Henny-Fullin K, Handschin A, et al
    [OP.6C.07] COMPLIANCE WITH ESH/ESC GUIDELINES FOR ARTERIAL HYPERTENSION IN SWISS PRIMARY CARE: PHARMACOLOGICAL THERAPY.
    J Hypertens. 2016;34 Suppl 2:e73-4.
    PubMed     Text format     Abstract available


  156. NEBIERIDZE D, Saricheva A
    [OP.6C.05] THE POSSIBILITY OF IMPROVING THE COMPLIANCE TO THE TREATMENT BY USING OF ELECTRONIC VERSION OF SCORE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e73.
    PubMed     Text format     Abstract available


  157. KARAKAYA G, Van Tielen R, Umbach I
    [OP.6C.02] RISK FACTORS ASSOCIATED WITH MEDICATION NON-COMPLIANCE IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e72.
    PubMed     Text format     Abstract available


  158. KASIAKOGIAS A, Tsioufis C, Athanasakis K, Andrikou E, et al
    [OP.6C.01] REAL-WORLD MEDICATION COMPLIANCE IN A SAMPLE OF PATIENTS RECEIVING ANTIHYPERTENSIVE TREATMENT IN GREECE.
    J Hypertens. 2016;34 Suppl 2:e72.
    PubMed     Text format     Abstract available


  159. BASTOS J, Pires J, Pinto J, Araujo A, et al
    [OP.6B.09] AMONG ALL DATA FROM 24-H BLOOD PRESSURE, NIGHTTIME SYSTOLIC BLOOD PRESSURE HAS THE HIGHEST PREDICTIVE VALUE OF CV EVENTS, STOKE AND HEART ATTACKS IN A PORTUGUESE SAMPLE OF TREATED HYPERTENSIVES PATIENTS FOLLOWED FOR 11,8 +/- 5,1 YEARS.
    J Hypertens. 2016;34 Suppl 2:e71.
    PubMed     Text format     Abstract available


  160. PIETRI P, Vlachopoulos C, Vyssoulis G, Ioakeimidis N, et al
    [OP.1B.08] ASSOCIATION OF APOB/APOA 1 RATIO WITH TARGET ORGAN DAMAGE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e7.
    PubMed     Text format     Abstract available


  161. MALDONADO J, Pereira T
    [OP.6A.03] PREVALENCE AND DETERMINANTS OF HYPERTENSION IN A COHORT OF 15.049 PORTUGUESE CHILDREN AND ADOLESCENTS. THE AVELEIRA REGISTRY.
    J Hypertens. 2016;34 Suppl 2:e66-7.
    PubMed     Text format     Abstract available


  162. BARRIENTOS G, Uceda A, Sgariglia A, Giardina G, et al
    [OP.5D.06] HYPERTENSION AS A PATERNAL FACTOR INFLUENCES MATERNAL ADAPTATION TO PREGNANCY AND IS ASSOCIATED WITH PLACENTAL INSUFFICIENCY AND FETAL GROWTH RESTRICTION.
    J Hypertens. 2016;34 Suppl 2:e64-5.
    PubMed     Text format     Abstract available


  163. SAMUELSSON A, Pombo JM, Coen CW, Mallard C, et al
    [OP.5D.03] CHRONIC INFLAMMATION DURING PREGNANCY INFLUENCE THE PROGRESSION OF EARLY SYMPATHETIC-MEDIATED HYPERTENSION IN OFFSPRING ARISING FROM MATERNAL OBESITY.
    J Hypertens. 2016;34 Suppl 2:e63.
    PubMed     Text format     Abstract available


  164. MORGAN H, Small HY, Beattie E, McBride MW, et al
    [OP.5D.02] TRANSCRIPTOMIC CHANGES IN EARLY PREGNANCY-ASSOCIATED UTERINE ARTERY REMODELLING IN STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 2:e63.
    PubMed     Text format     Abstract available


  165. SMALL H, Nosalski R, Morgan H, Beattie E, et al
    [OP.5D.01] INHIBITON OF TNF-ALPHA SIGNALLING USING ETANERCEPT IMPROVES DEFICIENT UTERINE ARTERY REMODELLING AND PREGNANCY OUTCOME IN THE STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 2:e63.
    PubMed     Text format     Abstract available


  166. ZVARTAU N, Krikunov A, Semakova A, Bolgova E, et al
    [OP.5C.08] FIVE-YEARS TRENDS IN DEMOGRAPHIC CHCRACTERISTICS OF HYPERTENSIVE PATIENTS REFERRED TO SPECIALIZED CARDIOLOGICAL CENTRE: AGE AND GENDER.
    J Hypertens. 2016;34 Suppl 2:e62.
    PubMed     Text format     Abstract available


  167. PALATINI P, Reboldi P, Pierdomenico S, Eguchi K, et al
    [OP.5C.06] MASKED TACHYCARDIA PREDICTS ADVERSE OUTCOME IN HYPERTENSION. THE ABP-INTERNATIONAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e61.
    PubMed     Text format     Abstract available


  168. CLEMENTI A, Buiatti M, Mussinelli R, Salinaro F, et al
    [OP.5C.03] HIGHER PREVALENCE OF HYPERTENSION IN MIGRANTS IN ITALY: A SNAPSHOT OF THE 2012 AND 2013C WORLD KIDNEY DAY.
    J Hypertens. 2016;34 Suppl 2:e60-1.
    PubMed     Text format     Abstract available


  169. MORISCO C, Meccariello A, Buono F, Orefice G, et al
    [OP.5C.02] MICROALBUMINURIA PREDICTS THE RECURRENCE OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e60.
    PubMed     Text format     Abstract available


  170. CREMER A, Boulestreau R, Gosse P
    [OP.1B.05] OVER-24H CENTRAL PULSE PRESSURE IS SUPERIOR TO PERIPHERAL PULSE PRESSURE FOR CARDIOVASCULAR EVENTS PREDICTION. RESULTS FROM THE BORDEAUX HYPERTENSIVE COHORT.
    J Hypertens. 2016;34 Suppl 2:e6.
    PubMed     Text format     Abstract available


  171. DI PILLA M, Bruno RM, Ghiadoni L, Stea F, et al
    [OP.5B.08] IMPACT OF SEASONALITY AND AIR POLLUTANTS ON CAROTID-FEMORAL PULSE WAVE VELOCITY IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e59.
    PubMed     Text format     Abstract available


  172. TERENTES-PRINTZIOS D, Vlachopoulos C, Vyssoulis G, Pietri P, et al
    [OP.5B.06] TOTAL ARTERIAL COMPLIANCE AND TARGET ORGAN DAMAGE IN HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 2:e58.
    PubMed     Text format     Abstract available


  173. GALLO A, Rosenbaum D, Mattina A, Koch E, et al
    [OP.5A.02] SHORT AND LONG-TERM EFFECTS OF ANTIHYPERTENSIVE TREATMENT ON HUMAN RETINAL ARTERIOLE REMODELING EVALUATED WITH ADAPTIVE OPTICS CAMERA.
    J Hypertens. 2016;34 Suppl 2:e54.
    PubMed     Text format     Abstract available


  174. MALLAMACI F, Tripepi R, Versace MC, Provenzano F, et al
    [OP.4D.08] DISORDERED SLEEP BREATHING (SDB) IS THE MAJOR DETERMINANT OF NON-DIPPING AND NOCTURNAL HYPERTENSION IN KIDNEY TRANSPLANT PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e53.
    PubMed     Text format     Abstract available


  175. RUAN C, Li Y, Ma Y, Kong LR, et al
    [OP.4D.02] ADIPONECTIN-MEDIATED EPITHILIAL AUTOPHAGY ATTENUATES HYPERTENSIVE RENAL FIBROSIS.
    J Hypertens. 2016;34 Suppl 2:e51.
    PubMed     Text format     Abstract available


  176. DEROSA G, Romano D, D'Angelo A, Maffioli P, et al
    [OP.4C.09] COMPARISON BETWEEN CANRENONE OR HYDROCHLOROTHIAZIDE IN ADDITION TO SARTANS IN HYPERTENSIVE DIABETIC PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e49.
    PubMed     Text format     Abstract available


  177. MAZZA A, Lenti S, Schiavon L, Ramazzina E, et al
    [OP.4C.08] ROLE OF THE FIXED-DOSE TRIPLE COMBINATION THERAPY IN THE MANAGEMENT OF UNCONTROLLED HYPERTENSION: FROM THE RANDOMIZED CLINICAL TRIALS TO CLINICAL PRACTICE.
    J Hypertens. 2016;34 Suppl 2:e49.
    PubMed     Text format     Abstract available


  178. KJELDSEN SE, Okin PM, Devereux RB
    [OP.4C.05] IMPACT OF ACHIEVED SYSTOLIC BLOOD PRESSURE ON RENAL FUNCTION IN HYPERTENSIVE PATIENTS: THE LIFE STUDY.
    J Hypertens. 2016;34 Suppl 2:e48.
    PubMed     Text format     Abstract available


  179. LOBO MD, Montarello J, Saxena M, Jain A, et al
    [OP.4C.04] SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH DRUG-RESISTANT HYPERTENSION: POOLED ANALYSES FROM THE ENLIGHTN 1, 2 AND 3 TRIALS.
    J Hypertens. 2016;34 Suppl 2:e48.
    PubMed     Text format     Abstract available


  180. OLIVERAS A, Armario P, Sans L, Clara A, et al
    [OP.4C.02] CHANGES IN SUBCLINICAL ORGAN DAMAGE IN PATIENTS WITH RESISTANT HYPERTENSION RANDOMIZED TO RECEIVE RENAL DENERVATION OR SPIRONOLACTONE AS ADD-ON THERAPY. THE DENERVHTA STUDY RESULTS.
    J Hypertens. 2016;34 Suppl 2:e47.
    PubMed     Text format     Abstract available


  181. SERAVALLE GL, Brambilla G, Dell'Oro R, Trevano FQ, et al
    [OP.4C.01] ANTIHYPERTENSIVE DRUG TREATMENT FAILS TO NORMALIZE SYMPATHETIC ACTIVITY: MICRONEUROGRAPHIC EVIDENCE AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 2:e47.
    PubMed     Text format     Abstract available


  182. SALVETTI M, Paini A, Rosei CA, Bertacchini F, et al
    [OP.4B.09] CARDIAC ORGAN DAMAGE IN HYPERTENSIVE PATIENTS ACCORDING TO ON-TREATMENT BLOOD PRESSURE VALUES.
    J Hypertens. 2016;34 Suppl 2:e46.
    PubMed     Text format     Abstract available


  183. BOMBELLI M, Seravalle G, Maloberti A, Macchiarulo M, et al
    [OP.4B.08] PROGNOSTIC RELEVANCE OF ELECTROCARDIOGRAPHIC TP-TE INTERVAL IN THE GENERAL AND IN THE HYPERTENSIVE POPULATION: DATA FROM THE PAMELA STUDY.
    J Hypertens. 2016;34 Suppl 2:e46.
    PubMed     Text format     Abstract available


  184. DIPLA K, Triantafyllou A, Koletsos N, Sachpekidis V, et al
    [OP.4B.07] EXAGGERATED BLOOD PRESSURE RESPONSE DURING HANDGRIP EXERCISE IN MASKED HYPERTENSIVE: CAN IT BE USED AS AN ADDITIONAL SCREENING TOOL?
    J Hypertens. 2016;34 Suppl 2:e45-6.
    PubMed     Text format     Abstract available


  185. TADIC M, Cuspidi C, Vukomanovic V, Kocijancic V, et al
    [OP.4B.06] THE IMPACT OF UPDATED LEFT VENTRICULAR GEOMETRY CLASSIFICATION ON RIGHT VENTRICULAR REMODELLING IN A HYPERTENSIVE POPULATION.
    J Hypertens. 2016;34 Suppl 2:e45.
    PubMed     Text format     Abstract available


  186. CATENA C, Colussi GL, Novello M, Nait F, et al
    [OP.4B.05] RELATIONSHIPS BETWEEN ALCOHOL INTAKE AND LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY.
    J Hypertens. 2016;34 Suppl 2:e45.
    PubMed     Text format     Abstract available


  187. MULE' G, Nardi E, Guarino L, Morreale M, et al
    [OP.4B.03] CIRCULATING ALDOSTERONE LEVELS ARE ASSOCIATED WITH CONCENTRIC LEFT VENTRICULAR GEOMETRY IN ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e44.
    PubMed     Text format     Abstract available


  188. BONNET B, Jourdan F, Cailar Gd, Fesler P, et al
    [OP.4B.02] NON INVASIVE EVALUATION OF END SYSTOLIC LEFT VENTRICULAR ELASTANCE ACCORDING TO PRESSURE-VOLUME CURVE MODELING DURING EJECTION IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e44.
    PubMed     Text format     Abstract available


  189. TADIC M, Cuspidi C, Vukomanovic V, Pencic B, et al
    [OP.4B.01] LEFT VENTRICULAR MECHANICS IN PATIENTS WITH MASKED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e44.
    PubMed     Text format     Abstract available


  190. DE LA SIERRA A, Pareja J, Armario P, Barrera A, et al
    [OP.4A.10] RENAL DENERVATION VERSUS SPIRONOLACTONE IN RESISTANT HYPERTENSION. EFFECTS ON CIRCADIAN PATTERNS AND BLOOD PRESSURE VARIABILITY.
    J Hypertens. 2016;34 Suppl 2:e43.
    PubMed     Text format     Abstract available


  191. SKULTETYOVA D, Filipova S
    [OP.4A.06] RELATIONSHIP BETWEEN CIRCADIAN PATTERNS OF BLOOD PRESSURE AND CAROTID ARTERY STIFFNESS AND WAVE INTENSITY IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e41-2.
    PubMed     Text format     Abstract available


  192. CHI C, Zhang Y, Yu S, Argyris A, et al
    [OP.4A.04] ASSOCIATION OF CARDIAC STRUCTURE AND FUNCTION WITH CENTRAL AND BRACHIAL BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS: THE SAFAR STUDY.
    J Hypertens. 2016;34 Suppl 2:e41.
    PubMed     Text format     Abstract available


  193. SALADINI F, Mos L, Fania C, Benetti E, et al
    [OP.4A.02] SHORT TERM BLOOD PRESSURE VARIABILTY AS PREDICTOR OF FUTURE EVENTS IN YOUNG STAGE I HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 2:e40.
    PubMed     Text format     Abstract available


  194. RAFAEL C, Khalek WA, Kouranti I, Clauser E, et al
    [OP.LB01.10] THE SKIPPING OF EXON 9 IN CULLIN-3 CAUSES A SEVERE FORM OF FAMILIAL HYPERKALEMIC HYPERTENSION IN MICE.
    J Hypertens. 2016;34 Suppl 2:e38-9.
    PubMed     Text format     Abstract available


  195. POULTER NR, Anjum A, Cross M, Falaschetti E, et al
    [OP.LB01.07] A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR AMBULATORY BLOOD PRESSURE MONITORING (ABPM) LEVELS: A RANDOMISED CROSS-OVER TRIAL.
    J Hypertens. 2016;34 Suppl 2:e37-8.
    PubMed     Text format     Abstract available


  196. MALEK F, Vondrakova D, Dvorak J, Sedlackova L, et al
    [OP.3D.07] CORRELATION OF CERULOPLASMIN WITH BIOMARKERS OF CARDIAC REMODELLING AND MYOFIBROSIS: NT-PROBNP, SST2, GALECTIN-3 IN PATIENTS WITH CHRONIC HEART FAILURE AND ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e34-5.
    PubMed     Text format     Abstract available


  197. CANIFFI C, Gomez M, Alcober L, Prentky E, et al
    [OP.3D.05] HYPERTENSION AND VASCULAR INJURY: CHRONIC TREATMENT WITH C-TYPE NATRIURETIC PEPTIDE SHOWS BENEFICIAL EFFECTS ON THE LEVEL OF OXIDATIVE STRESS AND PRO-INFLAMMATORY CYTOKINES.
    J Hypertens. 2016;34 Suppl 2:e34.
    PubMed     Text format     Abstract available


  198. KASZUBA A, Konior A, Mikolajczyk T, Prejbisz A, et al
    [OP.3D.04] ACTIVATED CD4+ AND CD8+ T-CELL SUBPOPULATIONS IN PATIENTS WITH PRIMARY HYPERALDOSTERONISM AND TRUE RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e33-4.
    PubMed     Text format     Abstract available


  199. NOSALSKI R, Siedlinski M, Cat AN, Skiba D, et al
    [OP.3D.02] MICRORNA-214 IS INVOLVED IN THE REGULATION OF PERIVASCULAR FIBROSIS IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e33.
    PubMed     Text format     Abstract available


  200. MUELA HC, Costa-Hong V, Machado MF, Yassuda MS, et al
    [OP.3C.03] ARTERIAL STIFFNESS IS ASSOCIATED WITH LOWER PERFORMANCE ON THE COGNITIVE TESTS AT DIFFERENT DOMAINS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e31.
    PubMed     Text format     Abstract available


  201. FOULQUIER S, Namsolleck P, Recarti C, Van Hagen BT, et al
    [OP.3C.01] MICROGLIAL ACTIVATION IN HYPERTENSION-MEDIATED COGNITIVE IMPAIRMENT.
    J Hypertens. 2016;34 Suppl 2:e31.
    PubMed     Text format     Abstract available


  202. JARDIM T, Jardim L, Sousa A, Barroso W, et al
    [OP.3B.07] MULTIDISCIPLINARY TREATMENT FOR THE VERY ELDERLY HYPERTENSIVE PATIENT.
    J Hypertens. 2016;34 Suppl 2:e30.
    PubMed     Text format     Abstract available


  203. SILVA AP, Matos A, Ribeiro R, Gil A, et al
    [OP.3B.06] WILL BE CENTENARIANS, HYPERTENSIVE INDIVIDUALS? HOW IS THE BLOOD PRESSURE CONTROL OF CENTENARIANS IN PORTUGAL?
    J Hypertens. 2016;34 Suppl 2:e30.
    PubMed     Text format     Abstract available


  204. ANDREEVA G, Gorbunov V, Beloliperskaya V, Kukushkin S, et al
    [OP.1A.09] THE RELATIONSHIP BETWEEN THE AGGRESSION LEVEL OF PATIENTS WITH ARTERIAL HYPERTENSION AND THE ANTIHYPERTENSIVE DRUG EFFECTIVENESS.
    J Hypertens. 2016;34 Suppl 2:e3.
    PubMed     Text format     Abstract available


  205. GAZZOLA K, Cammenga M, Van Der Hoeven N, Van Montfrans G, et al
    [OP.1A.07] INCREMENTAL DIFFERENCES BETWEEN HOME AND AMBULATORY BLOOD PRESSURE AND THEIR RELATION TO ANXIETY AND HYPERTENSIVE ORGAN DAMAGE: EVIDENCE FOR AN 'AUTO-CUFF' RESPONSE?
    J Hypertens. 2016;34 Suppl 2:e3.
    PubMed     Text format     Abstract available


  206. ZHAO X, Yu J
    [OP.3A.07] DROSPIRENONE WITH ESTRADIOL FOR POSTMENOPAUSAL WOMEN WITH HYPERTENSION: A SYSTEMIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 2:e28.
    PubMed     Text format     Abstract available


  207. JEKELL A, Kalani M, Kahan T
    [OP.2D.07] THE EFFECTS OF ALPHA 1-ADRENOCEPTOR-BLOCKADE BY DOXAZOSIN OR ACE-INHIBITION BY RAMIPRIL ON ENDOTHELIAL FUNCTION IN PRIMARY HYPERTENSION: THE DORA STUDY.
    J Hypertens. 2016;34 Suppl 2:e25.
    PubMed     Text format     Abstract available


  208. TRIANTAFYLLIDI H, Benas D, Vlachos S, Schoinas A, et al
    [OP.2D.06] DIFFERENCES IN ENDOTHELIAL GLYCOCALYX IN RECENTLY DIAGNOSED AND UNTREATED MIDDLE-AGED HYPERTENSIVE PATIENTS REGARDING INCREASED CARDIOVASCULAR RISK.
    J Hypertens. 2016;34 Suppl 2:e25.
    PubMed     Text format     Abstract available


  209. COTTONE S, Nardi E, Guarneri M, Guarino L, et al
    [OP.2D.05] RELATIONSHIP OF OXIDATIVE STRESS WITH CARDIAC HYPERTROPHY IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e25.
    PubMed     Text format     Abstract available


  210. IONIN V, Zaslavskaya EL, Belyaeva OD, Soboleva AV, et al
    [OP.2C.06] NEW RISK FACTORS FOR ATRIAL FIBRILLATION IN PATIENTS WITH HYPERTENSION AND OBESITY.
    J Hypertens. 2016;34 Suppl 2:e23.
    PubMed     Text format     Abstract available


  211. VARGA A, Tatar CM, Mitre A, Podoleanu C, et al
    [OP.2C: 05] ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS. A SINGLE PILOT ANTICOAGULATION RISK MANAGEMENT CENTER.
    J Hypertens. 2016;34 Suppl 2:e23.
    PubMed     Text format     Abstract available


  212. WANG Q, Chang P, Xu H, Bai F, et al
    [OP.2C.01] TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION THROUGH THE PI3K/P-AKT PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 2:e22.
    PubMed     Text format     Abstract available


  213. CHI C, Yu S, Bai B, Wang K, et al
    [OP.1A.06] HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 2:e2.
    PubMed     Text format     Abstract available


  214. VRDOLJAK A, Ivkovic V, Karanovic S, Dika Z, et al
    [OP.2B.03] GLOMERULAR HYPERFILTRATION AS A RISK FACTOR FOR RENAL IMPAIRMENT AND HYPERTENSION IN APPARENTLY HEALTHY SUBJECTS.
    J Hypertens. 2016;34 Suppl 2:e19.
    PubMed     Text format     Abstract available


  215. MARKETOU M, Parthenakis F, Kontaraki J, Maragoudakis F, et al
    [OP.2B.02] COMPARATIVE MICRORNA PROFILING IN RELATION TO URINARY ALBUMIN EXCRETION IN NEWLY DIAGNOSED HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e19.
    PubMed     Text format     Abstract available


  216. THOMAS-JEAN F, Pannier B, Hanon O, Czernichow S, et al
    [OP.2A.09] SYSTOLIC BLOOD PRESSURE VARIATION DURING 6 YEARS AND MORTALITY: THE AGE AMPLIFIES THE IMPACT OF A SPONTANEOUS INCREASE OR REDUCTION OF PRESSURE AMONG HYPERTENSIVE: IPC COHORT.
    J Hypertens. 2016;34 Suppl 2:e18.
    PubMed     Text format     Abstract available


  217. STERGIOU GS, Margetaki A, Boubouchairopoulou N, Mastrokostas A, et al
    [OP.2A.08] HYPERTENSION AND CARDIOVASCULAR DISEASE IN GREECE: INTERIM ANALYSIS OF THE EMENO NATIONAL EPIDEMIOLOGICAL STUDY.
    J Hypertens. 2016;34 Suppl 2:e17-8.
    PubMed     Text format     Abstract available


  218. DEBORDE T, Amar L, Bobrie G, Burgun A, et al
    [OP.2A.07] TRENDS IN PATIENTS ATTENDING A TERTIARY HYPERTENSION UNIT: PATIENTS' CHARACTERISTICS AND TREATMENT STRATEGIES STRONGLY EVOLVED OVER THE LAST 15 YEARS.
    J Hypertens. 2016;34 Suppl 2:e17.
    PubMed     Text format     Abstract available


  219. WALLENTIN F, Wettermark B, Kahan T
    [OP.2A.06] CURRENT DRUG TREATMENT OF HYPERTENSION IN SWEDEN IN RELATION TO GENDER, AGE, AND COMORBIDITY.
    J Hypertens. 2016;34 Suppl 2:e17.
    PubMed     Text format     Abstract available


  220. JUMAR A, Ott C, Kistner I, Friedrich S, et al
    [OP.1D.07] EARLY SIGNS OF END-ORGAN DAMAGE IN RETINAL ARTERIOLES IN TYPE 2 DIABETIC IN COMPARISON WITH HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e13.
    PubMed     Text format     Abstract available


  221. KARPANOU E, Vyssoulis G, Demerouti E, Grassos H, et al
    [OP.1D.06] SALT CONSUMPTION AND GLUCOSE METABOLISM IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e13.
    PubMed     Text format     Abstract available


  222. POLONIA J, Ferreira C, Castro P, Penas S, et al
    [OP.1D.03] NIGHTTIME BLOOD PRESSURE IS THE MAJOR DETERMINANT FACTOR OF BOTH MACROVASCULAR AND MICROVASCULAR LESIONS IN A COOHORT OF TYPE 2 DIABETIC AND NON-DIABETIC HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e12.
    PubMed     Text format     Abstract available


  223. NIBOUCHE N, Lanasri N, Chibane A, Zeraoulia F, et al
    [OP.1D.02] ORTHOSTATIC HYPERTENSION IN NORMOTENSIVE PATIENTS PREDICTS PERMANENT ARTERIAL HYPERTENSION IN TYPE 2 DIABETES MELLITUS.
    J Hypertens. 2016;34 Suppl 2:e12.
    PubMed     Text format     Abstract available


  224. WIJKMAN M, Lanne T, Ostgren CJ, Nystrom FH, et al
    [OP.1D.01] DIASTOLIC ORTHOSTATIC HYPERTENSION PREDICTS A FAVORABLE CARDIOVASCULAR PROGNOSIS IN TYPE 2 DIABETES.
    J Hypertens. 2016;34 Suppl 2:e12.
    PubMed     Text format     Abstract available


  225. TSIOUFIS C, Kasiakogias A, Dimitriadis K, Kalos T, et al
    [OP.LB03.07] EFFECTS OF LERCANIDIPINE/ENALAPRIL COMPARED WITH AMLODIPINE/ENALAPRIL AND HYDROCHLOROTHIAZIDE/ENALAPRIL ON TARGET ORGAN DAMAGE AND SYMPATHETIC ACTIVITY IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e113.
    PubMed     Text format     Abstract available


  226. AGNOLETTI D, Lieber A, Valbusa F, Arcaro G, et al
    [OP.LB03.03] THE RELATIONSHIP BETWEEN DIASTOLIC FUNCTION AND CENTRAL HEMODYNAMICS IN DIABETIC HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e111-2.
    PubMed     Text format     Abstract available


  227. BOUTOUYRIE P, Elmula F, Rebora P, Talvik A, et al
    [OP.LB03.02] NON-INVASIVE HEMODYNAMIC MONITORING IN UNCONTROLLED HYPERTENSIVE PATIENTS: EFFECT ON ARTERIAL STIFFNESS AND CENTRAL BLOOD PRESSURE: THE BEAUTY STUDY.
    J Hypertens. 2016;34 Suppl 2:e111.
    PubMed     Text format     Abstract available


  228. BURNIER M, Chappuis A, Glatz N, Bochud M, et al
    [OP.8E.08] REGIONAL VARIATIONS IN THE ASSOCIATIONS OF DIETARY PATTERNS WITH BLOOD PRESSURE AND HYPERTENSION IN SWITZERLAND.
    J Hypertens. 2016;34 Suppl 2:e110.
    PubMed     Text format     Abstract available


  229. LESIUK C, Courand PY, Milon H, Defforges-Ranc A, et al
    [OP.8E.06] A SUFFICIENT PROTEIN INTAKE SHOULD BE ENCOURAGED IN HYPERTENSIVE PATIENTS WITHOUT CHRONIC KIDNEY DISEASE: A LONG-TERM OUTCOMES STUDY.
    J Hypertens. 2016;34 Suppl 2:e109.
    PubMed     Text format     Abstract available


  230. MUIESAN ML, Riviera M, Pintossi C, Bertacchini F, et al
    [OP.8D.06] OCULAR FUNDUS PHOTOGRAPHY WITH A SMARTPHONE DEVICE IN ACUTE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e106-7.
    PubMed     Text format     Abstract available


  231. XU T, Sun JP, Lee AP, Yang Y, et al
    [OP.8D.05] LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e106.
    PubMed     Text format     Abstract available


  232. MARAIS L, Pernot M, Khettab H, Tanter M, et al
    [OP.8D.03] MEASUREMENT OF ARTERIAL STIFFNESS BY ULTRAFAST ECHO: COMPARISON WITH ECHOTRACKING IN NORMOTENSIVE SUBJECTS AND HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e105-6.
    PubMed     Text format     Abstract available


  233. MARC Y, Hmazzou R, Flahault A, Llorens-Cortes C, et al
    [OP.8C.06] CENTRAL ANTIHYPERTENSIVE EFFECTS OF CHRONIC TREATMENT WITH RB150/QGC001, AN ORALLY ACTIVE AMINOPEPTIDASE A INHIBITOR PRODRUG IN DOCA-SALT HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 2:e103.
    PubMed     Text format     Abstract available


  234. KONG L, Ruan C, Ma Y, Gao P, et al
    [OP.8C.05] A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIORENAL CONSEQUENCE.
    J Hypertens. 2016;34 Suppl 2:e103.
    PubMed     Text format     Abstract available


  235. ASHLEY Z, Leader C, Sammut I, McDonald F, et al
    [OP.8C.04] THE FLOW DETECTION ROLE OF THE VASCULAR EPITHELIAL SODIUM CHANNEL (ENAC) IN AN EXPERIMENTAL MODEL OF HYPERTENSION: THE NOVEL TARGET FOR SPIRONOLACTONE THERAPY?
    J Hypertens. 2016;34 Suppl 2:e103.
    PubMed     Text format     Abstract available


  236. GRABOWSKI K, Herlan L, Eisenreich A, Schulz A, et al
    [OP.8C.01] A NOVEL CANDIDATE GENE IDENTIFIED IN STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS HAS A MAJOR IMPACT ON ADVERSE LEFT VENTRICULAR REMODELING IN SALT-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e102.
    PubMed     Text format     Abstract available


  237. NOWAK MM, Komand A, Ostrowka D, Jancewicz M, et al
    [OP.8B.07] UTILITY OF SLEEP-POLYGRAPHIC STUDIES IN TERTIARY-CARE HYPERTENSION OUT-PATIENT CLINIC.
    J Hypertens. 2016;34 Suppl 2:e101.
    PubMed     Text format     Abstract available


  238. BUGAEV T, Ageeva NV, Dobrovolskiy AB, Litvin AY, et al
    [OP.8B.05] COAGULATION SYSTEM ACTIVITY IN PATIENTS WITH OBSTRUCTIVE SLEEP APNOEA SYNDROME AND ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 2:e101.
    PubMed     Text format     Abstract available


  239. BRUNO R, Ghiadoni L, Cervia S, Biancheri R, et al
    [OP.8B.04] GENDER DIFFERENCES IN THE IMPACT OF DYSFUNCTIONAL COPING IN A HYPERTENSIVE POPULATION.
    J Hypertens. 2016;34 Suppl 2:e101.
    PubMed     Text format     Abstract available


  240. LOMBARDI C, Parati G, Soranna D, Zambon A, et al
    [OP.8B.01] PERIODIC LIMB MOVEMENT DURING SLEEP, SLEEP RELATED BREATHING DISORDERS AND HYPERTENSION IN THE ESADA COHORT.
    J Hypertens. 2016;34 Suppl 2:e100.
    PubMed     Text format     Abstract available


  241. YANNOUTSOS A, Ahouah M, Dreyfuss Tubiana C, Topouchian J, et al
    [OP.1C.08] HEMODYNAMIC PARAMETERS IN HYPERTENSIVE DIABETIC PATIENTS.
    J Hypertens. 2016;34 Suppl 2:e10.
    PubMed     Text format     Abstract available


  242. RAYNER B
    SSA 05-4 DIFFERENCES IN MANAGEMENT OF HYPERTENSION BETWEEN ETHNIC GROUPS.
    J Hypertens. 2016;34 Suppl 1:e9.
    PubMed     Text format     Abstract available


  243. SCHUTTE A
    SSA 05-3 THE PROGRESSION OF HYPERTENSION IN AFRICA.
    J Hypertens. 2016;34 Suppl 1:e9.
    PubMed     Text format     Abstract available


  244. KADIRI S
    SSA 05-2 HYPERTENSION AND KIDNEY COMPLICATION IN AFRICA.
    J Hypertens. 2016;34 Suppl 1:e9.
    PubMed     Text format     Abstract available


  245. DAMASCENO A
    SSA 05-1 HYPERTENSION, STEADY BUT CONTINUING CHANGES IN DEVELOPING COUNTRIES.
    J Hypertens. 2016;34 Suppl 1:e9.
    PubMed     Text format     Abstract available


  246. WANG W, Ma L, Sui H, Liu L, et al
    OS 12-05 THE EFFECT OF INTENSIVE LIFESTYLE INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION, SUB-ANALYSIS FROM CHIEF.
    J Hypertens. 2016;34 Suppl 1:e77.
    PubMed     Text format     Abstract available


  247. KARIO K, Hoshide S
    OS 12-01 ARB AND CCB LONGEST COMBINATION TREATMENT ON AMBULATORY AND HOME BP IN HYPERTENSION WITH ATRIAL FIBRILLATION - MULTICENTER STUDY ON TIME OF DOSING (ACROBAT).
    J Hypertens. 2016;34 Suppl 1:e76.
    PubMed     Text format     Abstract available


  248. SOKOLOVIC S, Mehmedagic S
    OS 11-06 The effect of vagus nerve stimulation on arterial hypertension using active implantable device.
    J Hypertens. 2016;34 Suppl 1:e75.
    PubMed     Text format     Abstract available


  249. WALAS D, Von Roloff E, Paton J
    OS 11-05 Superior cervical ganglionectomy (SCGx) reduces sympathetic innervation of vertebrobasilar arteries but does not affect cerebrovascular remodelling in the adult spontaneously hypertensive rat (SHR).
    J Hypertens. 2016;34 Suppl 1:e75.
    PubMed     Text format     Abstract available


  250. NISHIYAMA A, Hitomi H, Nakano D, Fujisawa Y, et al
    OS 11-03 Role of renal nervous activity in the development of renovascular hypertension in rats.
    J Hypertens. 2016;34 Suppl 1:e74-5.
    PubMed     Text format     Abstract available


  251. KIM MN, Kim YB, Park SM, Kim YI, et al
    OS 11-02 Effect of estrogen on the change of GABA function in the vasopressin neurons of salt-dependent hypertension model rats.
    J Hypertens. 2016;34 Suppl 1:e74.
    PubMed     Text format     Abstract available


  252. WAINFORD R, Carmichael C, Walsh K
    OS 11-01 Afferent renal nerve modulation of sodium homeostasis and blood pressure: A sodium sensitive PVN Galphai2 protein dependent mechanism countering the development of salt-sensitive hypertension?
    J Hypertens. 2016;34 Suppl 1:e74.
    PubMed     Text format     Abstract available


  253. PAULETTO P, Puato M, Rattazzi M, Buso R, et al
    OS 10-06 THE IMPACT OF WELL CONTROLLED BLOOD PRESSURE LEVELS ON ARTERIAL PROPERTIES IN ESSENTIAL HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1:e73.
    PubMed     Text format     Abstract available


  254. LIU Z, Zhao Y, Dong Y, Lu B, et al
    OS 10-02 EFFECTS OF HELICOBACTER PYLORI INFECTION ON ATHEROSCLEROSIS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS IN AGED POPULATION.
    J Hypertens. 2016;34 Suppl 1:e72.
    PubMed     Text format     Abstract available


  255. BURSZTYN M, Ben-Dov IZ
    OS 09-03 EXTREME DIPPING IS NOT ASSOCIATED WITH INCREASED MORTALITY IN BOTH TREATED AND UNTREATED HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1:e70.
    PubMed     Text format     Abstract available


  256. GUO QH, Kang YY, Song J, Chen Q, et al
    OS 09-02 PREVALENCE AND DETERMINANTS OF EXAGGERATED MORNING SURGE AND MORNING HYPERTENSION IN CHINESE: THE CHINA AMBULATORY AND HOME BLOOD PRESSURE REGISTRY (ABPR).
    J Hypertens. 2016;34 Suppl 1:e70.
    PubMed     Text format     Abstract available


  257. FAN H, Yan Y, Dong H, Mi J, et al
    OS 09-01 PREVALENCE OF HYPERTENSION AFTER THREE SEPARATE OCCASIONS AMONG CHINESE CHILDREN: A NATIONAL REPRESENTATIVE CROSS-SECTION SURVEY.
    J Hypertens. 2016;34 Suppl 1:e70.
    PubMed     Text format     Abstract available


  258. QUINTANA FS
    SSA 04-4 CURRENT STATUS IN MANAGEMENT OF HYPERTENSION IN LATIN AMERICA.
    J Hypertens. 2016;34 Suppl 1:e7-8.
    PubMed     Text format     Abstract available


  259. HUANG F, Huang Q, Lin F, Zhu P, et al
    OS 08-02 APELIN AND APLN SINGLE NUCLEOTIDE POLYMORPHISMS AND COMBINED HYPERTENSION AND CENTRAL RETINAL ARTERY STENOSIS IN A CHINESE POPULATION.
    J Hypertens. 2016;34 Suppl 1:e68.
    PubMed     Text format     Abstract available


  260. RAZA ST, Abbas S, Mahdi F
    OS 08-01 ASSOCIATION OF ACE, FABP2, PPARG2, GST, FTO AND CYP46A1 GENES POLYMORPHISM WITH ESSENTIAL HYPERTENSION AMONG NORTH INDIAN POPULATION.
    J Hypertens. 2016;34 Suppl 1:e68.
    PubMed     Text format     Abstract available


  261. YI JE, Pyun WB, Lee Y, Park J, et al
    OS 07-05 DETERMINANTS OF MORNING BLOOD PRESSURE SURGE IN NORMOTENSIVE SUBJECTS AND UNTREATED HYPERTENSIVE PATIENTS: THE KOREAN AMBULATORY BLOOD PRESSURE MULTICENTER OBSERVATIONAL STUDY.
    J Hypertens. 2016;34 Suppl 1:e66.
    PubMed     Text format     Abstract available


  262. MA R, Wang Q, Li N, Zhao Y, et al
    OS 07-04 HOME BLOOD PRESSURE MONITORING IMPROVED SAFETY IN PATIENTS WITH SEVERE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e66.
    PubMed     Text format     Abstract available


  263. KARIO K, Bhatt D, Brar S, Bakris G, et al
    OS 07-02 DIFFERENCES IN CIRCADIAN BLOOD PRESSURE VARIABILITY PATTERNS BETWEEN JAPANESE AND AMERICAN TREATMENT-RESISTANT HYPERTENSIVE POPULATIONS.
    J Hypertens. 2016;34 Suppl 1:e65.
    PubMed     Text format     Abstract available


  264. ZHANG DY, Cheng YB, Guo QH, Xu TY, et al
    OS 07-01 SUBTYPES OF MASKED HYPERTENSION AND THEIR ASSOCIATIONS WITH TARGET ORGAN DAMAGE IN UNTREATED CHINESE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e65.
    PubMed     Text format     Abstract available


  265. VAN BALLEGOOIJEN A, Van Schoor N, Brouwer I, Visser M, et al
    OS 06-09 THE SYNERGISTIC ASSOCIATION BETWEEN VITAMIN D AND VITAMIN K WITH INCIDENT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e64.
    PubMed     Text format     Abstract available


  266. BURSZTYN M, Hammerman-Rozenberg A, Jacobs J, Stessman J, et al
    OS 06-06 PREVALENCE AND CONSEQUENCE OF ORTHOSTATIC HYPERTENSION IN COMMUNITY DWELLING 85, AND 90 YEAR OLDS.
    J Hypertens. 2016;34 Suppl 1:e63.
    PubMed     Text format     Abstract available


  267. MORE A, Kadam R, Mohite K, Mittal C, et al
    OS 06-05 HEALTHCARE STRUCTURE IN RURAL INDIA AND ITS IMPLICATIONS ON DIAGNOSIS AND MANAGEMENT OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e63.
    PubMed     Text format     Abstract available


  268. LIU L, Dow J, Simon B, Eisen H, et al
    OS 06-02 MULTIPLE ANTIHYPERTENSIVE MEDICATION USE, RESISTANT HYPERTENSION AND OUTCOMES IN THE UNITED STATES: FINDINGS FROM NHANES 1988 TO 2012.
    J Hypertens. 2016;34 Suppl 1:e62.
    PubMed     Text format     Abstract available


  269. MAMUN A
    OS 06-01 DEVELOPMENTAL STAGES OF HYPERTENSION BETWEEN MALES AND FEMALES- ARE THERE DIFFERENT MECHANISMS?
    J Hypertens. 2016;34 Suppl 1:e62.
    PubMed     Text format     Abstract available


  270. KIM S, Wang G, Lobaton G, Li E, et al
    OS 05-10 THE MICROBIAL METABOLITE, BUTYRATE ATTENUATES ANGIOTENSIN II-INDUCED HYPERTENSION AND DYSBIOSIS.
    J Hypertens. 2016;34 Suppl 1:e60-1.
    PubMed     Text format     Abstract available


  271. MAYOROV D, Kasparov S, Paton J
    OS 05-09 REDUCED VASODILATOR EFFICIENCY OF ADENOSINE IN THE BRAINSTEM OF YOUNG SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e60.
    PubMed     Text format     Abstract available


  272. NEZU M, Souma T, Yu L, Sekine H, et al
    OS 05-05 Nrf2 DEFICIENCY ALLEVIATES PERINATAL COMPLICATIONS IN PREGNANCY-ASSOCIATED HYPERTENSION MICE VIA ENHANCING PLACENTAL ANGIOGENESIS.
    J Hypertens. 2016;34 Suppl 1:e59.
    PubMed     Text format     Abstract available


  273. ABASSI Z, Leor J, Landa N, Younis F, et al
    OS 05-04 EMPAGLIFLOZIN EXERTS CARDIO- AND NEPHRO-PROTECTIVE EFFECTS IN COHEN-ROSENTHAL DIABETIC HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e58-9.
    PubMed     Text format     Abstract available


  274. ZICHA J, Behuliak M, Vaneckova I
    OS 05-03 DECREASED RHO-KINASE-BASED CALCIUM SENSITIZATION IN HYPERTENSIVE REN-2 TRANSGENIC RATS (TGR).
    J Hypertens. 2016;34 Suppl 1:e58.
    PubMed     Text format     Abstract available


  275. ZHU W, Li J, Sun X, Hua Q, et al
    OS 05-02 ASSOCIATION OF G-PROTEIN BETA3 SUBUNIT GENE C825T POLYMORPHISM WITH CARDIAC AND CEREBROVASCULAR EVENTS IN CHINESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e58.
    PubMed     Text format     Abstract available


  276. KOKKINOS P, Puneet N, Apostolos T, Michael D, et al
    OS 04-09 CARDIORESPIRATORY FITNESS AND RISK FOR DEVELOPING HEART FAILURE IN HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1:e57.
    PubMed     Text format     Abstract available


  277. SINNOTT SJ, Root A, Mathur R, Mansfield K, et al
    OS 04-07 THE COMPARATIVE EFFECTIVENESS OF 4TH LINE ANTI-HYPERTENSIVE AGENTS IN PATIENTS WITH RESISTANT HYPERTENSION: A META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 1:e56-7.
    PubMed     Text format     Abstract available


  278. MEENA J, Raghav P, Rustagi N
    LBOS 03-06 ANTI HYPERTENSIVE TREATMENT COMPLIANCE AND ADVERSE EFFECT PROFILE AMONG HYPERTENSION CLINIC ATTENDEES IN JODHPUR, INDIA.
    J Hypertens. 2016;34 Suppl 1:e552.
    PubMed     Text format     Abstract available


  279. KOHLI C, Gupta K
    LBOS 03-03 ECONOMIC IMPACT OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e551-2.
    PubMed     Text format     Abstract available


  280. KARAMAT F, Diemer F, Baldew S, Oehlers G, et al
    LBOS 03-02 PREHYPERTENSION AND HYPERTENSION IN URBAN SURINAME: THE HELISUR STUDY.
    J Hypertens. 2016;34 Suppl 1:e551.
    PubMed     Text format     Abstract available


  281. YUSUFALI A, Khatib R, Islam S, AlHabib K, et al
    LBOS 03-01 PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE MIDDLE EAST: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY.
    J Hypertens. 2016;34 Suppl 1:e551.
    PubMed     Text format     Abstract available


  282. DEY SK, Prabhakar P, Saini M, Joseph T, et al
    LBOS 02-05 INHIBITORS OF DOPAMINE-beta-HYDROXYLASE OBTAINED BY STRUCTURE BASED METHODS EXHIBITED ANTI-HYPERTENSIVE EFFECT IN L-NAME INDUCED HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e550.
    PubMed     Text format     Abstract available


  283. CRIPPA G, Zabzuni D, Bravi E, Rossi F, et al
    OS 04-04 ANTIHYPERTENSIVE EFFECT OF MILK-DERIVATIVE TRIPEPTIDES. RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON THE EFFECTS OF GRANA PADANO CHEESE DOP IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e55-6.
    PubMed     Text format     Abstract available


  284. LIU D
    LBOS 02-02 TELMISARTAN REDUCING MONOCYTE MITOCHONDRIA RESPIRATORY FUNCTION IS ASSOCIATED WITH INHIBITION OF TRANSIENT RECEPTOR POTENTIAL CHANNEL CANONICAL TYPE 3 CHANNELS IN HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e549.
    PubMed     Text format     Abstract available


  285. TAO J
    LBOS 02-01 HYPERTENSION, ALDOSTERONE AND EPC-MEDIATED ENDOTHALIAL INJURY REPAIR.
    J Hypertens. 2016;34 Suppl 1:e549.
    PubMed     Text format     Abstract available


  286. VILLEVALDE S, Kobalava Z
    LBOS 01-06 INTEGRATED APPROACH IMPROVED BLOOD PRESSURE CONTROL IN NON ADHERENT MOTIVATED HYPERTENSIVE PATIENTS: PRISMA STUDY.
    J Hypertens. 2016;34 Suppl 1:e548.
    PubMed     Text format     Abstract available


  287. CHO EJ, Lee HY, Sung KC, Park S, et al
    LBOS 01-05 24-HOUR CENTRAL BLOOD PRESSURE REDUCTION EFFICACY OF CALCIUM CHANNEL BLOCKER COMBINATION IS SUPERIOR TO DIURETICS COMBINATION WITH ANGIOTENSIN II RECEPTOR BLOCKER ESPECIALLY IN MALE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e548.
    PubMed     Text format     Abstract available


  288. SEVER P, Gupta A, Thompson D, Whitehouse A, et al
    LBOS 01-04 THE TRUE INCIDENCE OF STATIN -RELATED ADVERSE EVENTS IN HYPERTENSIVE PATIENTS REVEALED BY COMPARISON OF BLINDED AND UN-BLINDED USE OF STATIN IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT).
    J Hypertens. 2016;34 Suppl 1:e547-8.
    PubMed     Text format     Abstract available


  289. VILLEVALDE S, Kovbalava Z
    LBOS 01-03 MICROALBUMINURIA IS THE MOST INTEGRATED SIGN OF SUBCLINICAL ORGAN DAMAGE IN UNCOMPLICATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e547.
    PubMed     Text format     Abstract available


  290. MARCUS Y, Haran A, Shefer G, Stern N, et al
    LBOS 01-02 CLUSTERING OF SILENT HYPOTENSIVE EPISODES IN THE MORNING/LATE-MORNING HOURS IN SUBJECTS TREATED FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e547.
    PubMed     Text format     Abstract available


  291. POULTER N, Anjum A, Cross M, Falaschetti E, et al
    LBOS 01-01A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR ABPM LEVELS: A RANDOMISED CROSS-OVER TRIAL (HARMONY).
    J Hypertens. 2016;34 Suppl 1:e547.
    PubMed     Text format     Abstract available


  292. MUTHUSAMY VV
    BR 08-3 MANAGEMENT OF DYSLIPIDEMIA IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e545.
    PubMed     Text format     Abstract available


  293. PARK J
    BR 08-2 CARDIOVASCULAR RISK ASSESSMENT IN HYPERTENSIVES WITH CKD.
    J Hypertens. 2016;34 Suppl 1:e544-5.
    PubMed     Text format     Abstract available


  294. ZHU Z
    BR 08-1 HIGH SODIUM INTAKE REDUCTION IN DIABETES WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e544.
    PubMed     Text format     Abstract available


  295. PARK JB
    ME 04-2 AORTIC PWV FOR RISK STRATIFICATION IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e541.
    PubMed     Text format     Abstract available


  296. ZHANG P, Sun N, Wang H, Sun L, et al
    OS 03-08 EFFICACY OF TELMISARTAN 40 MG (T40) AND HYDROCHLOROTHIAZIDE 25 MG (H25) MONOTHERAPY IN HIGH SODIUM INTAKE PATIENTS WITH MILD TO MODERATE HYPERTENSION (THAT STUDY): A MULTICENTER RANDOMIZED DOUBLE-BLINDED PARALLEL CONTROLLED TRIAL.
    J Hypertens. 2016;34 Suppl 1:e54.
    PubMed     Text format     Abstract available


  297. KIM SH
    HW 03-2 EFFECT OF CPAP ON THE TREATMENT OF RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e538.
    PubMed     Text format     Abstract available


  298. KIM BK
    HW 03-1 RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION UNDER OPTIMAL DRUG THERAPY.
    J Hypertens. 2016;34 Suppl 1:e538.
    PubMed     Text format     Abstract available


  299. RAIZADA M
    SY 17-4 NEURO-IMMUNE COMMUNICATION IN HYPERTENSION: A NEW THERAPEUTIC ANGLE?
    J Hypertens. 2016;34 Suppl 1:e535.
    PubMed     Text format     Abstract available


  300. HARRISON D
    SY 17-2 INFLAMMATION, IMMUNITY AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e535.
    PubMed     Text format     Abstract available


  301. VAN BALLEGOOIJEN A
    SY 16-4 VITAMIN D WITH OR WITHOUT CALCIUM SUPPLEMENTATION IN RELATION TO HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e534.
    PubMed     Text format     Abstract available


  302. TURANA Y
    SSA 03-4 THE BRAIN SCREENING IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e5.
    PubMed     Text format     Abstract available


  303. OH VM
    SSA 03-3 DIETARY SALT INTAKE AND HYPERTENSION IN SINGAPORE.
    J Hypertens. 2016;34 Suppl 1:e5.
    PubMed     Text format     Abstract available


  304. WANG Q, Euy-Myoung J, Liu H, Gu L, et al
    OS 02-04 ASTRAGALOSIDE IV IMPROVES LEFT VENTRICULAR DIASTOLIC DYSFUNCTION IN HYPERTENSIVE MICE BY INCREASING THE PHOSPHORYLATION OF ENDOTHELIAL NITRIC OXIDE SYNTHASE.
    J Hypertens. 2016;34 Suppl 1:e48-9.
    PubMed     Text format     Abstract available


  305. HARVEY AP, Montezano A, Wong KC, Hood KY, et al
    OS 02-01 ROLE OF ALDOSTERONE AND NADPH OXIDASE 1 IN HYPERTENSION-ASSOCIATED VASCULAR AGING.
    J Hypertens. 2016;34 Suppl 1:e48.
    PubMed     Text format     Abstract available


  306. PARK SH, Park CG, Na JO, Choi CU, et al
    OS 01-08 IMPACT OF HYPERTENSION TREATMENT ON IMMUNOSENESCENCE PARAMETERS.
    J Hypertens. 2016;34 Suppl 1:e46.
    PubMed     Text format     Abstract available


  307. SUNG KC
    OS 01-06 LOW GRADE ALBUMINURIA IS A PREDICTOR OF INCIDENT HYPERTENSION AND CARDIOVASCULAR MORTALITY BUT IS NOT A PREDICTOR OF INCIDENT TYPE 2 DIABETES.
    J Hypertens. 2016;34 Suppl 1:e45-6.
    PubMed     Text format     Abstract available


  308. KWON A, Chung WB, Kim TH, Suh SM, et al
    OS 01-05 HIGH ALDOSTERONE-RENIN RATIO (ARR) IS ASSOCIATED WITH THE DEVELOPMENT OF ESSENTIAL HYPERTENSION FROM WHITE COAT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e45.
    PubMed     Text format     Abstract available


  309. SONG SK, Lee SR, Jung LY, Kim YS, et al
    OS 01-04 WHOLE BLOOD VISCOSITY WAS ELEVATED IN PATIENTS WITH BOTH HYPERTENSION AND ACUTE CORONARY SYNDROME.
    J Hypertens. 2016;34 Suppl 1:e45.
    PubMed     Text format     Abstract available


  310. KIM DO Y, Choi SW, Han SW, Youn JC, et al
    OS 01-03 NEUTROPHIL TO LYMPHOCYTE RATIO IS CLOSELY RELATED WITH BLOOD PRESSURE LEVEL IN HYPERTENSIVE INDIVIDUALS WITHOUT CARDIOVASCULAR DISEASES; DATA FROM THE KOREAN REGISTRY OF TARGET ORGAN DAMAGES IN HYPERTENSION (KorHR).
    J Hypertens. 2016;34 Suppl 1:e44-5.
    PubMed     Text format     Abstract available


  311. MALYSZKO J, Musialowska D, Zbroch E, Koc-Zorawska E, et al
    OS 01-02 ENDOCAN LEVEL IN ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e44.
    PubMed     Text format     Abstract available


  312. WANG Y, Zhang J, Qian Y, Tang X, et al
    OS 01-01 ASSOCIATION OF Lp-PLA2 MASS AND AYSMPTOMATIC INTRACRANIAL AND EXTRACRANIAL ARTERIAL STENOSIS IN HYPERTENSION PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e44.
    PubMed     Text format     Abstract available


  313. WALAS D, Nowicki-Osuch K, Alibhai D, Paton J, et al
    ISH NIA OS-06 PUTATIVE MECHANISMS FOR CEREBROVASCULAR REMODELLING IN THE SPONTANEOUSLY HYPERTENSIVE RAT (SHR) USING TRANSCRIPTOMICS.
    J Hypertens. 2016;34 Suppl 1:e43.
    PubMed     Text format     Abstract available


  314. PIJACKA W, McBryde F, Ford AP, Paton JF, et al
    ISH NIA OS-04 P2X3 RECEPTOR ACTIVITY IN THE CAROTID BODY (CB) OF SPONTANEOUSLY HYPERTENSIVE (SH) RATS CONTRIBUTES TO INCREASED CHEMOREFLEX HYPERSENSITIVITY AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e42-3.
    PubMed     Text format     Abstract available


  315. TIMASHEVA Y, Nasibullin T, Imaeva E, Mirsaeva G, et al
    ISH NIA OS-03 GENETIC DETERMINANTS OF ESSENTIAL HYPERTENSION IN THE POPULATION OF TATARS FROM RUSSIA.
    J Hypertens. 2016;34 Suppl 1:e42.
    PubMed     Text format     Abstract available


  316. AZEGAMI T, Yuki Y, Hayashi K, Nakamura M, et al
    ISH NIA OS-02 ATTENUATION OF HYPERTENSION BY LESS-INVASIVE INTRANASAL VACCINATION AGAINST ANGIOTENSIN II TYPE 1 RECEPTOR IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e42.
    PubMed     Text format     Abstract available


  317. XU T, Sun J, Lee AP, Yang Y, et al
    OS 37-09 LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e407.
    PubMed     Text format     Abstract available


  318. KIM D, Shim CY, Hong GR, Cho IJ, et al
    OS 37-08 ASSOCIATION OF CENTRAL HEMODYNAMICS AND NEUROHORMONAL FACTORS TO MECHANICAL ADAPTATION OF LEFT VENTRICLE IN HYPERTENSION: A STUDY WITH TWO DIMENSIONAL LAYER SPECIFIC SPECKLE TRACKING STRAIN IMAGING.
    J Hypertens. 2016;34 Suppl 1:e407.
    PubMed     Text format     Abstract available


  319. LIM HM, Chia YC, Ching SM
    OS 37-05 LONG-TERM VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE AND DECLINE IN RENAL FUNCTION IN HYPERTENSIVE PATIENTS OVER 15 YEARS.
    J Hypertens. 2016;34 Suppl 1:e406.
    PubMed     Text format     Abstract available


  320. CHO KI, Cho EA, Heo JH, Kim HS, et al
    OS 37-04 EFFECTS OF WHITE COAT HYPERTENSION ON HEART RATE RECOVERY AND BLOOD PRESSURE RESPONSE DURING EXERCISE TESTING.
    J Hypertens. 2016;34 Suppl 1:e406.
    PubMed     Text format     Abstract available


  321. LEE JY, Sung KC
    OS 37-03 IMPACT OF CHANGE IN EXERCISE DOSE ON RISK OF NEWLY DEVELOPED HYPERTENSION AND DIABETES MELLITUS IN KOREAN MEN.
    J Hypertens. 2016;34 Suppl 1:e405-6.
    PubMed     Text format     Abstract available


  322. AMUSA G, Awokola B, Isiguzo G, Onuh J, et al
    OS 37-02 HYPERTENSION IN HIV-INFECTED ADULTS IN NORTH-CENTRAL NIGERIA: PREVALENCE, ASSOCIATED RISK FACTORS AND ASSESSMENT OF RISK USING THE FRAMINGHAM RISK SCORE.
    J Hypertens. 2016;34 Suppl 1:e405.
    PubMed     Text format     Abstract available


  323. KONG L, Ruan C, Gao P
    OS 36-08 A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIOVASCULAR INJURY.
    J Hypertens. 2016;34 Suppl 1:e404.
    PubMed     Text format     Abstract available


  324. ZHONG JC, Zhang ZZ, Xu R, Chen LJ, et al
    OS 36-07 TREATMENT WITH APELIN-13 PREVENTS PRESSURE OVERLOAD-INDUCED AORTIC ADVENTITIAL REMODELING AND FIBROSIS IN HYPERTENSIVE RATS WITH TAC.
    J Hypertens. 2016;34 Suppl 1:e403-4.
    PubMed     Text format     Abstract available


  325. ZUO C
    OS 36-06 OSTEOGLYCIN INHIBITS HYPERTENSIVE CARDIAC FIBROSIS THOUGH SUPPRESSION OF EGFR SIGNALING.
    J Hypertens. 2016;34 Suppl 1:e403.
    PubMed     Text format     Abstract available


  326. WANG Q, Chang P, Xu H, Bai F, et al
    OS 36-05 TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION THROUGH THE PI3K/p-Akt PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e403.
    PubMed     Text format     Abstract available


  327. WANG Q, Xie A, Xu H, Yu J, et al
    OS 36-02 ASTRAGALOSIDE IV AMELIORATED MITOCHONDRIAL OXIDATIVE STRESS IN HYPERTENSIVE MICE WITH CARDIOMYOPATHY BY REGULATING MITOCHONDRIAL Ca2+ FLUX.
    J Hypertens. 2016;34 Suppl 1:e402.
    PubMed     Text format     Abstract available


  328. MAIOLINO G, Flego A, Rossi GP
    OS 35-09 LONG-TERM OUTCOME OF SURGICALLY- AND MEDICALLY-TREATED PATIENTS OF THE PRIMARY ALDOSTERONISM PREVALENCE IN HYPERTENSIVES (PAPY) STUDY.
    J Hypertens. 2016;34 Suppl 1:e401.
    PubMed     Text format     Abstract available


  329. XU J, Ge Q, Zhang J, Zhu L, et al
    OS 35-06 COMPARISON OF N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL IN PRIMARY ALDOSTERONISM AND ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e401.
    PubMed     Text format     Abstract available


  330. POGLITSCH M, Ahmed AH, Resl M, Stoller A, et al
    OS 35-04 THE AA2-RATIO: TOWARDS IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e400.
    PubMed     Text format     Abstract available


  331. RIPP T, Mordobin V, Ripp E, Semke G, et al
    ISH ADA-05 THE NEW TECHNOLOGY AND CLASSIFICATION FOR THE ARTERIES REACTIVITY IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e40.
    PubMed     Text format     Abstract available


  332. CHIA YC
    SSA 03-2 PREVALENCE AND PREDICTORS OF RESISTANT HYPERTENSION IN SOUTHEAST ASIA.
    J Hypertens. 2016;34 Suppl 1:e4-5.
    PubMed     Text format     Abstract available


  333. CASTILLO R
    SSA 03-1 PREVALENCE AND MANAGEMENT OF HYPERTENSION IN SOUTHEAST ASIA.
    J Hypertens. 2016;34 Suppl 1:e4.
    PubMed     Text format     Abstract available


  334. RYUNO H, Kamide K, Gondo Y, Kabayama M, et al
    OS 34-01 ASSOCIATION OF COMBINATION OF HYPERTENSION AND DIABETES WITH COGNITIVE FUNCTION AMONG THE 70-YEARS-OLD JAPANESE GENERAL POPULATION FROM LONGITUDINAL OBSERVATION IN THE SONIC STUDY.
    J Hypertens. 2016;34 Suppl 1:e396.
    PubMed     Text format     Abstract available


  335. WANG H, Chen H
    OS 33-09 ASSOCIATION OF CLOCK GENE POLYMORPHISM WITH INSULIN RESISTANCE IN HYPERTENSION: A CASE-CONTROL STUDY.
    J Hypertens. 2016;34 Suppl 1:e395.
    PubMed     Text format     Abstract available


  336. CAI A, Wang L, Zhou Y, Chen J, et al
    OS 33-08 OBSTRUCTIVE SLEEP APNEA PROMOTES CARDIOVASCULAR RISK IN HYPERTENSIVE POPULATIONS: A CROSS-SECTIONAL STUDY.
    J Hypertens. 2016;34 Suppl 1:e395.
    PubMed     Text format     Abstract available


  337. TANAKA M, Nishimura T, Sekioka R, Kawai T, et al
    OS 33-07 LOW SERUM ALBUMIN CONCENTRATION IN HYPERTENSIVE PATIENTS COMPLICATED BY TYPE 2 DIABETES IS ASSOCIATED WITH MICROVASCULAR COMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1:e394-5.
    PubMed     Text format     Abstract available


  338. OGOLA E
    OS 33-05 HIGH PREVALENCE AND POOR CONTROL OF HYPERTENSION AND ASSOCIATED CARDIOVASCULAR RISK FACORS IN DIABETIC PATIENTS IN A RURAL HOSPITAL IN KENYA.
    J Hypertens. 2016;34 Suppl 1:e394.
    PubMed     Text format     Abstract available


  339. OPARIL S, Calhoun DA, Ghazi L, Dudenbostel T, et al
    OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX.
    J Hypertens. 2016;34 Suppl 1:e393.
    PubMed     Text format     Abstract available


  340. PENG L, Xia K, Zhao Z, Li D, et al
    OS 32-09 THE BENEFICIAL EFFECT OF LOSARTAN ON PLATELET AGGREGATION RESULTS FROM THE REDUCTION OF ENDOGENOUS ASYMMETRIC DIMETHYL ARGININE IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e391-2.
    PubMed     Text format     Abstract available


  341. YANG Z, Ruixin M, Jing Y
    OS 32-02 EFFECTS OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON VAGINA AND CARDIAC EXPRESSION OF RAAS COMPONENTS IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e390.
    PubMed     Text format     Abstract available


  342. JHEE JH, Yoo TH, Jung SY, Kee YK, et al
    ISH ADA-03 ADEQUATELY CONTROLLED SYSTOLIC BLOOD PRESSURE IS SIGNIFICANTLY ASSOCIATED WITH BETTER SURVIVAL RATE, IRRESPECTIVE OF NUMBER OF ANTIHYPERTENSIVE AGENTS IN PREVALENT DIALYSIS PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e39-40.
    PubMed     Text format     Abstract available


  343. CHEN X, Wang S, Li J, Zhou X, et al
    OS 31-06 COMPARISON BETWEEN THE EFFECTS OF HYDROCHLOROTHIAZIDE AND INDAPAMIDE ON THE KIDNEY IN HYPERTENSIVE PATIENTS INADEQUATELY CONTROLLED WITH LOSARTAN.
    J Hypertens. 2016;34 Suppl 1:e389.
    PubMed     Text format     Abstract available


  344. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 31-04 COMPARISON OF CALCIUM CHANNEL BLOCKERS VERSUS CALCIUM CHANNEL BLOCKERS WITH RENIN ANGIOTENSIN SYSTEM BLOCKERS ON THE DEVELOPMENT OF NEW-ONSET DIABETES MELLITUS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e388-9.
    PubMed     Text format     Abstract available


  345. GIULIETTI F, Spannella F, Borioni E, Lombardi FE, et al
    OS 31-03 CLINICAL EFFECTIVENESS OF ANTI-HYPERTENSIVE THERAPY WITH ACEI OR ARB ASSESSED BY PLASMA RENIN ACTIVITY/PLASMA ALDOSTERONE CONCENTRATION RATIO.
    J Hypertens. 2016;34 Suppl 1:e388.
    PubMed     Text format     Abstract available


  346. ZENG W, Chu T, Hu M, Kong A, et al
    OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e388.
    PubMed     Text format     Abstract available


  347. KIM CH
    APSH PRE-1 WHAT CAN BE IMPROVED IN THE MANAGEMENT OF HYPERTENSION?
    J Hypertens. 2016;34 Suppl 1:e387.
    PubMed     Text format     Abstract available


  348. KANG YY, Li Y, Huang QF, Song J, et al
    APSH YI-05 CIGARETTE SMOKING AND MASKED HYPERTENSION IN CHINESE MEN.
    J Hypertens. 2016;34 Suppl 1:e386.
    PubMed     Text format     Abstract available


  349. LEE CJ, Oh J, Lee SH, Kang SM, et al
    APSH YI-01 EFFECTS OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE AGENTS ON SURVIVAL IN PATIENTS WITH UNCOMPLICATED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e385.
    PubMed     Text format     Abstract available


  350. TOUYZ RM
    ISH PRE-2 THE VASCULAR PHENOTYPE IN HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1:e384.
    PubMed     Text format     Abstract available


  351. SAFAR ME
    ISH PRE-1 REDUCTION OF CARDIOVASCULAR MORTALITY IN HYPERTENSIVES WITH COMORBIDITIES: BEYOND BLOOD PRESSURE LOWERING - THE ROLE OF ARTERIAL AGING.
    J Hypertens. 2016;34 Suppl 1:e384.
    PubMed     Text format     Abstract available


  352. POGLITSCH M
    JS ISH-ECCR-4 THE PLASMA ALDOSTERONE / ANGIOTENSIN II RATIO FOR THE SCREENING OF SECONDARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e382-3.
    PubMed     Text format     Abstract available


  353. ROSSI GP
    JS ISH-ECCR-3 A NOVEL ALGORITHM FOR THE CASE DETECTION OF THE MOST COMMON FORM OF ENDOCRINE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e382.
    PubMed     Text format     Abstract available


  354. FUJITA T
    ME 03-1 ROLE OF ALDOSTERNE AND MINERALOCORTICOID RECEPTOR IN SALT-SENSITIVE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e379.
    PubMed     Text format     Abstract available


  355. WHELTON P
    SP 05-1 SHOULD THE TARGET FOR BLOOD PRESSURE REDUCTION BE LOWER IN ADULTS WITH HYPERTENSION AND A HISTORY OF CARDIOVASCULAR DISEASE.
    J Hypertens. 2016;34 Suppl 1:e378.
    PubMed     Text format     Abstract available


  356. BAKRIS G
    DB 03-2 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (CON).
    J Hypertens. 2016;34 Suppl 1:e375.
    PubMed     Text format     Abstract available


  357. SCHLAICH M
    DB 03-1 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (PRO).
    J Hypertens. 2016;34 Suppl 1:e375.
    PubMed     Text format     Abstract available


  358. SHI L
    ED 08-4 DIAGNOSIS AND TREATMENT OF HYPERTENSIVE EMERGENCY IN CHILDREN.
    J Hypertens. 2016;34 Suppl 1:e373-4.
    PubMed     Text format     Abstract available


  359. AWAZU M
    ED 08-3 APPLICATION OF ABP MONITORING IN THE MANAGEMENT OF PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e373.
    PubMed     Text format     Abstract available


  360. DAVIES PF, Manduchi E, Stoeckert CJ, Jiang YZ, et al
    SY 15-2 ENDOTHELIAL EPIGENETICS AND ITS ROLE IN MEDIATING BIOMECHANICAL STRESS OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e371.
    PubMed     Text format     Abstract available


  361. SCHIFFRIN E
    SY 15-1 MECHANISM OF ENDOTHELIN-1 REGULATION IN HYPERTENSION: THE ROLE OF ENDOTHELIN TYPE A RECEPTORS.
    J Hypertens. 2016;34 Suppl 1:e371.
    PubMed     Text format     Abstract available


  362. TSIMPLOULIS A, Doumas M, Pittaras A, Faselis C, et al
    YIA 01-06 CARDIORESPIRATORY FITNESS AND MORTALITY RISK IN HYPERTENSIVE MEN >/=70 YEARS.
    J Hypertens. 2016;34 Suppl 1:e37-8.
    PubMed     Text format     Abstract available


  363. MORISHITA R
    SY 14-4 VACCINE THERAPY FOR RESISTANT HYPERTENSION: IS IT A DYING ISSUE?
    J Hypertens. 2016;34 Suppl 1:e369-70.
    PubMed     Text format     Abstract available


  364. CALHOUN D
    SY 14-3 PRIMARY ALDOSTERONISM IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e369.
    PubMed     Text format     Abstract available


  365. VONGPATANASIN W
    SY 14-1 THERAPEUTIC DRUG MONITORING FACILITATES BLOOD PRESSURE CONTROL IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e369.
    PubMed     Text format     Abstract available


  366. DANIELS SR
    SY 13-2 LONG-TERM CARDIOVASCULAR RISK REDUCTION IN PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e368.
    PubMed     Text format     Abstract available


  367. BURRELL L
    SY 12-1 RENIN ANGIOTENSIN PATHWAY BEYOND ACE AND ANGIOTENSIN II RECEPTORS: HOW IT RELATES TO THE PATHOPHYSIOLOGY OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e367.
    PubMed     Text format     Abstract available


  368. RYAN MJ
    SY 11-4 CONNECTIVE TISSUE DISEASE AND ITS ASSOCIATION WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e366.
    PubMed     Text format     Abstract available


  369. OPARIL S
    SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?
    J Hypertens. 2016;34 Suppl 1:e366.
    PubMed     Text format     Abstract available


  370. KJELDSEN S
    PL 03-3 THE FUTURE DEVELOPMENT OF DRUG THERAPY FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e365.
    PubMed     Text format     Abstract available


  371. IMAI Y
    PL 03-2 REMOTE BLOOD PRESSURE MONITORING IN HYPERTENSION CARE: PRACTICE OF HYPERTENSION BY TELETRANSMISSION OF HOME BLOOD PRESSURE.
    J Hypertens. 2016;34 Suppl 1:e364-5.
    PubMed     Text format     Abstract available


  372. STEINHUBL S
    PL 03-1 HYPERTENSION MANAGEMENT IN THE ERA OF DIGITAL INFORMATION AND COMMUNICATION TECHNOLOGIES.
    J Hypertens. 2016;34 Suppl 1:e364.
    PubMed     Text format     Abstract available


  373. KUWABARA M, Hoshide S, Hamasaki H, Shiga T, et al
    YIA 01-04 HYPOXIA-INDUCED SURGE NOCTURNAL HYPERTENSION IDENTIFIED BY OXYGEN-TRIGGERED NOCTURNAL BLOOD PRESSURE MONITORING IN SLEEP APNEA SYNDROME.
    J Hypertens. 2016;34 Suppl 1:e36-7.
    PubMed     Text format     Abstract available


  374. LEE HY, Park CS, Na SH, Kim KJ, et al
    ISH AHA-2 A CASE OF CHRONIC INDOLENT PHEOCHROMOCYTOMA WHICH CAUSED MEDICALLY-CONTROLLED HYPERTENSION BUT TREATMENT-RESISTANT DIABETES MELLITUS.
    J Hypertens. 2016;34 Suppl 1:e35.
    PubMed     Text format     Abstract available


  375. LEE CJ, Woo Y, Kim BK, Yoon KB, et al
    ISH AHA-1 A CASE OF REFRACTORY HYPERTENSION CONTROLLED BY REPEATED RENAL DENERVATION AND CELIAC PLEXUS BLOCK: A CASE OF REFRACTORY SYMPATHETIC OVERLOAD.
    J Hypertens. 2016;34 Suppl 1:e35.
    PubMed     Text format     Abstract available


  376. PARK JB
    POA 02-4 BLOOD PRESSURE BEHAVIORS APPROACH FOR HYPERTENSION MANAGEMENT.
    J Hypertens. 2016;34 Suppl 1:e33-4.
    PubMed     Text format     Abstract available


  377. TOUYZ RM
    POA 02-3 SMALL VESSEL DISEASE AND HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1:e33.
    PubMed     Text format     Abstract available


  378. AVOLIO A
    POA 02-2 ATHEROGENIC VASCULAR STIFFNESS AND HYPERTENSION: CAUSE OR EFFECT?
    J Hypertens. 2016;34 Suppl 1:e33.
    PubMed     Text format     Abstract available


  379. DOMINICZAK AF
    POA 02-1 GENETIC BASIS OF BLOOD PRESSURE AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e33.
    PubMed     Text format     Abstract available


  380. LI Y
    CHL 01-3 MORNING AND NOCTURNAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e31.
    PubMed     Text format     Abstract available


  381. CHEN CH
    CHL 01-2 CENTRAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e31.
    PubMed     Text format     Abstract available


  382. STERN N
    BR 02-2 HYPERTENSION MANAGEMENT IN CANCER PATIENTS UNDERGOING CHEMOTHERAPY.
    J Hypertens. 2016;34 Suppl 1:e30.
    PubMed     Text format     Abstract available


  383. KIM YJ
    BR 02-1 MANAGEMENT OF HYPERTENSION IN SEVERE AORTIC STENOSIS.
    J Hypertens. 2016;34 Suppl 1:e30.
    PubMed     Text format     Abstract available


  384. KARIO K
    ME 01-2 ASSESSMENT AND TREATMENT OF MORNING HYPERTENSION: UPDATE.
    J Hypertens. 2016;34 Suppl 1:e29.
    PubMed     Text format     Abstract available


  385. SATOH F
    SP 01-2 HYPERTENSIVE TARGET ORGAN DAMAGE IN PRIMARY ALDOSTERONISM.
    J Hypertens. 2016;34 Suppl 1:e28.
    PubMed     Text format     Abstract available


  386. FUJITA T
    SP 01-1 ALDOSTERONE ANTAGONISTS FOR THE TREATMENT OF HYPERTENSIVE NEPHROPATHY.
    J Hypertens. 2016;34 Suppl 1:e28.
    PubMed     Text format     Abstract available


  387. SHIRAI K
    HW 01-4 CARDIOANKLE VASCULAR INDEX (CAVI) IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e27.
    PubMed     Text format     Abstract available


  388. LEE SC
    HW 01-3 CARDIAC AND VASCULAR MRI IN HYPERTENSION EVALUATION.
    J Hypertens. 2016;34 Suppl 1:e27.
    PubMed     Text format     Abstract available


  389. JAMERSON K
    DB 01-1 RACIAL AND ETHNIC DIFFERENCES EXIST IN TERMS OF EFFICACY OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE MEDICATIONS (PRO).
    J Hypertens. 2016;34 Suppl 1:e26.
    PubMed     Text format     Abstract available


  390. SUGIURA T, Takase H, Murai S, Yamashiya S, et al
    OS 30-04 FUTURE HYPERTENSION CAN BE PREDICTED USING ELECTROCARDIOGRAM.
    J Hypertens. 2016;34 Suppl 1:e255-6.
    PubMed     Text format     Abstract available


  391. GAFAROV V, Gromova E, Panov D, Gagulin I, et al
    OS 30-03 GENDER DIFFERENCES OF AN ARTERIAL HYPERTENSION RISK IN POPULATION WITH SLEEP DISTURBANCE IN RUSSIA / SIBERIA: WHO PROGRAM MONICA-PSYCHOSOCIAL.
    J Hypertens. 2016;34 Suppl 1:e255.
    PubMed     Text format     Abstract available


  392. DENTON K, Moritz K, Booth L, May C, et al
    OS 29-06 RESPONSE TO HEMORRHAGE FOLLOWING CATHETER-BASED RENAL DENERVATION IN SHEEP WITH HYPERTENSIVE KIDNEY DISEASE.
    J Hypertens. 2016;34 Suppl 1:e254.
    PubMed     Text format     Abstract available


  393. LI X, Hong M, Zhu D, Gao P, et al
    OS 29-05 RENAL DENERVATION ATTENUATES ALDOSTERONE EXPRESSION AND ASSOCIATED CARDIOVASCULAR PATHOPHYSIOLOGY IN ANGIOTENSIN II-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e254.
    PubMed     Text format     Abstract available


  394. LIM JK, Burke S, Head G
    OS 29-01 TRANS-GENERATIONAL PROGRAMMING OF OBESITY RELATED HYPERTENSION: AMPLIFICATION OF LEPTIN SIGNALLING PATHWAY.
    J Hypertens. 2016;34 Suppl 1:e253.
    PubMed     Text format     Abstract available


  395. YADAV R, Yadav RK, Khadgawat R, Mehta N, et al
    OS 28-06 BENEFICIAL EFFECTS OF A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND ADIPOKINES IN SUBJECTS WITH PRE-HYPERTENSION OR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e252.
    PubMed     Text format     Abstract available


  396. URATA H, Devarajan S, Okamura K
    OS 28-05 ANTIHYPERTENSIVE EFFECT OF CHYMASE INHIBITORY JAPANESE WATER PEPPER INTAKE IN SALT-DEPENDENT MODERATE HYPERTENSION MOUSE MODEL AND IN HUMAN.
    J Hypertens. 2016;34 Suppl 1:e252.
    PubMed     Text format     Abstract available


  397. OTT C, Kistner I, Schmid A, Friedrich S, et al
    OS 28-03 SECRETORY CAPACITY OF PANCREATIC BETA CELLS IS ENHANCED 6 MONTHS AFTER RENAL DENERVATION IN TREATMENT RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e251.
    PubMed     Text format     Abstract available


  398. SCHLAICH M, Hering D, Marusic P, Walton A, et al
    OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e251.
    PubMed     Text format     Abstract available


  399. ITO S
    ED 04-3 ASSESSMENT OF RENAL FUNCTION DURING FOLLOW UP OF HYPERTENSIVE SUBJECTS.
    J Hypertens. 2016;34 Suppl 1:e25.
    PubMed     Text format     Abstract available


  400. LI Y
    ED 04-2 ASSESSMENT OF TARGET ORGAN DAMAGE DURING ANTI-HYPERTENSIVE TREATMENT: WHAT TO USE AND HOW FREQUENTLY WE SHOULD MEASURE.
    J Hypertens. 2016;34 Suppl 1:e25.
    PubMed     Text format     Abstract available


  401. HRISTOVA K, Bogdanova V, Marinov R
    OS 27-04 PREDICTION OF LEFT VENTRICULAR DYSTOLIC DYSFUNCTION IN PATIENT WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e249-50.
    PubMed     Text format     Abstract available


  402. YOON HJ
    OS 27-03 IMPAIRED DIASTOLIC RECOVERY BEFORE DISCHARGE IS ASSOCIATED WITH RE-HOSPITALIZATION WITH HYPERTENSIVE HEART FAILURE.
    J Hypertens. 2016;34 Suppl 1:e249.
    PubMed     Text format     Abstract available


  403. KIM MN, Cho D, Shim JM, Choi JI, et al
    OS 27-01 IS HYPERTENSION A RISK FACTOR FOR RECURRENCE AFTER RADIOFREQUENCY CATHETER ABLATION IN ATRIAL FIBRILLATION?
    J Hypertens. 2016;34 Suppl 1:e249.
    PubMed     Text format     Abstract available


  404. SUN J, Steffen LM, Xi B
    OS 26-05 HOW TO ACCURATELY DEFINE PEDIATRIC HYPERTENSION: A SYSTEMATIC REVIEW.
    J Hypertens. 2016;34 Suppl 1:e248.
    PubMed     Text format     Abstract available


  405. NGUI D, Qiu MJ, Mann M
    OS 26-04 TARGETING CARE GAPS IN PATIENTS WITH HYPERTENSION: A QUALITY IMPROVEMENT PROJECT UTILIZING EMR HYPERTENSION DASHBOARDS AND A CHRONIC DISEASE COORDINATOR.
    J Hypertens. 2016;34 Suppl 1:e247-8.
    PubMed     Text format     Abstract available


  406. KOCHARYAN L, Baghdasaryan L
    OS 26-02 A NEW APPROACH FOR THE MANAGEMENT AND MONITORING OF ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e247.
    PubMed     Text format     Abstract available


  407. MELIN P, Prado-Arechiga G, Pulido M, Miramontes I, et al
    OS 26-01 CLASSIFICATION OF ARTERIAL HYPERTENSION USING A COMPUTATIONAL MODEL BASED ON ARTIFICIAL MODULAR NEURAL NETWORKS.
    J Hypertens. 2016;34 Suppl 1:e247.
    PubMed     Text format     Abstract available


  408. CHAN J, Lo CS, Shi Y, Chenier I, et al
    OS 25-03 OVEREXPRESSION OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F PREVENTS SYSTEMIC HYPERTENSION AND KIDNEY INJURY AND NORMALIZES RENAL RENIN-ANGIOTENSIN SYSTEM GENES EXPRESSION IN TYPE 2 DIABETIC DB/DB TRANSGENIC MICE.
    J Hypertens. 2016;34 Suppl 1:e245.
    PubMed     Text format     Abstract available


  409. LIM JK, Barzel B, Burke S
    OS 25-02 ORIGIN OF NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY.
    J Hypertens. 2016;34 Suppl 1:e245.
    PubMed     Text format     Abstract available


  410. LEE JH, Baek JS, Yu JJ, Kim YH, et al
    OS 24-06 HIGH B-TYPE NATRIURETIC PEPTIDE IS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY AND HEART FAILURE IN CHILDREN WITH HYPERTENSION ON PERITONEAL DIALYSIS.
    J Hypertens. 2016;34 Suppl 1:e244.
    PubMed     Text format     Abstract available


  411. PALL D, Katona E, Zrinyi M, Lengyel S, et al
    OS 24-01 ASSESSMENT OF TARGET-ORGAN DAMAGE IN ADOLESCENT WHITE COAT AND SUSTAINED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e243.
    PubMed     Text format     Abstract available


  412. SHIN MS, Park SM, Kim MN, Kim HL, et al
    OS 23-05 LEFT VENTRICULAR HYPERTROPHY AND SIGNIFICANT CORONARY ARTERIAL STENOSIS INTERACTION IN HYPERTENSIVE WOMEN.
    J Hypertens. 2016;34 Suppl 1:e242.
    PubMed     Text format     Abstract available


  413. ZHAO X, Yu J
    OS 23-04 A NOVEL HORMONE THERAPY, DROSPIRENONE WITH ESTRADIOL FOR HYPERTENSIVE POSTMENOPAUSAL WOMEN: A SYSTEMIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 1:e242.
    PubMed     Text format     Abstract available


  414. KIM SA, Park JB
    OS 23-03 MID-TRIMESTER RISK PREDICTION OF SUPERIMPOSED PRE-ECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e241.
    PubMed     Text format     Abstract available


  415. KIM S, Lim NK, Lee JH, Park HY, et al
    OS 22-09 Population-attributable risk of hypertension in development of Stroke: using the National Sample Cohort.
    J Hypertens. 2016;34 Suppl 1:e240.
    PubMed     Text format     Abstract available


  416. LI N, Yao X, Zhou L, Abulikem S, et al
    OS 22-08 Prevalence of primary aldosteronism and its cardio-metabolic factors Chinese hypertensive patients in Xinjiang of China.
    J Hypertens. 2016;34 Suppl 1:e240.
    PubMed     Text format     Abstract available


  417. PATIL M, Durairaj M, Tauseef SM
    OS 22-06 Evaluating the Health Related Quality of Life of Hypertensive Patients.
    J Hypertens. 2016;34 Suppl 1:e239.
    PubMed     Text format     Abstract available


  418. ARAKAWA K, Ibaraki A, Kawamoto Y, Inoue M, et al
    OS 22-05 Variability of urinary salt excretion in treated hypertensive patients during several years.
    J Hypertens. 2016;34 Suppl 1:e239.
    PubMed     Text format     Abstract available


  419. LEE JW, Lim NK, Lee JH, Park HY, et al
    OS 22-03 Joint effect of pre-existing hypertension and diabetes on cardiovascular diseases and mortality in the middle-aged Koreans.
    J Hypertens. 2016;34 Suppl 1:e238-9.
    PubMed     Text format     Abstract available


  420. WANG HH, Wang JJ, Lawson KD, Wong SY, et al
    OS 22-02 Hypertensive patients with multimorbidity in mainland China, Scotland, and Hong Kong: a cross-country population-based study.
    J Hypertens. 2016;34 Suppl 1:e238.
    PubMed     Text format     Abstract available


  421. LEE CJ, Oh J, Lee SH, Kang SM, et al
    OS 22-01Treatment of Hypertension with Low Cardiovascular Risk is associated with significantly lowered mortality.
    J Hypertens. 2016;34 Suppl 1:e238.
    PubMed     Text format     Abstract available


  422. NISHIYAMA A, Sufiun A, Fujisawa Y, Rahman A, et al
    OS 21-09 DIPPING PATTERN OF BLOOD PRESSURE AND RENAL INJURY IN DAHL SALT-SENSITIVE HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1:e237.
    PubMed     Text format     Abstract available


  423. VAVRINOVA A, Behuliak M, Zicha J
    OS 21-07 EXPRESSION OF CATECHOLAMINERGIC SYSTEM GENES IN ADRENAL MEDULLA OR SYMPATHETIC GANGLIA OF SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 1:e236-7.
    PubMed     Text format     Abstract available


  424. KROTOVA V, Khomazyuk T
    OS 20-09 DIAGNOSIS AND TREATMENT OF COGNITIVE DISORDERS IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e234.
    PubMed     Text format     Abstract available


  425. ISHIKAWA J, Toba A, Yamanaka Y, Watanabe S, et al
    OS 20-08 GENDER-ADJUSTMENT AND CUTOFF LEVELS OF CORNELL PRODUCT IN ELECTROCARDIOGRAM AMONG JAPANESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1:e234.
    PubMed     Text format     Abstract available


  426. SECHI L, Colussi G, Novello M, Pezzutto F, et al
    OS 20-06 DAILY ALCOHOL CONSUMPTION AFFECTS LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY.
    J Hypertens. 2016;34 Suppl 1:e233.
    PubMed     Text format     Abstract available


  427. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 20-05 IMPACT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS UNDERWENT SUCCESSFUL PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENTS ON LONG-TERM CLINICAL OUTCOMES.
    J Hypertens. 2016;34 Suppl 1:e233.
    PubMed     Text format     Abstract available


  428. CHI C, Zhang Y, Wang K, Wang L, et al
    OS 20-02 HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 1:e232.
    PubMed     Text format     Abstract available


  429. JUNG SM, Ryu DR, Kim CT
    OS 19-07 PRESCRIPTION PATTERN OF RAS BLOCKADE IN KOREAN HYPERTENSIVE PATIENTS WITH PROTEINURIA.
    J Hypertens. 2016;34 Suppl 1:e230.
    PubMed     Text format     Abstract available


  430. JEFFERS B, Zho D
    OS 19-02 RELATIONSHIP BETWEEN VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY (BPV) AND KIDNEY FUNCTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1:e228.
    PubMed     Text format     Abstract available


  431. MEENA J, Raghav P, Rustagi N
    LBOS 03-06 ANTI HYPERTENSIVE TREATMENT COMPLIANCE AND ADVERSE EFFECT PROFILE AMONG HYPERTENSION CLINIC ATTENDEES IN JODHPUR, INDIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e552.
    PubMed     Text format     Abstract available


  432. KOHLI C, Gupta K
    LBOS 03-03 ECONOMIC IMPACT OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e551-e552.
    PubMed     Text format     Abstract available


  433. KARAMAT F, Diemer F, Baldew S, Oehlers G, et al
    LBOS 03-02 PREHYPERTENSION AND HYPERTENSION IN URBAN SURINAME: THE HELISUR STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e551.
    PubMed     Text format     Abstract available


  434. YUSUFALI A, Khatib R, Islam S, AlHabib K, et al
    LBOS 03-01 PREVALENCE, AWARENESS, TREATMENT, AND CONTROL OF HYPERTENSION IN THE MIDDLE EAST: RESULTS FROM THE PROSPECTIVE URBAN RURAL EPIDEMIOLOGY (PURE) STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e551.
    PubMed     Text format     Abstract available


  435. DEY SK, Prabhakar P, Saini M, Joseph T, et al
    LBOS 02-05 INHIBITORS OF DOPAMINE-beta-HYDROXYLASE OBTAINED BY STRUCTURE BASED METHODS EXHIBITED ANTI-HYPERTENSIVE EFFECT IN L-NAME INDUCED HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e550.
    PubMed     Text format     Abstract available


  436. LIU D
    LBOS 02-02 TELMISARTAN REDUCING MONOCYTE MITOCHONDRIA RESPIRATORY FUNCTION IS ASSOCIATED WITH INHIBITION OF TRANSIENT RECEPTOR POTENTIAL CHANNEL CANONICAL TYPE 3 CHANNELS IN HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e549.
    PubMed     Text format     Abstract available


  437. TAO J
    LBOS 02-01 HYPERTENSION, ALDOSTERONE AND EPC-MEDIATED ENDOTHALIAL INJURY REPAIR.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e549.
    PubMed     Text format     Abstract available


  438. VILLEVALDE S, Kobalava Z
    LBOS 01-06 INTEGRATED APPROACH IMPROVED BLOOD PRESSURE CONTROL IN NON ADHERENT MOTIVATED HYPERTENSIVE PATIENTS: PRISMA STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e548.
    PubMed     Text format     Abstract available


  439. CHO EJ, Lee HY, Sung KC, Park S, et al
    LBOS 01-05 24-HOUR CENTRAL BLOOD PRESSURE REDUCTION EFFICACY OF CALCIUM CHANNEL BLOCKER COMBINATION IS SUPERIOR TO DIURETICS COMBINATION WITH ANGIOTENSIN II RECEPTOR BLOCKER ESPECIALLY IN MALE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e548.
    PubMed     Text format     Abstract available


  440. SEVER P, Gupta A, Thompson D, Whitehouse A, et al
    LBOS 01-04 THE TRUE INCIDENCE OF STATIN -RELATED ADVERSE EVENTS IN HYPERTENSIVE PATIENTS REVEALED BY COMPARISON OF BLINDED AND UN-BLINDED USE OF STATIN IN THE ANGLO-SCANDINAVIAN CARDIAC OUTCOMES TRIAL (ASCOT).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547-e548.
    PubMed     Text format     Abstract available


  441. VILLEVALDE S, Kovbalava Z
    LBOS 01-03 MICROALBUMINURIA IS THE MOST INTEGRATED SIGN OF SUBCLINICAL ORGAN DAMAGE IN UNCOMPLICATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547.
    PubMed     Text format     Abstract available


  442. MARCUS Y, Haran A, Shefer G, Stern N, et al
    LBOS 01-02 CLUSTERING OF SILENT HYPOTENSIVE EPISODES IN THE MORNING/LATE-MORNING HOURS IN SUBJECTS TREATED FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547.
    PubMed     Text format     Abstract available


  443. POULTER N, Anjum A, Cross M, Falaschetti E, et al
    LBOS 01-01A COMPARISON OF THE IMPACT OF MORNING OR NIGHT DELIVERY OF ANTIHYPERTENSIVE AGENTS ON 24 HOUR ABPM LEVELS: A RANDOMISED CROSS-OVER TRIAL (HARMONY).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e547.
    PubMed     Text format     Abstract available


  444. MUTHUSAMY VV
    BR 08-3 MANAGEMENT OF DYSLIPIDEMIA IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e545.
    PubMed     Text format     Abstract available


  445. PARK J
    BR 08-2 CARDIOVASCULAR RISK ASSESSMENT IN HYPERTENSIVES WITH CKD.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e544-e545.
    PubMed     Text format     Abstract available


  446. ZHU Z
    BR 08-1 HIGH SODIUM INTAKE REDUCTION IN DIABETES WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e544.
    PubMed     Text format     Abstract available


  447. PARK JB
    ME 04-2 AORTIC PWV FOR RISK STRATIFICATION IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e541.
    PubMed     Text format     Abstract available


  448. KIM SH
    HW 03-2 EFFECT OF CPAP ON THE TREATMENT OF RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e538.
    PubMed     Text format     Abstract available


  449. KIM BK
    HW 03-1 RENAL SYMPATHETIC DENERVATION FOR RESISTANT HYPERTENSION UNDER OPTIMAL DRUG THERAPY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e538.
    PubMed     Text format     Abstract available


  450. RAIZADA M
    SY 17-4 NEURO-IMMUNE COMMUNICATION IN HYPERTENSION: A NEW THERAPEUTIC ANGLE?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e535.
    PubMed     Text format     Abstract available


  451. HARRISON D
    SY 17-2 INFLAMMATION, IMMUNITY AND HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e535.
    PubMed     Text format     Abstract available


  452. VAN BALLEGOOIJEN A
    SY 16-4 VITAMIN D WITH OR WITHOUT CALCIUM SUPPLEMENTATION IN RELATION TO HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e534.
    PubMed     Text format     Abstract available


  453. XU T, Sun J, Lee AP, Yang Y, et al
    OS 37-09 LAYER-SPECIFIC QUANTIFICATION OF MYOCARDIAL DEFORMATION MAY DISCLOSE THE SUBCLINICAL SYSTOLIC DYSFUNCTION AND THE MECHANISM OF RESERVED EJECTION FRACTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e407.
    PubMed     Text format     Abstract available


  454. KIM D, Shim CY, Hong GR, Cho IJ, et al
    OS 37-08 ASSOCIATION OF CENTRAL HEMODYNAMICS AND NEUROHORMONAL FACTORS TO MECHANICAL ADAPTATION OF LEFT VENTRICLE IN HYPERTENSION: A STUDY WITH TWO DIMENSIONAL LAYER SPECIFIC SPECKLE TRACKING STRAIN IMAGING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e407.
    PubMed     Text format     Abstract available


  455. LIM HM, Chia YC, Ching SM
    OS 37-05 LONG-TERM VISIT-TO-VISIT VARIABILITY OF SYSTOLIC BLOOD PRESSURE AND DECLINE IN RENAL FUNCTION IN HYPERTENSIVE PATIENTS OVER 15 YEARS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e406.
    PubMed     Text format     Abstract available


  456. CHO KI, Cho EA, Heo JH, Kim HS, et al
    OS 37-04 EFFECTS OF WHITE COAT HYPERTENSION ON HEART RATE RECOVERY AND BLOOD PRESSURE RESPONSE DURING EXERCISE TESTING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e406.
    PubMed     Text format     Abstract available


  457. LEE JY, Sung KC
    OS 37-03 IMPACT OF CHANGE IN EXERCISE DOSE ON RISK OF NEWLY DEVELOPED HYPERTENSION AND DIABETES MELLITUS IN KOREAN MEN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e405-e406.
    PubMed     Text format     Abstract available


  458. AMUSA G, Awokola B, Isiguzo G, Onuh J, et al
    OS 37-02 HYPERTENSION IN HIV-INFECTED ADULTS IN NORTH-CENTRAL NIGERIA: PREVALENCE, ASSOCIATED RISK FACTORS AND ASSESSMENT OF RISK USING THE FRAMINGHAM RISK SCORE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e405.
    PubMed     Text format     Abstract available


  459. KONG L, Ruan C, Gao P
    OS 36-08 A2A RECEPTOR-MEDIATED ACTIVATION OF REGULATORY T CELLS ATTENUATES HYPERTENSION-INDUCED CARDIOVASCULAR INJURY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e404.
    PubMed     Text format     Abstract available


  460. ZHONG JC, Zhang ZZ, Xu R, Chen LJ, et al
    OS 36-07 TREATMENT WITH APELIN-13 PREVENTS PRESSURE OVERLOAD-INDUCED AORTIC ADVENTITIAL REMODELING AND FIBROSIS IN HYPERTENSIVE RATS WITH TAC.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e403-e404.
    PubMed     Text format     Abstract available


  461. ZUO C
    OS 36-06 OSTEOGLYCIN INHIBITS HYPERTENSIVE CARDIAC FIBROSIS THOUGH SUPPRESSION OF EGFR SIGNALING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e403.
    PubMed     Text format     Abstract available


  462. WANG Q, Chang P, Xu H, Bai F, et al
    OS 36-05 TETRAHYDROBIOPTERIN REVERSE LEFT VENTRICULAR HYPERTROPHY AND DIASTOLIC DYSFUNCTION THROUGH THE PI3K/p-Akt PATHWAY IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e403.
    PubMed     Text format     Abstract available


  463. WANG Q, Xie A, Xu H, Yu J, et al
    OS 36-02 ASTRAGALOSIDE IV AMELIORATED MITOCHONDRIAL OXIDATIVE STRESS IN HYPERTENSIVE MICE WITH CARDIOMYOPATHY BY REGULATING MITOCHONDRIAL Ca2+ FLUX.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e402.
    PubMed     Text format     Abstract available


  464. MAIOLINO G, Flego A, Rossi GP
    OS 35-09 LONG-TERM OUTCOME OF SURGICALLY- AND MEDICALLY-TREATED PATIENTS OF THE PRIMARY ALDOSTERONISM PREVALENCE IN HYPERTENSIVES (PAPY) STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e401.
    PubMed     Text format     Abstract available


  465. XU J, Ge Q, Zhang J, Zhu L, et al
    OS 35-06 COMPARISON OF N-TERMINAL PRO-B-TYPE NATRIURETIC PEPTIDE LEVEL IN PRIMARY ALDOSTERONISM AND ESSENTIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e401.
    PubMed     Text format     Abstract available


  466. POGLITSCH M, Ahmed AH, Resl M, Stoller A, et al
    OS 35-04 THE AA2-RATIO: TOWARDS IMPROVED SCREENING FOR PRIMARY ALDOSTERONISM IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e400.
    PubMed     Text format     Abstract available


  467. RYUNO H, Kamide K, Gondo Y, Kabayama M, et al
    OS 34-01 ASSOCIATION OF COMBINATION OF HYPERTENSION AND DIABETES WITH COGNITIVE FUNCTION AMONG THE 70-YEARS-OLD JAPANESE GENERAL POPULATION FROM LONGITUDINAL OBSERVATION IN THE SONIC STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e396.
    PubMed     Text format     Abstract available


  468. WANG H, Chen H
    OS 33-09 ASSOCIATION OF CLOCK GENE POLYMORPHISM WITH INSULIN RESISTANCE IN HYPERTENSION: A CASE-CONTROL STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e395.
    PubMed     Text format     Abstract available


  469. CAI A, Wang L, Zhou Y, Chen J, et al
    OS 33-08 OBSTRUCTIVE SLEEP APNEA PROMOTES CARDIOVASCULAR RISK IN HYPERTENSIVE POPULATIONS: A CROSS-SECTIONAL STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e395.
    PubMed     Text format     Abstract available


  470. TANAKA M, Nishimura T, Sekioka R, Kawai T, et al
    OS 33-07 LOW SERUM ALBUMIN CONCENTRATION IN HYPERTENSIVE PATIENTS COMPLICATED BY TYPE 2 DIABETES IS ASSOCIATED WITH MICROVASCULAR COMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e394-e395.
    PubMed     Text format     Abstract available


  471. OGOLA E
    OS 33-05 HIGH PREVALENCE AND POOR CONTROL OF HYPERTENSION AND ASSOCIATED CARDIOVASCULAR RISK FACORS IN DIABETIC PATIENTS IN A RURAL HOSPITAL IN KENYA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e394.
    PubMed     Text format     Abstract available


  472. OPARIL S, Calhoun DA, Ghazi L, Dudenbostel T, et al
    OS 33-02 IN PATIENTS WITH RESISTANT HYPERTENSION INCREASED 24-H URINARY CORTISOL LEVEL PREDICT INCREASED BODY MASS INDEX.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e393.
    PubMed     Text format     Abstract available


  473. PENG L, Xia K, Zhao Z, Li D, et al
    OS 32-09 THE BENEFICIAL EFFECT OF LOSARTAN ON PLATELET AGGREGATION RESULTS FROM THE REDUCTION OF ENDOGENOUS ASYMMETRIC DIMETHYL ARGININE IN SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e391-e392.
    PubMed     Text format     Abstract available


  474. YANG Z, Ruixin M, Jing Y
    OS 32-02 EFFECTS OF RENIN-ANGIOTENSIN SYSTEM INHIBITORS ON VAGINA AND CARDIAC EXPRESSION OF RAAS COMPONENTS IN FEMALE SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e390.
    PubMed     Text format     Abstract available


  475. CHEN X, Wang S, Li J, Zhou X, et al
    OS 31-06 COMPARISON BETWEEN THE EFFECTS OF HYDROCHLOROTHIAZIDE AND INDAPAMIDE ON THE KIDNEY IN HYPERTENSIVE PATIENTS INADEQUATELY CONTROLLED WITH LOSARTAN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e389.
    PubMed     Text format     Abstract available


  476. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 31-04 COMPARISON OF CALCIUM CHANNEL BLOCKERS VERSUS CALCIUM CHANNEL BLOCKERS WITH RENIN ANGIOTENSIN SYSTEM BLOCKERS ON THE DEVELOPMENT OF NEW-ONSET DIABETES MELLITUS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e388-e389.
    PubMed     Text format     Abstract available


  477. GIULIETTI F, Spannella F, Borioni E, Lombardi FE, et al
    OS 31-03 CLINICAL EFFECTIVENESS OF ANTI-HYPERTENSIVE THERAPY WITH ACEI OR ARB ASSESSED BY PLASMA RENIN ACTIVITY/PLASMA ALDOSTERONE CONCENTRATION RATIO.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e388.
    PubMed     Text format     Abstract available


  478. ZENG W, Chu T, Hu M, Kong A, et al
    OS 31-02 ANTIHYPERTENSIVE RESPONSE TO BISOPROLOL WAS NOT RELATED TO POLYMORPHISMS IN ADRB1 Or CYP2D6 IN CHINESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e388.
    PubMed     Text format     Abstract available


  479. KIM CH
    APSH PRE-1 WHAT CAN BE IMPROVED IN THE MANAGEMENT OF HYPERTENSION?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e387.
    PubMed     Text format     Abstract available


  480. KANG YY, Li Y, Huang QF, Song J, et al
    APSH YI-05 CIGARETTE SMOKING AND MASKED HYPERTENSION IN CHINESE MEN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e386.
    PubMed     Text format     Abstract available


  481. LEE CJ, Oh J, Lee SH, Kang SM, et al
    APSH YI-01 EFFECTS OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE AGENTS ON SURVIVAL IN PATIENTS WITH UNCOMPLICATED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e385.
    PubMed     Text format     Abstract available


  482. TOUYZ RM
    ISH PRE-2 THE VASCULAR PHENOTYPE IN HYPERTENSION - MOLECULAR MECHANISMS AND CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e384.
    PubMed     Text format     Abstract available


  483. SAFAR ME
    ISH PRE-1 REDUCTION OF CARDIOVASCULAR MORTALITY IN HYPERTENSIVES WITH COMORBIDITIES: BEYOND BLOOD PRESSURE LOWERING - THE ROLE OF ARTERIAL AGING.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e384.
    PubMed     Text format     Abstract available


  484. POGLITSCH M
    JS ISH-ECCR-4 THE PLASMA ALDOSTERONE / ANGIOTENSIN II RATIO FOR THE SCREENING OF SECONDARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e382-e383.
    PubMed     Text format     Abstract available


  485. ROSSI GP
    JS ISH-ECCR-3 A NOVEL ALGORITHM FOR THE CASE DETECTION OF THE MOST COMMON FORM OF ENDOCRINE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e382.
    PubMed     Text format     Abstract available


  486. FUJITA T
    ME 03-1 ROLE OF ALDOSTERNE AND MINERALOCORTICOID RECEPTOR IN SALT-SENSITIVE HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e379.
    PubMed     Text format     Abstract available


  487. WHELTON P
    SP 05-1 SHOULD THE TARGET FOR BLOOD PRESSURE REDUCTION BE LOWER IN ADULTS WITH HYPERTENSION AND A HISTORY OF CARDIOVASCULAR DISEASE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e378.
    PubMed     Text format     Abstract available


  488. BAKRIS G
    DB 03-2 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (CON).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e375.
    PubMed     Text format     Abstract available


  489. SCHLAICH M
    DB 03-1 RENAL SYMPATHETIC DENERVATION IS STILL A VIABLE OPTION FOR TREATING RESISTANT HYPERTENSION (PRO).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e375.
    PubMed     Text format     Abstract available


  490. SHI L
    ED 08-4 DIAGNOSIS AND TREATMENT OF HYPERTENSIVE EMERGENCY IN CHILDREN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e373-e374.
    PubMed     Text format     Abstract available


  491. AWAZU M
    ED 08-3 APPLICATION OF ABP MONITORING IN THE MANAGEMENT OF PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e373.
    PubMed     Text format     Abstract available


  492. DAVIES PF, Manduchi E, Stoeckert CJ, Jiang YZ, et al
    SY 15-2 ENDOTHELIAL EPIGENETICS AND ITS ROLE IN MEDIATING BIOMECHANICAL STRESS OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e371.
    PubMed     Text format     Abstract available


  493. SCHIFFRIN E
    SY 15-1 MECHANISM OF ENDOTHELIN-1 REGULATION IN HYPERTENSION: THE ROLE OF ENDOTHELIN TYPE A RECEPTORS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e371.
    PubMed     Text format     Abstract available


  494. MORISHITA R
    SY 14-4 VACCINE THERAPY FOR RESISTANT HYPERTENSION: IS IT A DYING ISSUE?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e369-e370.
    PubMed     Text format     Abstract available


  495. CALHOUN D
    SY 14-3 PRIMARY ALDOSTERONISM IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e369.
    PubMed     Text format     Abstract available


  496. VONGPATANASIN W
    SY 14-1 THERAPEUTIC DRUG MONITORING FACILITATES BLOOD PRESSURE CONTROL IN RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e369.
    PubMed     Text format     Abstract available


  497. DANIELS SR
    SY 13-2 LONG-TERM CARDIOVASCULAR RISK REDUCTION IN PEDIATRIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e368.
    PubMed     Text format     Abstract available


  498. BURRELL L
    SY 12-1 RENIN ANGIOTENSIN PATHWAY BEYOND ACE AND ANGIOTENSIN II RECEPTORS: HOW IT RELATES TO THE PATHOPHYSIOLOGY OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e367.
    PubMed     Text format     Abstract available


  499. RYAN MJ
    SY 11-4 CONNECTIVE TISSUE DISEASE AND ITS ASSOCIATION WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e366.
    PubMed     Text format     Abstract available


  500. OPARIL S
    SY 11-3 HYPERTENSION IN WOMEN: MORE DANGEROUS THAN IN MEN?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e366.
    PubMed     Text format     Abstract available


  501. KJELDSEN S
    PL 03-3 THE FUTURE DEVELOPMENT OF DRUG THERAPY FOR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e365.
    PubMed     Text format     Abstract available


  502. IMAI Y
    PL 03-2 REMOTE BLOOD PRESSURE MONITORING IN HYPERTENSION CARE: PRACTICE OF HYPERTENSION BY TELETRANSMISSION OF HOME BLOOD PRESSURE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e364-e365.
    PubMed     Text format     Abstract available


  503. STEINHUBL S
    PL 03-1 HYPERTENSION MANAGEMENT IN THE ERA OF DIGITAL INFORMATION AND COMMUNICATION TECHNOLOGIES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e364.
    PubMed     Text format     Abstract available


  504. SUGIURA T, Takase H, Murai S, Yamashiya S, et al
    OS 30-04 FUTURE HYPERTENSION CAN BE PREDICTED USING ELECTROCARDIOGRAM.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e255-e256.
    PubMed     Text format     Abstract available


  505. GAFAROV V, Gromova E, Panov D, Gagulin I, et al
    OS 30-03 GENDER DIFFERENCES OF AN ARTERIAL HYPERTENSION RISK IN POPULATION WITH SLEEP DISTURBANCE IN RUSSIA / SIBERIA: WHO PROGRAM MONICA-PSYCHOSOCIAL.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e255.
    PubMed     Text format     Abstract available


  506. DENTON K, Moritz K, Booth L, May C, et al
    OS 29-06 RESPONSE TO HEMORRHAGE FOLLOWING CATHETER-BASED RENAL DENERVATION IN SHEEP WITH HYPERTENSIVE KIDNEY DISEASE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e254.
    PubMed     Text format     Abstract available


  507. LI X, Hong M, Zhu D, Gao P, et al
    OS 29-05 RENAL DENERVATION ATTENUATES ALDOSTERONE EXPRESSION AND ASSOCIATED CARDIOVASCULAR PATHOPHYSIOLOGY IN ANGIOTENSIN II-INDUCED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e254.
    PubMed     Text format     Abstract available


  508. LIM JK, Burke S, Head G
    OS 29-01 TRANS-GENERATIONAL PROGRAMMING OF OBESITY RELATED HYPERTENSION: AMPLIFICATION OF LEPTIN SIGNALLING PATHWAY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e253.
    PubMed     Text format     Abstract available


  509. YADAV R, Yadav RK, Khadgawat R, Mehta N, et al
    OS 28-06 BENEFICIAL EFFECTS OF A 12-WEEK YOGA-BASED LIFESTYLE INTERVENTION ON CARDIO-METABOLIC RISK FACTORS AND ADIPOKINES IN SUBJECTS WITH PRE-HYPERTENSION OR HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e252.
    PubMed     Text format     Abstract available


  510. URATA H, Devarajan S, Okamura K
    OS 28-05 ANTIHYPERTENSIVE EFFECT OF CHYMASE INHIBITORY JAPANESE WATER PEPPER INTAKE IN SALT-DEPENDENT MODERATE HYPERTENSION MOUSE MODEL AND IN HUMAN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e252.
    PubMed     Text format     Abstract available


  511. OTT C, Kistner I, Schmid A, Friedrich S, et al
    OS 28-03 SECRETORY CAPACITY OF PANCREATIC BETA CELLS IS ENHANCED 6 MONTHS AFTER RENAL DENERVATION IN TREATMENT RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e251.
    PubMed     Text format     Abstract available


  512. SCHLAICH M, Hering D, Marusic P, Walton A, et al
    OS 28-02 RENAL DENERVATION ALTERS ADIPOKINE LEVELS IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e251.
    PubMed     Text format     Abstract available


  513. HRISTOVA K, Bogdanova V, Marinov R
    OS 27-04 PREDICTION OF LEFT VENTRICULAR DYSTOLIC DYSFUNCTION IN PATIENT WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e249-e250.
    PubMed     Text format     Abstract available


  514. YOON HJ
    OS 27-03 IMPAIRED DIASTOLIC RECOVERY BEFORE DISCHARGE IS ASSOCIATED WITH RE-HOSPITALIZATION WITH HYPERTENSIVE HEART FAILURE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e249.
    PubMed     Text format     Abstract available


  515. KIM MN, Cho D, Shim JM, Choi JI, et al
    OS 27-01 IS HYPERTENSION A RISK FACTOR FOR RECURRENCE AFTER RADIOFREQUENCY CATHETER ABLATION IN ATRIAL FIBRILLATION?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e249.
    PubMed     Text format     Abstract available


  516. SUN J, Steffen LM, Xi B
    OS 26-05 HOW TO ACCURATELY DEFINE PEDIATRIC HYPERTENSION: A SYSTEMATIC REVIEW.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e248.
    PubMed     Text format     Abstract available


  517. NGUI D, Qiu MJ, Mann M
    OS 26-04 TARGETING CARE GAPS IN PATIENTS WITH HYPERTENSION: A QUALITY IMPROVEMENT PROJECT UTILIZING EMR HYPERTENSION DASHBOARDS AND A CHRONIC DISEASE COORDINATOR.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e247-e248.
    PubMed     Text format     Abstract available


  518. KOCHARYAN L, Baghdasaryan L
    OS 26-02 A NEW APPROACH FOR THE MANAGEMENT AND MONITORING OF ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e247.
    PubMed     Text format     Abstract available


  519. MELIN P, Prado-Arechiga G, Pulido M, Miramontes I, et al
    OS 26-01 CLASSIFICATION OF ARTERIAL HYPERTENSION USING A COMPUTATIONAL MODEL BASED ON ARTIFICIAL MODULAR NEURAL NETWORKS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e247.
    PubMed     Text format     Abstract available


  520. CHAN J, Lo CS, Shi Y, Chenier I, et al
    OS 25-03 OVEREXPRESSION OF HETEROGENEOUS NUCLEAR RIBONUCLEOPROTEIN F PREVENTS SYSTEMIC HYPERTENSION AND KIDNEY INJURY AND NORMALIZES RENAL RENIN-ANGIOTENSIN SYSTEM GENES EXPRESSION IN TYPE 2 DIABETIC DB/DB TRANSGENIC MICE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e245.
    PubMed     Text format     Abstract available


  521. LIM JK, Barzel B, Burke S
    OS 25-02 ORIGIN OF NEUROGENIC HYPERTENSION AND THE SYMPATHO-EXCITATION IN DIET INDUCED OBESITY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e245.
    PubMed     Text format     Abstract available


  522. LEE JH, Baek JS, Yu JJ, Kim YH, et al
    OS 24-06 HIGH B-TYPE NATRIURETIC PEPTIDE IS ASSOCIATED WITH LEFT VENTRICULAR HYPERTROPHY AND HEART FAILURE IN CHILDREN WITH HYPERTENSION ON PERITONEAL DIALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e244.
    PubMed     Text format     Abstract available


  523. PALL D, Katona E, Zrinyi M, Lengyel S, et al
    OS 24-01 ASSESSMENT OF TARGET-ORGAN DAMAGE IN ADOLESCENT WHITE COAT AND SUSTAINED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e243.
    PubMed     Text format     Abstract available


  524. SHIN MS, Park SM, Kim MN, Kim HL, et al
    OS 23-05 LEFT VENTRICULAR HYPERTROPHY AND SIGNIFICANT CORONARY ARTERIAL STENOSIS INTERACTION IN HYPERTENSIVE WOMEN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e242.
    PubMed     Text format     Abstract available


  525. ZHAO X, Yu J
    OS 23-04 A NOVEL HORMONE THERAPY, DROSPIRENONE WITH ESTRADIOL FOR HYPERTENSIVE POSTMENOPAUSAL WOMEN: A SYSTEMIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e242.
    PubMed     Text format     Abstract available


  526. KIM SA, Park JB
    OS 23-03 MID-TRIMESTER RISK PREDICTION OF SUPERIMPOSED PRE-ECLAMPSIA IN PREGNANT WOMEN WITH CHRONIC HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e241.
    PubMed     Text format     Abstract available


  527. KIM S, Lim NK, Lee JH, Park HY, et al
    OS 22-09 Population-attributable risk of hypertension in development of Stroke: using the National Sample Cohort.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e240.
    PubMed     Text format     Abstract available


  528. LI N, Yao X, Zhou L, Abulikem S, et al
    OS 22-08 Prevalence of primary aldosteronism and its cardio-metabolic factors Chinese hypertensive patients in Xinjiang of China.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e240.
    PubMed     Text format     Abstract available


  529. PATIL M, Durairaj M, Tauseef SM
    OS 22-06 Evaluating the Health Related Quality of Life of Hypertensive Patients.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e239.
    PubMed     Text format     Abstract available


  530. ARAKAWA K, Ibaraki A, Kawamoto Y, Inoue M, et al
    OS 22-05 Variability of urinary salt excretion in treated hypertensive patients during several years.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e239.
    PubMed     Text format     Abstract available


  531. LEE JW, Lim NK, Lee JH, Park HY, et al
    OS 22-03 Joint effect of pre-existing hypertension and diabetes on cardiovascular diseases and mortality in the middle-aged Koreans.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e238-e239.
    PubMed     Text format     Abstract available


  532. WANG HH, Wang JJ, Lawson KD, Wong SY, et al
    OS 22-02 Hypertensive patients with multimorbidity in mainland China, Scotland, and Hong Kong: a cross-country population-based study.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e238.
    PubMed     Text format     Abstract available


  533. LEE CJ, Oh J, Lee SH, Kang SM, et al
    OS 22-01Treatment of Hypertension with Low Cardiovascular Risk is associated with significantly lowered mortality.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e238.
    PubMed     Text format     Abstract available


  534. NISHIYAMA A, Sufiun A, Fujisawa Y, Rahman A, et al
    OS 21-09 DIPPING PATTERN OF BLOOD PRESSURE AND RENAL INJURY IN DAHL SALT-SENSITIVE HYPERTENSIVE RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e237.
    PubMed     Text format     Abstract available


  535. VAVRINOVA A, Behuliak M, Zicha J
    OS 21-07 EXPRESSION OF CATECHOLAMINERGIC SYSTEM GENES IN ADRENAL MEDULLA OR SYMPATHETIC GANGLIA OF SPONTANEOUSLY HYPERTENSIVE RAT.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e236-e237.
    PubMed     Text format     Abstract available


  536. KROTOVA V, Khomazyuk T
    OS 20-09 DIAGNOSIS AND TREATMENT OF COGNITIVE DISORDERS IN ARTERIAL HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e234.
    PubMed     Text format     Abstract available


  537. ISHIKAWA J, Toba A, Yamanaka Y, Watanabe S, et al
    OS 20-08 GENDER-ADJUSTMENT AND CUTOFF LEVELS OF CORNELL PRODUCT IN ELECTROCARDIOGRAM AMONG JAPANESE HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e234.
    PubMed     Text format     Abstract available


  538. SECHI L, Colussi G, Novello M, Pezzutto F, et al
    OS 20-06 DAILY ALCOHOL CONSUMPTION AFFECTS LEFT VENTRICULAR DIASTOLIC FUNCTION IN HYPERTENSION: A TISSUE-DOPPLER STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e233.
    PubMed     Text format     Abstract available


  539. SEUNG-WOON R, Geol CB, Hu L, Oh NJ, et al
    OS 20-05 IMPACT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS UNDERWENT SUCCESSFUL PERCUTANEOUS CORONARY INTERVENTION WITH DRUG ELUTING STENTS ON LONG-TERM CLINICAL OUTCOMES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e233.
    PubMed     Text format     Abstract available


  540. CHI C, Zhang Y, Wang K, Wang L, et al
    OS 20-02 HYPERTENSIVE TARGET ORGAN DAMAGES ARE BETTER ASSOCIATED WITH CENTRAL THAN BRACHIAL BLOOD PRESSURE: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e232.
    PubMed     Text format     Abstract available


  541. JUNG SM, Ryu DR, Kim CT
    OS 19-07 PRESCRIPTION PATTERN OF RAS BLOCKADE IN KOREAN HYPERTENSIVE PATIENTS WITH PROTEINURIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e230.
    PubMed     Text format     Abstract available


  542. JEFFERS B, Zho D
    OS 19-02 RELATIONSHIP BETWEEN VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY (BPV) AND KIDNEY FUNCTION IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e228.
    PubMed     Text format     Abstract available


  543. ZHANG Y, Lu Y, Bai B, Yu S, et al
    OS 18-09 COMPARISON OF CAROTID-FEMORAL AND BRACHIAL-ANKLE PULSE WAVE VELOCITY IN THE ASSOCIATION WITH HYPERTENSIVE TARGET ORGAN DAMAGES IN THE COMMUNITY-DWELLING ELDERLY: THE NORTHERN SHANGHAI STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e226-e227.
    PubMed     Text format     Abstract available


  544. UCHIWA H, Kai H, Iwamoto Y, Anegawa T, et al
    OS 18-07 SAFETY AND EFFICACY OF ARB/HCTZ COMBINATION THERAPY IN CONTROLLING MORNING HYPERTENSION IN VERY ELDERLY PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e226.
    PubMed     Text format     Abstract available


  545. TRIAM-ANURUCK U, Vathesatogkit P, Yingchoncharoen T, Katekao W, et al
    OS 18-04 HYPERTENSION AS A PREDICTOR OF PATTERN OF LV HYPERTROPHY AND GEOMETRIC REMODELING IN ELDERLY: HAPPY MODEL STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e225.
    PubMed     Text format     Abstract available


  546. BOHLENDER J, Nussberger J, Bohlender B
    OS 18-02 ANTIHYPERTENSIVE TREATMENT AND RISK OF BRAIN ISCHEMIA DUE TO CAROTID STENOSIS IN A SURVEY OF HOSPITALISED PATIENTS AGED 90 YEARS AND OLDER.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e224.
    PubMed     Text format     Abstract available


  547. DE LA COLINA AN, Wu R, Desjardins-Crepeau L, Larochelle P, et al
    OS 18-01 CORRELATION BETWEEN COGNITIVE DECLINE AND BLOOD PRESSURE IN ELDERLY PATIENTS WITH CONTROLLED HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e224.
    PubMed     Text format     Abstract available


  548. WANG Z, Chen Z, Wang X, Hao G, et al
    OS 16-07 COST-EFFECTIVENESS OF NITRENDIPINE PLUS HYDROCHLOROTHIAZIDE OR METOPROLOL TO TREAT HYPERTENSION IN RURAL COMMUNITY HEALTH CENTERS IN CHINA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e220.
    PubMed     Text format     Abstract available


  549. REYNOLDS K, Shimbo D, Bowling CB, Deng L, et al
    OS 16-06 RISK FACTORS FOR SERIOUS FALL INJURIES FOLLOWING INITIATION OF ANTIHYPERTENSIVE MEDICATION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e219-e220.
    PubMed     Text format     Abstract available


  550. KAUSER M, Sr V, Rc K, Afreen A, et al
    OS 16-05 STUDY OF DETERMINANTS OF NONADHERENCE TO ANTI-HYPERTENSIVE MEDICATIONS IN ESSENTIAL HYPERTENSION AT A TEACHING HOSPITAL IN SOUTHERN INDIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e219.
    PubMed     Text format     Abstract available


  551. CHANG C, Zeng Q, Ji Y, Sun X, et al
    OS 16-04 EFFECTS OF HEALTH LITERACY ON BLOOD PRESSURE CONTROL AMONG HYPERTENSIVE: A MEDIATING EFFECT ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e219.
    PubMed     Text format     Abstract available


  552. YU Q, Liu B, Na R
    OS 16-01 THE EPIDEMIOLOGY SURVEY OF THE PREVALENCE AND RISK FACTORS OF HYPERTENSION AMONG RESIDENTS IN COUNTRY OF DALIAN ZHUANGHE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e218.
    PubMed     Text format     Abstract available


  553. HOOD KY, Yusuf H, Findlay JE, Santos RA, et al
    OS 15-08 Ang(1-7) INFLUENCES ET-1 SIGNALING THROUGH MAS: ETBR INTERACTIONS: IMPLICATIONS IN PULMONARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e216.
    PubMed     Text format     Abstract available


  554. KIM YG, Lee S, Moon JY, Kim SY, et al
    OS 15-06 SEQUENTIAL ACTIVATION OF INTRARENAL ACE/ACE2 AS THE PROGRESSION OF HYPERTENSIVE NEPHROPATHY IN 2-KIDNEY 10CLIP (2K1C) GOLDBLATT RATS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e216.
    PubMed     Text format     Abstract available


  555. SEO M, Sung KC
    OS 14-05 THE EFFECT OF URINARY ALBUMIN AND HYPERTENSION IN ALL-CAUSE AND CVD MORTALITY IN EAST ASIAN.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e213.
    PubMed     Text format     Abstract available


  556. SALVETTI M, Paini A, Rosei CA, Stassaldi D, et al
    OS 14-02 ON TREATMENT BLOOD PRESSURE VALUES AND CARDIAC ORGAN DAMAGE IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e212.
    PubMed     Text format     Abstract available


  557. ZHANG X, Zhang Y, Liu L, Zanchetti A, et al
    OS 14-01 AN ESTIMATED OPTIMAL HYPERTENSION LEVEL OF GOALS ON DRUG THERAPY FROM THE FEVER TRIAL.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e212.
    PubMed     Text format     Abstract available


  558. ZHANG Y, Chi C, Yu S, Argyris A, et al
    OS 13-08 ASSOCIATION OF CARDIAC STRUCTURE AND FUNCTION WITH CENTRAL AND BRACHIAL BLOOD PRESSURE VARIABILITY IN HYPERTENSIVE PATIENTS: THE SAFAR STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e210.
    PubMed     Text format     Abstract available


  559. CHENG YB, Xu TY, Yang Y, Guo QH, et al
    OS 13-05 PREVALENCE OF CENTRAL HYPERTENSION AND ITS ASSOCIATION WITH TARGET ORGAN DAMAGE IN UNTREATED CHINESE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e209.
    PubMed     Text format     Abstract available


  560. SALADINI F, Benetti E, Fania C, Mos L, et al
    OS 13-02 ASSOCIATION BETWEEN URIC ACID, METABOLIC VARIABLES AND ARTERIAL STIFFNESS IN THE EARLY PHASE OF HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e208.
    PubMed     Text format     Abstract available


  561. PANDEY D, Tori D, Nomura Y, Berkowitz D, et al
    YIA 03-10 ENDOTHELIAL KRUPPEL-LIKE FACTOR 15: A NOVEL TARGET FOR THE TREATMENT OF PULMONARY HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e206-e207.
    PubMed     Text format     Abstract available


  562. RAMADHIANI R, Rohman MS, Widodo N, Putri VY, et al
    YIA 03-05 BLOOD PRESSURE REDUCTION AND DIFFERENT C/EBPalpha-DNA BINDING PATTERN IN TELMISARTAN-TREATED ANGIOTENSINOGEN G-217A POLYMORPHISM HYPERTENSIVE PATIENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e205.
    PubMed     Text format     Abstract available


  563. BEHULIAK M, Bencze M, Vavrinova A, Vaneckova I, et al
    YIA 03-03 EFFECT OF GABAPENTIN, LIGAND OF ALPHA 2 DELTA SUBUNIT OF VOLTAGE-DEPENDENT CALCIUM CHANNELS, ON BLOOD PRESSURE AND BAROREFLEX SENSITIVITY IN SPONTANEOUSLY HYPERTENSIVE RATS: THE INFLUENCE OF GUANETHIDINE-INDUCED SYMPATHECTOMY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e204.
    PubMed     Text format     Abstract available


  564. RUAN CC, Li Y, Ma Y, Zhu DL, et al
    YIA 03-02 ADIPONECTIN-MEDIATED EPITHELIAL AUTOPHAGY ATTENUATES HYPERTENSIVE RENAL FIBROSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e204.
    PubMed     Text format     Abstract available


  565. PERI-OKONNY P, Ayers C, Maalouf N, Das S, et al
    YIA 02-04 RELATIONSHIP BETWEEN LEPTIN AND INCIDENT HYPERTENSION; OBSERVATIONS FROM THE DALLAS HEART STUDY.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e203.
    PubMed     Text format     Abstract available


  566. SUNG KC
    JS KSH-JSH-CHL 01-2 HYPERTENSION, ADDITIONAL MAKERS AND MORTALITY IN SUBJECTS WITH METABOLIC SYNDROME: BIG DATA ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e200.
    PubMed     Text format     Abstract available


  567. ITOH H
    JS KSH-JSH-CHL 01-1 CARDIO-METABOLIC RISKS IN HYPERTENSION: ARE WE DIFFERENT FROM WESTERN SOCIETIES?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e200.
    PubMed     Text format     Abstract available


  568. YIM DS
    BR 04-2 CONCENTRATION-RESPONSE MODELING OF ANTIHYPERTENSIVE DRUGS - IMPLICATION IN CLINICAL DEVELOPMENT.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e198.
    PubMed     Text format     Abstract available


  569. WEBB DJ
    BR 04-1MANAGEMENT OF TREATMENT-RESISTANT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e198.
    PubMed     Text format     Abstract available


  570. CARLBERG B
    ME 02-1 IS LOWER REALLY BETTER? ISSUE OF THE J CURVE HYPOTHESIS IN HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e196.
    PubMed     Text format     Abstract available


  571. TOMASZEWSKI M
    SP 03-2 ASSESSMENT OF ADHERENCE TO ANTIHYPERTENSIVE TREATMENT BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY-TANDEM MASS SPECTROMETRY (HP LC-MS/MS) URINE ANALYSIS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e195.
    PubMed     Text format     Abstract available


  572. SCHIFFRIN E
    SP 02-5 DO WE NEED A NEW DEFINITION OF HYPERTENSION?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e194.
    PubMed     Text format     Abstract available


  573. CUSHMAN WC
    JS ISH-ESH-4 WHAT DO CLINICAL TRIALS TEACH US ABOUT SELECTION OF ANTIHYPERTENSIVE DRUGS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e193.
    PubMed     Text format     Abstract available


  574. DECHEND R
    JS ISH-ESH-3 RESISTANT HYPERTENSION - A GROWING CHALLENGE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e193.
    PubMed     Text format     Abstract available


  575. ROSEI EA
    JS ISH-ESH-2 UPDATE ON THE DETECTION AND FOLLOW-UP OF EARLY HYPERTENSIVE HEART DISEASE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e192-e193.
    PubMed     Text format     Abstract available


  576. BAKRIS G
    JS ISH-ISN-2 ROLE OF THE KIDNEY IN RESISTANT HYPERTENSION: WHY SO RESISTANT TO BP CONTROL IN CKD PATIENTS?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e191.
    PubMed     Text format     Abstract available


  577. WILCOX C
    JS ISH-ISN-1 OXIDATIVE STRESS, THE KIDNEY AND HYPERTENSION CLINICAL IMPLICATIONS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e191.
    PubMed     Text format     Abstract available


  578. APPEL L
    DB 02-3 STRICT CONTROL OF HYPERTENSION IN THE ELDERLY WITH DIABETES AND CHRONIC KIDNEY DISEASE (PRO).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e190.
    PubMed     Text format     Abstract available


  579. RAKUGI H
    DB 02-2 STRICT CONTROL OF HYPERTENSION IN THE FRAIL ELDERLY: IS IT BENEFICIAL? (CON).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e190.
    PubMed     Text format     Abstract available


  580. KIM KI
    DB 02-1 STRICT CONTROL OF HYPERTENSION IN THE FRAIL ELDERLY: IS IT BENEFICIAL? (PRO).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e190.
    PubMed     Text format     Abstract available


  581. SHARMAN J
    ED 07-4 IS EXERCISE-INDUCED HYPERTENSION ASSOCIATED WITH ADVERSE CARDIOVASCULAR OUTCOMES?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e189.
    PubMed     Text format     Abstract available


  582. KOKKINOS P
    ED 07-2 TO LIFT, WALK OR RUN: WHAT IS THE OPTIMAL MODE OF EXERCISE TO REDUCE HYPERTENSION AND PREVENT CARDIOVASCULAR DISEASE?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e189.
    PubMed     Text format     Abstract available


  583. JAE SY
    ED 07-1 CONTRIBUTION OF CARDIOPULMONARY FITNESS IN OBESITY PHENOTYPES AND INCIDENT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e189.
    PubMed     Text format     Abstract available


  584. SARZANI R
    ED 05-4 NATRIURETIC PEPTIDES, METABOLIC SYNDROME AND HYPERTENSION: AN INTEGRATED VIEW.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e187.
    PubMed     Text format     Abstract available


  585. MERTENS P
    SY 10-3 SGLT2 INHIBITORS AS POTENTIAL ANTIHYPERTENSIVE AND RENOPROTECTIVE AGENTS.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e186.
    PubMed     Text format     Abstract available


  586. NISHIYAMA A
    SY 09-3 ROLE OF INTRARENAL RAS IN THE PATHOGENESIS OF SALT-DEPENDENT HYPERTENSION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e184-e185.
    PubMed     Text format     Abstract available


  587. SHIMADA K
    SY 08-2 HYPERTENSION MANAGEMENT FOR SECONDARY PREVENTION OF STROKE.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e183.
    PubMed     Text format     Abstract available


  588. WEBER M
    PL 02-3 MANAGEMENT OF ELDERLY HYPERTENSION: WHOM TO TREAT AND HOW LOW TO GO.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e182.
    PubMed     Text format     Abstract available


  589. KOKUBO Y
    PL 02-2 PERSPECTIVE ON ELDERLY HYPERTENSION IN ASIA.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e182.
    PubMed     Text format     Abstract available


  590. WANG W, Ma L, Sui H, Liu L, et al
    OS 12-05 THE EFFECT OF INTENSIVE LIFESTYLE INTERVENTION ON BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION, SUB-ANALYSIS FROM CHIEF.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e77.
    PubMed     Text format     Abstract available


  591. KARIO K, Hoshide S
    OS 12-01 ARB AND CCB LONGEST COMBINATION TREATMENT ON AMBULATORY AND HOME BP IN HYPERTENSION WITH ATRIAL FIBRILLATION - MULTICENTER STUDY ON TIME OF DOSING (ACROBAT).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e76.
    PubMed     Text format     Abstract available


  592. SOKOLOVIC S, Mehmedagic S
    OS 11-06 The effect of vagus nerve stimulation on arterial hypertension using active implantable device.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e75.
    PubMed     Text format     Abstract available


  593. WALAS D, Von Roloff E, Paton J
    OS 11-05 Superior cervical ganglionectomy (SCGx) reduces sympathetic innervation of vertebrobasilar arteries but does not affect cerebrovascular remodelling in the adult spontaneously hypertensive rat (SHR).
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e75.
    PubMed     Text format     Abstract available


  594. NISHIYAMA A, Hitomi H, Nakano D, Fujisawa Y, et al
    OS 11-03 Role of renal nervous activity in the development of renovascular hypertension in rats.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e74-e75.
    PubMed     Text format     Abstract available


  595. KIM MN, Kim YB, Park SM, Kim YI, et al
    OS 11-02 Effect of estrogen on the change of GABA function in the vasopressin neurons of salt-dependent hypertension model rats.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e74.
    PubMed     Text format     Abstract available


  596. WAINFORD R, Carmichael C, Walsh K
    OS 11-01 Afferent renal nerve modulation of sodium homeostasis and blood pressure: A sodium sensitive PVN Galphai2 protein dependent mechanism countering the development of salt-sensitive hypertension?
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e74.
    PubMed     Text format     Abstract available


  597. PAULETTO P, Puato M, Rattazzi M, Buso R, et al
    OS 10-06 THE IMPACT OF WELL CONTROLLED BLOOD PRESSURE LEVELS ON ARTERIAL PROPERTIES IN ESSENTIAL HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e73.
    PubMed     Text format     Abstract available


  598. LIU Z, Zhao Y, Dong Y, Lu B, et al
    OS 10-02 EFFECTS OF HELICOBACTER PYLORI INFECTION ON ATHEROSCLEROSIS WITH HYPERTENSION AND TYPE 2 DIABETES MELLITUS IN AGED POPULATION.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e72.
    PubMed     Text format     Abstract available


  599. BURSZTYN M, Ben-Dov IZ
    OS 09-03 EXTREME DIPPING IS NOT ASSOCIATED WITH INCREASED MORTALITY IN BOTH TREATED AND UNTREATED HYPERTENSIVES.
    J Hypertens. 2016;34 Suppl 1 - ISH 2016 Abstract Book:e70.
    PubMed     Text format     Abstract available


    August 2016
  600. ZANCHETTI A
    Genetic and environmental factors in development of hypertension.
    J Hypertens. 2016.
    PubMed     Text format    


  601. MUSICHA C, Crampin AC, Kayuni N, Koole O, et al
    Accessing clinical services and retention in care following screening for hypertension and diabetes among Malawian adults: an urban/rural comparison.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  602. ANTIKAINEN RL, Peters R, Beckett NS, Fagard RH, et al
    Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  603. KARAMAT FA, Oudman I, Haan YC, van Kuilenburg AB, et al
    Creatine kinase inhibition lowers systemic arterial blood pressure in spontaneously hypertensive rats: a randomized controlled trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  604. LEHMANN N, Erbel R, Mahabadi AA, Kalsch H, et al
    Accelerated progression of coronary artery calcification in hypertension but also prehypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  605. KIM GR, Cho SN, Kim HS, Yu SY, et al
    Histone deacetylase and GATA-binding factor 6 regulate arterial remodeling in angiotensin II-induced hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  606. WOHLFAHRT P, Cifkova R, Movsisyan N, Kunzova S, et al
    Threshold for diagnosing hypertension by automated office blood pressure using random sample population data.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  607. CHUANG SY, Chiu TH, Lee CY, Liu TT, et al
    Vegetarian diet reduces the risk of hypertension independent of abdominal obesity and inflammation: a prospective study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  608. OMBONI S, Aristizabal D, De la Sierra A, Dolan E, et al
    Hypertension types defined by clinic and ambulatory blood pressure in 14 143 patients referred to hypertension clinics worldwide. Data from the ARTEMIS study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  609. SALAZAR MR, Espeche WG, Leiva Sisnieguez BC, Balbin E, et al
    Significance of masked and nocturnal hypertension in normotensive women coursing a high-risk pregnancy.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  610. MUNTNER P, Booth JN 3rd, Shimbo D, Schwartz JE, et al
    Is white-coat hypertension associated with increased cardiovascular and mortality risk?
    J Hypertens. 2016;34:1655-8.
    PubMed     Text format    


  611. SCHLAICH MP, Schultz C, Shetty S
    Renal denervation for resistant hypertension: closing in on potential confounders.
    J Hypertens. 2016;34:1505-6.
    PubMed     Text format    


  612. JORDAN J, Grassi G, Tank J
    Device-based treatments in hypertension: think physiology.
    J Hypertens. 2016;34:1502-4.
    PubMed     Text format    


  613. TADDEI S, Bruno RM
    Endothelial dysfunction in hypertension: achievements and open questions.
    J Hypertens. 2016;34:1492-3.
    PubMed     Text format    


  614. KJELDSEN SE, Os I, Redon J
    Treatment of hypertension and the price to pay; adverse events and discontinuation from randomized treatment in clinical trials.
    J Hypertens. 2016;34:1489-91.
    PubMed     Text format    


  615. ZANCHETTI A
    Challenges of antihypertensive treatment.
    J Hypertens. 2016;34:1449-50.
    PubMed     Text format    


    July 2016
  616. ZANCHETTI A
    The approach to hypertension: from childhood to old age.
    J Hypertens. 2016.
    PubMed     Text format    


  617. ONWUBERE B, Coca A, Damasceno A, Kadiri S, et al
    Report of the International Society of Hypertension Teaching Seminar organized by the International Society of Hypertension Africa Regional Advisory Group: Maputo, Mozambique, 2016.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  618. LURBE E, Agabiti-Rosei E, Cruickshank JK, Dominiczak A, et al
    2016 European Society of Hypertension guidelines for the management of high blood pressure in children and adolescents.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  619. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood-pressure-lowering treatment in hypertension: 9. Discontinuations for adverse events attributed to different classes of antihypertensive drugs: meta-analyses of randomized trials.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  620. DE COSMO S, Viazzi F, Piscitelli P, Giorda C, et al
    Blood pressure status and the incidence of diabetic kidney disease in patients with hypertension and type 2 diabetes.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  621. BURSZTYN M, Jacobs JM, Hammerman-Rozenberg A, Stessman J, et al
    Prevalence of orthostatic hypertension in the very elderly and its relationship to all-cause mortality.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  622. TENTORI S, Messaggio E, Brioni E, Casamassima N, et al
    Endogenous ouabain and aldosterone are coelevated in the circulation of patients with essential hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  623. HERRERA NA, Jesus I, Shinohara AL, Dionisio TJ, et al
    Exercise training attenuates dexamethasone-induced hypertension by improving autonomic balance to the heart, sympathetic vascular modulation and skeletal muscle microcirculation.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  624. JICHOVA S, Kopkan L, Huskova Z, Dolezelova S, et al
    Epoxyeicosatrienoic acid analog attenuates the development of malignant hypertension, but does not reverse it once established: a study in Cyp1a1-Ren-2 transgenic rats.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  625. IMPRIALOS K, Boutari C, Stavropoulos K, Doumas M, et al
    Depression in hypertensive patients: the role of comorbidities.
    J Hypertens. 2016;34:1441.
    PubMed     Text format    


  626. ZANCHETTI A
    From pregnancy to childhood and adulthood: the trajectory of hypertension.
    J Hypertens. 2016;34:1235-1236.
    PubMed     Text format    


  627. NIEMIRSKA A, Litwin M, Trojanek J, Gackowska L, et al
    Altered matrix metalloproteinase 9 and tissue inhibitor of metalloproteinases 1 levels in children with primary hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  628. HAMER M, Kivimaki M, Batty GD
    Pulse rate reactivity in childhood as a risk factor for adult hypertension: the 1970 British cohort study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  629. MAHFOUD F, Moon LB, Pipenhagen CA, Jensen JA, et al
    Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


    June 2016
  630. SANTOS LP, Moraes RS, Vieira PJ, Ash GI, et al
    Effects of aerobic exercise intensity on ambulatory blood pressure and vascular responses in resistant hypertension: a crossover trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  631. DE SIMONE G, Izzo R, Losi MA, Stabile E, et al
    Depressed myocardial energetic efficiency is associated with increased cardiovascular risk in hypertensive left ventricular hypertrophy.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  632. BOMBELLI M, Maloberti A, Raina L, Facchetti R, et al
    Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: data from the Pressioni Arteriose Monitorate E Loro Associazioni study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  633. MAATOUK I, Herzog W, Bohlen F, Quinzler R, et al
    Association of hypertension with depression and generalized anxiety symptoms in a large population-based sample of older adults.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  634. OLIVERAS A, Armario P, Clara A, Sans-Atxer L, et al
    Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  635. RAUTIAINEN S, Wang L, Lee IM, Manson JE, et al
    Multivitamin use and the risk of hypertension in a prospective cohort study of women.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  636. SHIMADA K, Kario K, Kushiro T, Teramukai S, et al
    Prognostic significance of on-treatment home and clinic blood pressure for predicting cardiovascular events in hypertensive patients in the HONEST study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  637. SONG J, Sheng CS, Huang QF, Li LH, et al
    Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians: a China registry.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  638. LEEUW JV, Berra E, Gu Y, Petit T, et al
    Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension?
    J Hypertens. 2016.
    PubMed     Text format    


  639. REDON J, Mourad JJ, Schmieder RE, Volpe M, et al
    Why in 2016 are patients with hypertension not 100% controlled? A call to action.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  640. LI Z, Guo X, Sun Y
    Relationship between aortic root size and glomerular filtration rate in hypertensive patients.
    J Hypertens. 2016;34:1232-3.
    PubMed     Text format    


  641. GALDERISI M, Trimarco B
    Global longitudinal strain: a novel hallmark of cardiac risk in arterial hypertension.
    J Hypertens. 2016;34:1050-1.
    PubMed     Text format    


  642. VIAZZI F, Grassi G, Pontremoli R
    Can we predict outcome by noninvasive assessment of renal haemodynamics in hypertension? The role of renal resistive index.
    J Hypertens. 2016;34:1047-9.
    PubMed     Text format    


    May 2016
  643. VIAZZI F, Muiesan ML, Schillaci G, Salvetti M, et al
    Changes in albuminuria and cardiovascular risk under antihypertensive treatment: a systematic review and meta-regression analysis.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  644. OKIN PM, Kamel H, Kjeldsen SE, Devereux RB, et al
    Electrocardiographic left atrial abnormality and risk of incident stroke in hypertensive patients with electrocardiographic left ventricular hypertrophy.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  645. CHEN X, Liu Y, Wang WE, Chen C, et al
    Effect of D3 dopamine receptor on dopamine D4 receptor expression and function in renal proximal tubule cells from Wistar-Kyoto rats and spontaneously hypertensive rats.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  646. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood pressure lowering treatment in hypertension: 8. Outcome reductions vs. discontinuations because of adverse drug events - meta-analyses of randomized trials.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  647. MATHIASSEN ON, Vase H, Bech JN, Christensen KL, et al
    Renal denervation in treatment-resistant essential hypertension. A randomized, SHAM-controlled, double-blinded 24-h blood pressure-based trial.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  648. SOULLIER C, Niamkey JT, Ricci JE, Messner-Pellenc P, et al
    Hypertensive patients with left ventricular hypertrophy have global left atrial dysfunction and impaired atrio-ventricular coupling.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  649. STERGIOU GS, Parati G, Vlachopoulos C, Achimastos A, et al
    Methodology and technology for peripheral and central blood pressure and blood pressure variability measurement: current status and future directions - Position statement of the European Society of Hypertension Working Group on blood pressure monitori
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  650. VAN TWIST DJ, Houben AJ, de Leeuw PW, Kroon AA, et al
    Acute eprosartan-induced intrarenal vasodilation in hypertensive humans is not influenced by dietary sodium intake or angiotensin II co-infusion.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  651. ANDERSEN H, Hansen PB, Bistrup C, Nielsen F, et al
    Significant natriuretic and antihypertensive action of the epithelial sodium channel blocker amiloride in diabetic patients with and without nephropathy.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  652. MORDI I, Mordi N, Delles C, Tzemos N, et al
    Endothelial dysfunction in human essential hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  653. IOAKEIMIDIS N, Vlachopoulos C, Rokkas K, Kratiras Z, et al
    Dynamic penile peak systolic velocity predicts major adverse cardiovascular events in hypertensive patients with erectile dysfunction.
    J Hypertens. 2016;34:860-868.
    PubMed     Text format     Abstract available


  654. NARGESI AA, Esteghamati S, Heidari B, Hafezi-Nejad N, et al
    Nonlinear relation between pulse pressure and coronary heart disease in patients with type 2 diabetes or hypertension.
    J Hypertens. 2016;34:974-80.
    PubMed     Text format     Abstract available


  655. BANG CN, Okin PM
    Does electrocardiography still have a place in hypertension?
    J Hypertens. 2016;34:842-4.
    PubMed     Text format    


  656. SPRADLEY FT
    Optimizing inhibition of the renin-angiotensin system in hypertension.
    J Hypertens. 2016;34:838-41.
    PubMed     Text format    


  657. FERREIRA I, Healy GN
    Shifting away from sedentary time, and FITTing exercise into the treatment of hypertension.
    J Hypertens. 2016;34:830-2.
    PubMed     Text format    


  658. RAHMAN A, Kittikulsuth W, Fujisawa Y, Sufiun A, et al
    Effects of diuretics on sodium-dependent glucose cotransporter 2 inhibitor-induced changes in blood pressure in obese rats suffering from the metabolic syndrome.
    J Hypertens. 2016;34:893-906.
    PubMed     Text format     Abstract available


  659. MARIE PY, Mandry D, Huttin O, Micard E, et al
    Comprehensive monitoring of cardiac remodeling with aortic stroke volume values provided by a phase-contrast MRI sequence.
    J Hypertens. 2016;34:967-73.
    PubMed     Text format     Abstract available


    April 2016
  660. HU T, Guralnik JM, Yao L, Gustat J, et al
    Postural hand tremor and incident hypertension in young to middle-aged adults: the Bogalusa heart study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  661. ROHLA M, Haberfeld H, Tscharre M, Huber K, et al
    Awareness, treatment, and control of hypertension in Austria: a multicentre cross-sectional study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  662. SANCHEZ-INIGO L, Navarro-Gonzalez D, Pastrana-Delgado J, Fernandez-Montero A, et al
    Association of triglycerides and new lipid markers with the incidence of hypertension in a Spanish cohort.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  663. CARLISLE RE, Werner KE, Yum V, Lu C, et al
    Endoplasmic reticulum stress inhibition reduces hypertension through the preservation of resistance blood vessel structure and function.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  664. LUPAT A, Hengelbrock J, Luissin M, Fix M, et al
    Brunei epidemiological stroke study: patterns of hypertension and stroke risk.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  665. FYFE-JOHNSON AL, Alonso A, Selvin E, Bower JK, et al
    Serum fibroblast growth factor-23 and incident hypertension: the atherosclerosis risk in communities study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  666. ZANCHETTI A
    Prediction, diagnosis and treatment of hypertension.
    J Hypertens. 2016.
    PubMed     Text format    


  667. LONNEBAKKEN MT, Izzo R, Mancusi C, Losi MA, et al
    Aortic root dimension and arterial stiffness in arterial hypertension: the Campania Salute Network.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  668. REDON J, Tellez-Plaza M, Orozco-Beltran D, Gil-Guillen V, et al
    Impact of hypertension on mortality and cardiovascular disease burden in patients with cardiovascular risk factors from a general practice setting: the ESCARVAL-risk study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  669. IWASHIMA Y, Fukuda T, Yoshihara F, Kusunoki H, et al
    Incidence and risk factors for restenosis, and its impact on blood pressure control after percutaneous transluminal renal angioplasty in hypertensive patients with renal artery stenosis.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  670. ROSENBAUM D, Mattina A, Koch E, Rossant F, et al
    Effects of age, blood pressure and antihypertensive treatments on retinal arterioles remodeling assessed by adaptive optics.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  671. BUUS NH, Mulvany MJ, Eiskjaer H, Christensen KL, et al
    Renal resistance and long-term blood pressure in individuals genetically predisposed for essential hypertension: 10-year follow-up of the Danish Hypertension Prevention Project.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  672. FUCHS FD, Scala LC, Vilela-Martin JF, de Mello RB, et al
    Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial.
    J Hypertens. 2016;34:798-806.
    PubMed     Text format     Abstract available


  673. JORDAN J, Grassi G
    Precision medicine should become more 'sympathetic' in managing hypertension.
    J Hypertens. 2016;34:629-31.
    PubMed     Text format    


  674. MANCIA G
    Clinical significance of white-coat hypertension.
    J Hypertens. 2016;34:623-6.
    PubMed     Text format    


  675. COCA A, Camafort M
    Relationship between systolic blood pressure and mortality in patients with severe cognitive impairment: extremes are bad.
    J Hypertens. 2016;34:632-3.
    PubMed     Text format    


  676. HIRAKAWA Y, Arima H, Webster R, Zoungas S, et al
    Risks associated with permanent discontinuation of blood pressure-lowering medications in patients with type 2 diabetes.
    J Hypertens. 2016;34:781-7.
    PubMed     Text format     Abstract available


  677. KERLEY CP, Dolan E, Cormican L
    Dietary nitrate decreased blood pressure in obstructive sleep apnoea syndrome: a series of N-of-1 trials.
    J Hypertens. 2016;34:808-10.
    PubMed     Text format    


  678. MISSOURIS CG, Markandu ND, He FJ, Papavasileiou MV, et al
    Urinary catecholamines and the relationship with blood pressure and pharmacological therapy.
    J Hypertens. 2016;34:704-9.
    PubMed     Text format     Abstract available


    March 2016
  679. LEE WH, Liu YW, Yang LT, Tsai WC, et al
    Prognostic value of longitudinal strain of subepicardial myocardium in patients with hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  680. KUNUTSOR SK, Laukkanen JA
    Serum zinc concentrations and incident hypertension: new findings from a population-based cohort study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  681. THOMAS HN, Evans GW, Berlowitz DR, Chertow GM, et al
    Antihypertensive medications and sexual function in women: baseline data from the SBP intervention trial (SPRINT).
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  682. SATOH M, Haga T, Hosaka M, Obara T, et al
    The velocity of antihypertensive effects of seven angiotensin II receptor blockers determined by home blood pressure measurements.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  683. LEMBO M, Esposito R, Lo Iudice F, Santoro C, et al
    Impact of pulse pressure on left ventricular global longitudinal strain in normotensive and newly diagnosed, untreated hypertensive patients.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  684. YANNOUTSOS A, Ahouah M, Tubiana CD, Topouchian J, et al
    Hemodynamic parameters in hypertensive diabetic patients.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  685. SENGUL S, Akpolat T, Erdem Y, Derici U, et al
    Changes in hypertension prevalence, awareness, treatment, and control rates in Turkey from 2003 to 2012.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  686. LIANTONIO A, Imbrici P, Camerino GM, Fracchiolla G, et al
    Kidney CLC-K chloride channels inhibitors: structure-based studies and efficacy in hypertension and associated CLC-K polymorphisms.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  687. ZANCHETTI A
    Prognostic, diagnostic, and therapeutic advances in hypertension.
    J Hypertens. 2016.
    PubMed     Text format    


  688. PALATINI P, Rosei EA, Casiglia E, Chalmers J, et al
    Management of the hypertensive patient with elevated heart rate: statement of the second consensus conference endorsed by the European Society of Hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  689. SONAWANE KB, Qian J, Garza KB, Wright BM, et al
    Patterns of treatment modifications among newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation?
    J Hypertens. 2016;34:548-57.
    PubMed     Text format     Abstract available


  690. FERNALD FF, van den Born BJ, Snijder MB, Brewster LM, et al
    Hypertension awareness, treatment, and control among diabetic and nondiabetic individuals in a multiethnic population in the Netherlands: the HELIUS study.
    J Hypertens. 2016;34:539-47.
    PubMed     Text format     Abstract available


  691. BARZEL B, Lim K, Davern PJ, Burke SL, et al
    Central proopiomelanocortin but not neuropeptide Y mediates sympathoexcitation and hypertension in fat fed conscious rabbits.
    J Hypertens. 2016;34:464-73.
    PubMed     Text format     Abstract available


  692. ZANCHETTI A
    Dietary, clinical and therapeutic aspects of hypertension.
    J Hypertens. 2016;34:371-2.
    PubMed     Text format    


  693. CHANG CH, Chiang CH, Yen CJ, Wu LC, et al
    Antihypertensive agents and the risk of breast cancer in women aged 55 years and older: a nested case-control study.
    J Hypertens. 2016;34:558-66.
    PubMed     Text format     Abstract available


  694. GRAHAM N, Smith DJ
    Comorbidity of depression and anxiety disorders in patients with hypertension.
    J Hypertens. 2016;34:397-8.
    PubMed     Text format    


    February 2016
  695. GOSMANOV AR, Lu JL, Sumida K, Potukuchi PK, et al
    Synergistic association of combined glycemic and blood pressure level with risk of complications in US veterans with diabetes.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  696. MECCARIELLO A, Buono F, Verrengia E, Orefice G, et al
    Microalbuminuria predicts the recurrence of cardiovascular events in patients with essential hypertension.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  697. WANG YK, Yu Q, Tan X, Wu ZT, et al
    Centrally acting drug moxonidine decreases reactive oxygen species via inactivation of the phosphoinositide-3 kinase signaling in the rostral ventrolateral medulla in hypertensive rats.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  698. LEHTONEN AO, Puukka P, Varis J, Porthan K, et al
    Prevalence and prognosis of ECG abnormalities in normotensive and hypertensive individuals.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  699. TULLY PJ, Hanon O, Cosh S, Tzourio C, et al
    Diuretic antihypertensive drugs and incident dementia risk: a systematic review, meta-analysis and meta-regression of prospective studies.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  700. GHAZI L, Dudenbostel T, Lin CP, Oparil S, et al
    Urinary sodium excretion predicts blood pressure response to spironolactone in patients with resistant hypertension independent of aldosterone status.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  701. WANG IK, Chen JH, Muo CH, Chou CY, et al
    Subsequent risk of gout for women with hypertensive disorders in pregnancy: a retrospective cohort study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  702. NIE X, Qin G, Mao W, Wang W, et al
    Axis inhibition protein 2 deficiency leads to hypoxic pulmonary hypertension through beta-catenin signaling pathway.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  703. KIKUCHI N, Jujo K, Yamaguchi J, Ogawa H, et al
    Impact of left ventricular ejection function on blood pressure-lowering therapy in hypertensive patients with coronary artery disease.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  704. ZANCHETTI A
    Prediction and prevention of hypertension-related events.
    J Hypertens. 2016.
    PubMed     Text format    


  705. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  706. MCLEAN G, Band R, Saunderson K, Hanlon P, et al
    Digital interventions to promote self-management in adults with hypertension systematic review and meta-analysis.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  707. PIETILA-EFFATI PM, Salmela AK, Niemi RT, Ylitalo AS, et al
    Renal sympathetic denervation in treating drug-resistant hypertension in a patient on hemodialysis.
    J Hypertens. 2016;34:368-70.
    PubMed     Text format     Abstract available


  708. BOOTH JN 3RD, Muntner P, Abdalla M, Diaz KM, et al
    Differences in night-time and daytime ambulatory blood pressure when diurnal periods are defined by self-report, fixed-times, and actigraphy: Improving the Detection of Hypertension study.
    J Hypertens. 2016;34:235-43.
    PubMed     Text format     Abstract available


  709. YAO L, Folsom AR, Pankow JS, Selvin E, et al
    Parathyroid hormone and the risk of incident hypertension: the Atherosclerosis Risk in Communities study.
    J Hypertens. 2016;34:196-203.
    PubMed     Text format     Abstract available


  710. REDON J
    The risk of visit-to-visit blood pressure variability in chronic kidney disease: cause or consequence.
    J Hypertens. 2016;34:188-90.
    PubMed     Text format    


  711. REDON J, Pichler G
    Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
    J Hypertens. 2016;34:359-67.
    PubMed     Text format     Abstract available


  712. KOTON S, Eizenberg Y, Tanne D, Grossman E, et al
    Trends in admission blood pressure and stroke outcome in patients with acute stroke and transient ischemic attack in a National Acute Stroke registry.
    J Hypertens. 2016;34:316-22.
    PubMed     Text format     Abstract available


  713. GRIFFIN TP, Browne GA, Wall D, Dennedy MC, et al
    A cross-sectional study of the effects of beta-blocker therapy on the interpretation of the aldosterone/renin ratio: can dosing regimen predict effect?
    J Hypertens. 2016;34:307-15.
    PubMed     Text format     Abstract available


  714. NORMAN G, Norton GR, Gomes M, Michel F, et al
    Circulating resistin concentrations are independently associated with aortic pulse wave velocity in a community sample.
    J Hypertens. 2016;34:274-81.
    PubMed     Text format     Abstract available


  715. MIDDLEMISS JE, Miles KL, McDonnell BJ, Yasmin, et al
    Mechanisms underlying elevated SBP differ with adiposity in young adults: the Enigma study.
    J Hypertens. 2016;34:290-7.
    PubMed     Text format     Abstract available


  716. SOUZA BDA S, Cunha DB, Pereira RA, Sichieri R, et al
    Soft drink consumption, mainly diet ones, is associated with increased blood pressure in adolescents.
    J Hypertens. 2016;34:221-5.
    PubMed     Text format     Abstract available


  717. BENEZET-MAZUECOS J, Iglesias JA, Cortes M, Vieja JJ, et al
    Silent brain infarcts in high blood pressure patients with cardiac implantable electronic devices: unmasking silent atrial fibrillation.
    J Hypertens. 2016;34:338-44.
    PubMed     Text format     Abstract available


  718. LURBE E, Ingelfinger JR
    Blood pressure in children and adolescents: current insights.
    J Hypertens. 2016;34:176-83.
    PubMed     Text format     Abstract available


  719. RIPHAGEN IJ, Gijsbers L, van Gastel MD, Kema IP, et al
    Effects of potassium supplementation on markers of osmoregulation and volume regulation: results of a fully controlled dietary intervention study.
    J Hypertens. 2016;34:215-20.
    PubMed     Text format     Abstract available


  720. CHANG TI, Tabada GH, Yang J, Tan TC, et al
    Visit-to-visit variability of blood pressure and death, end-stage renal disease, and cardiovascular events in patients with chronic kidney disease.
    J Hypertens. 2016;34:244-52.
    PubMed     Text format     Abstract available


  721. VELASCO A, Ayers C, Das SR, de Lemos JA, et al
    Target organ complications and prognostic significance of alerting reaction: analysis from the Dallas Heart Study.
    J Hypertens. 2016;34:226-34.
    PubMed     Text format     Abstract available


    January 2016
  722. LOPRINZI PD
    Accelerometer-determined physical activity and all-cause mortality in a national prospective cohort study of hypertensive adults.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  723. TADIC M, Cuspidi C, Pencic B, Andric A, et al
    The interaction between blood pressure variability, obesity, and left ventricular mechanics: findings from the hypertensive population.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  724. BLACK MH, Zhou H, Sacks DA, Dublin S, et al
    Hypertensive disorders first identified in pregnancy increase risk for incident prehypertension and hypertension in the year after delivery.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  725. ZANCHETTI A, Liu L, Mancia G, Parati G, et al
    Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after stroke.
    J Hypertens. 2016.
    PubMed     Text format    


  726. ZDROJEWSKI T, Wizner B, Wiecek A, Slusarczyk P, et al
    Prevalence, awareness, and control of hypertension in elderly and very elderly in Poland: results of a cross-sectional representative survey.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  727. MULE G, Nardi E, Morreale M, D'Amico S, et al
    Relationship between aortic root size and glomerular filtration rate in hypertensive patients.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  728. KARATZI K, Georgiopoulos G, Yannakoulia M, Efthimiou E, et al
    Eating frequency predicts new onset hypertension and the rate of progression of blood pressure, arterial stiffness, and wave reflections.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  729. KIM SH, Kim YH, Kim JS, Lim SY, et al
    Target-organ damage and incident hypertension: the Korean genome and epidemiology study.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  730. SANDSTROM YK, Ljunggren G, Wandell P, Wahlstrom L, et al
    Psychiatric comorbidities in patients with hypertension - a study of registered diagnoses 2009-2013 in the total population in Stockholm County, Sweden.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  731. BRIASOULIS A, Androulakis E, Palla M, Papageorgiou N, et al
    White-coat hypertension and cardiovascular events: a meta-analysis.
    J Hypertens. 2016.
    PubMed     Text format     Abstract available


  732. HARDING JL, Sooriyakumaran M, Anstey KJ, Adams R, et al
    Hypertension, antihypertensive treatment and cancer incidence and mortality: a pooled collaborative analysis of 12 Australian and New Zealand cohorts.
    J Hypertens. 2016;34:149-55.
    PubMed     Text format     Abstract available


  733. MANCIA G, Omboni S, Chazova I, Coca A, et al
    Effects of the lercanidipine-enalapril combination vs. the corresponding monotherapies on home blood pressure in hypertension: evidence from a large database.
    J Hypertens. 2016;34:139-48.
    PubMed     Text format     Abstract available


  734. SIVEN SS, Niiranen TJ, Kantola IM, Jula AM, et al
    White-coat and masked hypertension as risk factors for progression to sustained hypertension: the Finn-Home study.
    J Hypertens. 2016;34:54-60.
    PubMed     Text format     Abstract available


  735. PARK JS, Jung I, Youn JC, Cho HY, et al
    Impact of adolescent pregnancy on hypertension in postmenopausal women.
    J Hypertens. 2016;34:47-53.
    PubMed     Text format     Abstract available


  736. LI W, Gu H, Teo KK, Bo J, et al
    Hypertension prevalence, awareness, treatment, and control in 115 rural and urban communities involving 47 000 people from China.
    J Hypertens. 2016;34:39-46.
    PubMed     Text format     Abstract available


  737. GALAN M, Salaices M
    T-regulatory cells and vascular function: the importance of their immunosuppressive action in hypertensive disease.
    J Hypertens. 2016;34:36-8.
    PubMed     Text format    


  738. HE J
    Hypertension in China: a large and increasing public health challenge.
    J Hypertens. 2016;34:29-31.
    PubMed     Text format    


  739. BISOGNI V, Rossitto G, Reghin F, Padrini R, et al
    Antihypertensive therapy in patients on chronic lithium treatment for bipolar disorders.
    J Hypertens. 2016;34:20-8.
    PubMed     Text format     Abstract available


  740. MIAN MO, Barhoumi T, Briet M, Paradis P, et al
    Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses.
    J Hypertens. 2016;34:97-108.
    PubMed     Text format     Abstract available


  741. JUHANOJA EP, Niiranen TJ, Johansson JK, Puukka PJ, et al
    Agreement between ambulatory, home, and office blood pressure variability.
    J Hypertens. 2016;34:61-7.
    PubMed     Text format     Abstract available


    December 2015
  742. MODESTI PA, Omboni S, Taddei S, Ghione S, et al
    Zofenopril or irbesartan plus hydrochlorothiazide in elderly patients with isolated systolic hypertension untreated or uncontrolled by previous treatment: a double-blind, randomized study.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  743. LINHART C, Tukana I, Lin S, Taylor R, et al
    Continued increases in hypertension over three decades in Fiji, and the influence of obesity.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  744. KOTSIS V, Grassi G
    The enigma of obesity-induced hypertension mechanisms in the youth.
    J Hypertens. 2015.
    PubMed     Text format    


  745. PRZEWOZNY T, Gojska-Grymajlo A, Kwarciany M, Graff B, et al
    Hypertension is associated with dysfunction of both peripheral and central auditory system.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  746. KATSI VK, Marketou ME, Vrachatis DA, Manolis AJ, et al
    Essential hypertension in the pathogenesis of age-related macular degeneration: a review of the current evidence.
    J Hypertens. 2015;33:2382-8.
    PubMed     Text format     Abstract available


  747. ZANCHETTI A
    Large and small vessel disease and other aspects of hypertension.
    J Hypertens. 2015;33:2371-2.
    PubMed     Text format    


    November 2015
  748. HU J, Wang Y, Xiang X, Peng C, et al
    Serum bisphenol A as a predictor of chronic kidney disease progression in primary hypertension: a 6-year prospective study.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  749. ZANCHETTI A
    From risk factors to treatment of hypertension.
    J Hypertens. 2015.
    PubMed     Text format    


  750. FORST T, Michelson G, Diessel S, Jahnke J, et al
    Microvascular effects of the inhibition of dipeptidylpeptidase IV by linagliptin in nondiabetic hypertensive patients.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  751. HUERTA A, Lopez B, Ravassa S, Jose GS, et al
    Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  752. ROHLA M, Nahler A, Lambert T, Reiter C, et al
    Predictors of response to renal denervation for resistant arterial hypertension: a single center experience.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  753. TURIN TC, Okamura T, Afzal AR, Rumana N, et al
    Hypertension and lifetime risk of stroke.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  754. GONG Y, McDonough CW, Beitelshees AL, Rouby NE, et al
    PTPRD gene associated with blood pressure response to atenolol and resistant hypertension.
    J Hypertens. 2015;33:2278-2285.
    PubMed     Text format     Abstract available


  755. CUSPIDI C, Sala C, Grassi G
    Updated classification of hypertensive retinopathy: which role for cardiovascular risk stratification?
    J Hypertens. 2015;33:2204-2206.
    PubMed     Text format    


  756. DE BUYZERE M
    Where there's smoke there might be hypertension.
    J Hypertens. 2015;33:2200-2203.
    PubMed     Text format    


  757. ZANCHETTI A
    Lifestyle and therapeutic interventions for hypertension.
    J Hypertens. 2015;33:2183-2184.
    PubMed     Text format    


    October 2015
  758. BURNIER M, Wuerzner G
    Drug adherence monitoring in clinical trials: a necessity for a correct assessment of the efficacy and safety of antihypertensive therapies.
    J Hypertens. 2015.
    PubMed     Text format    


  759. KUNUTSOR SK, Apekey TA, Cheung BM
    Gamma-glutamyltransferase and risk of hypertension: a systematic review and dose-response meta-analysis of prospective evidence.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  760. EWEN S, Dorr O, Ukena C, Linz D, et al
    Blood pressure variability after catheter-based renal sympathetic denervation in patients with resistant hypertension.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  761. FADL ELMULA FE, Rebora P, Talvik A, Salerno S, et al
    A randomized and controlled study of noninvasive hemodynamic monitoring as a guide to drug treatment of uncontrolled hypertensive patients.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  762. GENOVESI S, Antolini L, Giussani M
    Hypertension screening in children: is it necessary?
    J Hypertens. 2015;33:2179-80.
    PubMed     Text format    


  763. CREMER A, Laine M, Papaioannou G, Yeim S, et al
    Increased arterial stiffness is an independent predictor of atrial fibrillation in hypertensive patients.
    J Hypertens. 2015;33:2150-5.
    PubMed     Text format     Abstract available


  764. PATEL RK, Jeemon P, Stevens KK, Mccallum L, et al
    Association between serum phosphate and calcium, long-term blood pressure, and mortality in treated hypertensive adults.
    J Hypertens. 2015;33:2046-53.
    PubMed     Text format     Abstract available


  765. OKELLO S, Kanyesigye M, Muyindike WR, Annex BH, et al
    Incidence and predictors of hypertension in adults with HIV-initiating antiretroviral therapy in south-western Uganda.
    J Hypertens. 2015;33:2039-45.
    PubMed     Text format     Abstract available


  766. ZANCHETTI A
    Hypertension-related mortality and morbidity.
    J Hypertens. 2015;33:1979-80.
    PubMed     Text format    


  767. NILSSON PM
    Blood pressure control in type 2 diabetes over time - what can we learn from different trajectories?
    J Hypertens. 2015;33:2018-9.
    PubMed     Text format    


    September 2015
  768. BEHULIAK M, Vavrinova A, Bencze M, Polgarova K, et al
    Ontogenetic changes in contribution of calcium sensitization and calcium entry to blood pressure maintenance of Wistar-Kyoto and spontaneously hypertensive rats.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  769. IZZO R, Stabile E, Esposito G, Trimarco V, et al
    Development of new atherosclerotic plaque in hypertensive patients: an observational registry study from the Campania-Salute network.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  770. BEAUSSIER H, Boutouyrie P, Bobrie G, Frank M, et al
    True antihypertensive efficacy of sequential nephron blockade in patients with resistant hypertension and confirmed medication adherence.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  771. KHANAM MA, Lindeboom W, Razzaque A, Niessen L, et al
    Undiagnosed and uncontrolled hypertension among the adults in rural Bangladesh: findings from a community-based study.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  772. ZOCCALI C, Mallamaci F, Grassi G
    20-Hydroxyeicosatetraenoic acid, a far-reaching autacoid in chronic kidney disease: hypertension and beyond.
    J Hypertens. 2015;33:1764-6.
    PubMed     Text format    


  773. POLONIKOV AV, Ushachev DV, Ivanov VP, Churnosov MI, et al
    Altered erythrocyte membrane protein composition mirrors pleiotropic effects of hypertension susceptibility genes and disease pathogenesis.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  774. AISSOPOU EK, Papathanassiou M, Nasothimiou EG, Konstantonis GD, et al
    The Keith-Wagener-Barker and Mitchell-Wong grading systems for hypertensive retinopathy: association with target organ damage in individuals below 55 years.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


    August 2015
  775. AYME-DIETRICH E, Marzak H, Lawson R, Mokni W, et al
    Contribution of serotonin to cardiac remodeling associated with hypertensive diastolic ventricular dysfunction in rats.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  776. LI N, Li Z, Chen S, Yang N, et al
    Effects of passive smoking on hypertension in rural Chinese nonsmoking women.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  777. HO AK, Thorpe CT, Pandhi N, Palta M, et al
    Association of anxiety and depression with hypertension control: a US multidisciplinary group practice observational study.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  778. GUO J, Zhu YC, Chen YP, Hu Y, et al
    The dynamics of hypertension prevalence, awareness, treatment, control and associated factors in Chinese adults: results from CHNS 1991-2011.
    J Hypertens. 2015;33:1688-1696.
    PubMed     Text format     Abstract available


  779. GU P, Cheng M, Hui X, Lu B, et al
    Elevating circulation chemerin level is associated with endothelial dysfunction and early atherosclerotic changes in essential hypertensive patients.
    J Hypertens. 2015;33:1624-1632.
    PubMed     Text format     Abstract available


  780. LAINE MK, Kujala UM, Eriksson JG, Wasenius NS, et al
    Former male elite athletes and risk of hypertension in later life.
    J Hypertens. 2015;33:1549-1554.
    PubMed     Text format     Abstract available


  781. PALATINI P, Grassi G
    Nondipping status and impaired nitroglycerin-mediated vasodilation in resistant hypertension: evidence and mechanisms.
    J Hypertens. 2015;33:1533-1535.
    PubMed     Text format    


  782. STERGIOU GS, Omboni S, Parati G
    Home or ambulatory blood pressure monitoring for the diagnosis of hypertension?
    J Hypertens. 2015;33:1528-1530.
    PubMed     Text format    


  783. SCHILLACI G, Fiorenzano G, Pucci G
    Sleep apnea and night-time hypertension: a role for the vasopressin system?
    J Hypertens. 2015;33:1524-1527.
    PubMed     Text format    


    July 2015
  784. KHEDER-ELFEKIH R, Yannoutsos A, Blacher J, London GM, et al
    Hypertension and chronic kidney disease: respective contribution of mean and pulse pressure and arterial stiffness.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  785. BORGI L, Curhan GC, Willett WC, Hu FB, et al
    Long-term intake of animal flesh and risk of developing hypertension in three prospective cohort studies.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  786. BELLINAZZI VR, Cipolli JA, Pimenta MV, Guimaraes PV, et al
    Carotid flow velocity/diameter ratio is a predictor of cardiovascular events in hypertensive patients.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  787. PENA MJ, Jankowski J, Heinze G, Kohl M, et al
    Plasma proteomics classifiers improve risk prediction for renal disease in patients with hypertension or type 2 diabetes.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  788. PETERS R, Collerton J, Granic A, Davies K, et al
    Antihypertensive drug use and risk of cognitive decline in the very old: an observational study - The Newcastle 85+ Study.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  789. WALRAVEN I, Mast MR, Hoekstra T, Jansen AP, et al
    Real-world evidence of suboptimal blood pressure control in patients with type 2 diabetes.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  790. THIJS AM, van Herpen CM, Verweij V, Pertijs J, et al
    Impaired endothelium-dependent vasodilation does not initiate the development of sunitinib-associated hypertension.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  791. ZANCHETTI A
    Studying arterial wall in hypertension.
    J Hypertens. 2015.
    PubMed     Text format    


  792. SZELENYI Z, Fazakas A, Szenasi G, Tegze N, et al
    The mechanism of reduced longitudinal left ventricular systolic function in hypertensive patients with normal ejection fraction.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  793. KAHAN T
    Safety of digoxin use in patients with hypertensive heart disease and atrial fibrillation.
    J Hypertens. 2015;33:1371-2.
    PubMed     Text format    


  794. STERGIOU GS, Vazeou A, Stabouli S, Ntineri A, et al
    Screening for hypertension in children and adolescents: the controversy, the research questions and a plan for action.
    J Hypertens. 2015;33:1359-63.
    PubMed     Text format    


  795. DE GROOTE K, Demulier L, De Backer J, De Wolf D, et al
    Arterial hypertension in Turner syndrome: a review of the literature and a practical approach for diagnosis and treatment.
    J Hypertens. 2015;33:1342-51.
    PubMed     Text format     Abstract available


  796. THOMOPOULOS C, Parati G, Zanchetti A
    Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs - overview and meta-analyses.
    J Hypertens. 2015;33:1321-41.
    PubMed     Text format     Abstract available


  797. ZANCHETTI A
    From blood pressure measurement to antihypertensive treatment.
    J Hypertens. 2015;33:1319-20.
    PubMed     Text format    


  798. SALMAN IM, Phillips JK, Ameer OZ, Hildreth CM, et al
    Abnormal central control underlies impaired baroreflex control of heart rate and sympathetic nerve activity in female Lewis polycystic kidney rats.
    J Hypertens. 2015;33:1418-28.
    PubMed     Text format     Abstract available


  799. BURNIER M
    Urinary angiotensinogen and salt sensitivity of blood pressure: the challenge of finding biomarkers of salt-sensitivity.
    J Hypertens. 2015;33:1368-70.
    PubMed     Text format    


  800. PARATI G, Zhang Y
    Assessing blood pressure response to exercise: methodological issues and clinical relevance.
    J Hypertens. 2015;33:1364-7.
    PubMed     Text format    


  801. WANG D, Wang C, Zhou Y, Wang A, et al
    Different blood pressure indexes on intracranial arterial stenosis in Asymptomatic Polyvascular Abnormalities in Community study in China.
    J Hypertens. 2015;33:1452-7.
    PubMed     Text format     Abstract available


  802. SERAVALLE G, Lonati L, Buzzi S, Cairo M, et al
    Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states.
    J Hypertens. 2015;33:1411-7.
    PubMed     Text format     Abstract available


  803. VERGER A, van der Gucht A, Guedj E, Marie PY, et al
    Central pulse pressure is a determinant of heart and brain remodeling in the elderly: a quantitative MRI and PET pilot study.
    J Hypertens. 2015;33:1378-85.
    PubMed     Text format     Abstract available


  804. REBHOLZ CM, Chen J, Zhao Q, Chen JC, et al
    Urine angiotensinogen and salt-sensitivity and potassium-sensitivity of blood pressure.
    J Hypertens. 2015;33:1394-400.
    PubMed     Text format     Abstract available


  805. CUNHA PG, Cotter J, Oliveira P, Vila I, et al
    Pulse wave velocity distribution in a cohort study: from arterial stiffness to early vascular aging.
    J Hypertens. 2015;33:1438-45.
    PubMed     Text format     Abstract available


  806. RUBATTU S, Di Castro S, Cotugno M, Bianchi F, et al
    Protective effects of Brassica oleracea sprouts extract toward renal damage in high-salt-fed SHRSP: role of AMPK/PPARalpha/UCP2 axis.
    J Hypertens. 2015;33:1465-79.
    PubMed     Text format     Abstract available


    June 2015
  807. BLACK MH, Zhou H, Sacks DA, Dublin S, et al
    Prehypertension prior to or during early pregnancy is associated with increased risk for hypertensive disorders in pregnancy and gestational diabetes.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  808. TORAL M, Gomez-Guzman M, Jimenez R, Romero M, et al
    Chronic peroxisome proliferator-activated receptorbeta/delta agonist GW0742 prevents hypertension, vascular inflammatory and oxidative status, and endothelial dysfunction in diet-induced obesity.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  809. HALBACH M, Hickethier T, Madershahian N, Reuter H, et al
    Acute on/off effects and chronic blood pressure reduction after long-term baroreflex activation therapy in resistant hypertension.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  810. KOTSIS V, Nilsson P, Grassi G, Mancia G, et al
    New developments in the pathogenesis of obesity-induced hypertension.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  811. KANG YY, Li Y, Huang QF, Song J, et al
    Accuracy of home versus ambulatory blood pressure monitoring in the diagnosis of white-coat and masked hypertension.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  812. SKARN SN, Flaa A, Kjeldsen SE, Rostrup M, et al
    Family history of hypertension and serum triglycerides predict future insulin sensitivity: a 17-year follow-up study of young men.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  813. CHAUVET C, Menard A, Deng AY
    Two candidate genes for two quantitative trait loci epistatically attenuate hypertension in a novel pathway.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  814. WANG Z, Zeng X, Chen Z, Wang X, et al
    Association of visceral and total body fat with hypertension and prehypertension in a middle-aged Chinese population.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  815. RAKUGI H, Ogihara T, Saruta T, Kawai T, et al
    Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  816. XU H, Garver H, Fernandes R, Phelps JT, et al
    BK channel beta1-subunit deficiency exacerbates vascular fibrosis and remodelling but does not promote hypertension in high-fat fed obesity in mice.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  817. BASTOS, Filipa S, Joana S, Raquel F, et al
    6A.05: THE PROGNOSTIC VALUE OF AMBULATORY ARTERIAL STIFFNESS INDEX AS A PREDICTOR OF CARDIOVASCULAR EVENTS IN RESISTANT HYPERTENSIVE PATIENTS?
    J Hypertens. 2015;33 Suppl 1:e74.
    PubMed     Text format     Abstract available


  818. CATENA C, Colussi GL, Frangipane A, Clinaz L, et al
    7C.10: PROTHROMBOTIC MARKERS ARE RELATED TO CAROTID STIFFNESS IN ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e99.
    PubMed     Text format     Abstract available


  819. ROSENBAUM D, Girerd X, Kachenoura N, De Cesare A, et al
    7C.08: STIFFNESS MODIFICATIONS ALONG AORTIC ARCH ARE DIFFERENT IN HYPERTENSIVES AND CONTROLS.
    J Hypertens. 2015;33 Suppl 1:e98.
    PubMed     Text format     Abstract available


  820. TAUTU O, Darabont R, Onciul S, Deaconu A, et al
    7C.05: PREDICTORS OF INCREASED ARTERIALL STIFFNESS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e97.
    PubMed     Text format     Abstract available


  821. ANTZA C, Papakatsika S, Dimopoulos C, Mikoudi K, et al
    7C.01: ARTERIAL STIFFNESS IN ISOLATED OFFICE SYSTOLIC HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e96.
    PubMed     Text format     Abstract available


  822. BOKRANTZ T, Ljungman C, Kahan T, Schioler L, et al
    7B.10: THIAZIDE DIURETICS AND FRACTURE-RISK AMONG HYPERTENSIVE PATIENTS. RESULTS FROM THE SWEDISH PRIMARY CARE CARDIOVASCULAR DATABASE (SPCCD).
    J Hypertens. 2015;33 Suppl 1:e94-5.
    PubMed     Text format     Abstract available


  823. HUANG Q, Li Y, Sheng C, Dou Y, et al
    7B.09: BLOOD PRESSURE LOWERING EFFICACY OF AMLODIPINE AND NIFEDIPINE-GITS IN AMBULATORY HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e94.
    PubMed     Text format     Abstract available


  824. KANTOLA I, Merikari M, Tervo J, Koskio L, et al
    7B.08: HIGH BLOOD PRESSURE AND ITS VARIATION AND THE USE OF BETA BLOCKING AGENTS AND STATINS DECREASE QUALITY OF LIFE IN DRUG-TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e94.
    PubMed     Text format     Abstract available


  825. MAHMUD A, Wadi H, Feely J, Silke B, et al
    7B.07: CIGARETTE SMOKING REDUCES BLOOD PRESSURE RESPONSE TO ANTIHYPERTENSIVE TREATMENT IN NEWLY DIAGNOSED HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e94.
    PubMed     Text format     Abstract available


  826. HAMDIDOUCHE I, Jullien V, Billaud EM, Boutouyrie P, et al
    7B.06: ROUTINE URINARY DETECTION OF ANTIHYPERTENSIVE DRUGS FOR ESTIMATION OF ADHERENCE TO TREATMENT: A CROSS SECTIONAL STUDY.
    J Hypertens. 2015;33 Suppl 1:e93.
    PubMed     Text format     Abstract available


  827. VACLAVIK J, Krenkova A, Kocianova E, Vaclavik T, et al
    7B.04: EFFECT OF SERTRALINE IN PAROXYSMAL HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e93.
    PubMed     Text format     Abstract available


  828. DOLGUSHEVA I, Agapova O, Zykov K, Sivacova O, et al
    7B.03: SAFETY OF BETA-AGONISTS WITH DIFFERENT DURATION OF ACTION IN PATIENTS WITH ARTERIAL HYPERTENSION AND BRONCHO-OBSTRUCTIVE DISEASES.
    J Hypertens. 2015;33 Suppl 1:e92-3.
    PubMed     Text format     Abstract available


  829. LJUNGMAN C, Kahan T, Schioler L, Wettermark B, et al
    7B.02: THE ASSOCIATION BETWEEN NON-STEROIDAL ANTI-INFLAMMATORY DRUGS AND BLOOD PRESSURE CONTROL IN HYPERTENSIVE PATIENTS AND THE RELATION TO GENDER.
    J Hypertens. 2015;33 Suppl 1:e92.
    PubMed     Text format     Abstract available


  830. SCHMIEDER RE, Ott C, Veelken R, Schmid A, et al
    7B.01: FINAL ANALYSIS ON ADHERENCE TO ANTIHYPERTENSIVE MEDICATION IN TREATMENT RESISTANT HYPERTENSION (TRH) UNDERGOING RENAL DENERVATION (RDN).
    J Hypertens. 2015;33 Suppl 1:e92.
    PubMed     Text format     Abstract available


  831. GEORGIOPOULOS G, Tsioufis C, Tsiachris D, Dimitriadis K, et al
    7A.10: METABOLIC SYNDROME PREDICTS INDEPENDENTLY FROM ITS COMPONENTS ADVERSE EVENTS IN ESSENTIAL HYPERTENSIVE SUBJECTS.
    J Hypertens. 2015;33 Suppl 1:e91.
    PubMed     Text format     Abstract available


  832. NORTON G, Majane O, Djami-Tchatchou A, Maseko M, et al
    7A.07: LIMITED CONTRIBUTION OF OBESITY TO VARIATIONS IN OFFICE, AMBULATORY AND AORTIC BLOOD PRESSURES IN A BLACK AFRICAN COMMUNITY WITH PREVALENT OBESITY AND HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e91.
    PubMed     Text format     Abstract available


  833. LIM J, Burke S, Head GA
    7A.06: MATERNAL OBESITY AND THE DEVELOPMENTAL PROGRAMMING OF HYPERTENSION: ALTERED LEPTIN SIGNALLING PATHWAY IN THE CENTRAL NERVOUS SYSTEM.
    J Hypertens. 2015;33 Suppl 1:e90.
    PubMed     Text format     Abstract available


  834. QI Y, Rathinasabapathy A, Huo T, Zhang J, et al
    7A.04: DYSFUNCTIONAL ADIPOSE STEM CELL IS LINKED TO OBESITY, ELEVATED INFLAMMATORY CYTOKINES AND RESISTANT HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e90.
    PubMed     Text format     Abstract available


  835. AMOSOVA K, Rudenko IU
    1C.03: GENDER DIFFERENCES IN OFFICE AND HOME BLOOD PRESSURE CONTROL IN UNCOMPLICATED HYPERTENSIVES, WHO OBTAINED STANDARDIZED ALGORITHMIC TREATMENT IN LONGITUDINAL REAL-LIFE STUDY.
    J Hypertens. 2015;33 Suppl 1:e9-e10.
    PubMed     Text format     Abstract available


  836. AGNOLETTI D, Valbusa F, Labat C, Mourad JJ, et al
    1C.02: EVIDENCE FOR A PROGNOSTIC ROLE OF ORTHOSTATIC HYPERTENSION ON SURVIVAL IN A VERY OLD INSTITUTIONALIZED POPULATION.
    J Hypertens. 2015;33 Suppl 1:e9.
    PubMed     Text format     Abstract available


  837. LIP S, McCallum L, Touyz RH, Dominiczak AF, et al
    LB02.06: CLINICAL IMPLICATIONS OF THE DIASTOLIC BLOOD PRESSURE 'J CURVE' IN TREATED HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e87.
    PubMed     Text format     Abstract available


  838. SCHMIEDER RE, Ott C, Lobo MD, Sobotka PA, et al
    LB02.02: EFFECT OF ARTERIOVENOUS ANASTOMOSIS ON BLOOD PRESSURE REDUCTION IN PATIENTS WITH ISOLATED SYSTOLIC HYPERTENSION COMPARED TO COMBINED HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e85.
    PubMed     Text format     Abstract available


  839. CLARK C, Smith L, Glynn L, Cloutier L, et al
    LB02.01: CHANGES IN BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION RECEIVING USUAL CARE IN RANDOMISED CONTROLLED TRIALS. FINDINGS FROM A SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2015;33 Suppl 1:e85.
    PubMed     Text format     Abstract available


  840. MAFFIOLI P, Cicero AF, Romano D, D'Angelo A, et al
    6D.07: AMLODIPINE ALONE COMPARED TO AMLODIPINE + ACETYLSALICYLIC ACID ON INFLAMMATION AND ENDOTHELIAL DAMAGE MARKERS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e84.
    PubMed     Text format     Abstract available


  841. VIRDIS A, Duranti E, Lorenzini G, Taddei S, et al
    6D.02: GHRELIN RESTORES NITRIC OXIDE AVAILABILITY IN THE FOREARM MICROCIRCULATION OF ESSENTIAL HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e82.
    PubMed     Text format     Abstract available


  842. PERSU A, Evenepoel L, Jin Y, Mendola A, et al
    6C.05: STK39 AND WNK1 ARE POTENTIAL HYPERTENSION SUSCEPTIBILITY GENES IN THE BELHYPGEN COHORT.
    J Hypertens. 2015;33 Suppl 1:e80.
    PubMed     Text format     Abstract available


  843. PICARD HL, Latreche S, Thurairajasingam N, Auzan C, et al
    6C.01: CULLIN-3 MUTATIONS LEADING TO SKIPPING OF EXON 9 ARE RESPONSIBLE FOR SEVERE CASES OF FAMILIAL HYPERKALAEMIC HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e79.
    PubMed     Text format     Abstract available


  844. MAIDA KD, Souza HC
    6B.08: EFFECTS OF TREATMENT WITH ENALAPRIL OR LOSARTAN ASSOCIATED WITH AEROBIC PHYSICAL TRAINING ON CARDIOVASCULAR AUTONOMIC CONTROL IN SPONTANEOUSLY HYPERTENSIVE RATS (SHR).
    J Hypertens. 2015;33 Suppl 1:e78.
    PubMed     Text format     Abstract available


  845. KIM S, Rodriguez V, Santisteban M, Yang T, et al
    6B.07: HYPERTENSIVE PATIENTS EXHIBIT GUT MICROBIAL DYSBIOSIS AND AN INCREASE IN TH17 CELLS.
    J Hypertens. 2015;33 Suppl 1:e77-8.
    PubMed     Text format     Abstract available


  846. RUAN C, Ma Y, Li Y, Ge Q, et al
    6B.04: COMPLEMENT-INHIBITED PERIVASCULAR ADIPONECTIN EXPRESSION CONTRIBUTES TO VASCULAR INJURY IN HYPERTENSIVE MICE.
    J Hypertens. 2015;33 Suppl 1:e76-7.
    PubMed     Text format     Abstract available


  847. XU H, Wang Q, Yang M, Yu J, et al
    6B.03: TETRAHYDROBIOPTERIN EFFECTS LEFT VENTRICULAR DIASTOLIC FUNCTION BY UPREGULATING PROTEIN KINASE C epsilon SIGNALING PATHWAY IN DESOXYCORTICOSTERONE ACETATE-SALT HYPERTENSIVE MICE.
    J Hypertens. 2015;33 Suppl 1:e76.
    PubMed     Text format     Abstract available


  848. HEAD GA, Gueguen C, Marques FZ, Jackson KL, et al
    6B.01: EFFECT OF RENAL DENERVATION ON BLOOD PRESSURE AND MICRORNA 181A IN HYPERTENSIVE SCHLAGER MICE.
    J Hypertens. 2015;33 Suppl 1:e76.
    PubMed     Text format     Abstract available


  849. SCHUTTE AE, Ware LJ, Rennie KL, Gafane LF, et al
    6A.08: HIGH FREQUENCY OF MASKED HYPERTENSION AND ASSOCIATED ARTERIAL STIFFNESS IN AFRICANS.
    J Hypertens. 2015;33 Suppl 1:e75.
    PubMed     Text format     Abstract available


  850. KOTOVSKAYA Y, Bunyatov T, Kobalava Z
    6A.04: DEFINING SPURIOUS SYSTOLIC HYPERTENSION IN YOUNG HYPERTENSIVE MEN USING CENTRAL BLOOD PRESSURE REFERENCE VALUES.
    J Hypertens. 2015;33 Suppl 1:e73-4.
    PubMed     Text format     Abstract available


  851. PALATINI P, Benetti E, Fania C, Mos L, et al
    6A.02: WHITE-COAT HYPERTENSION AS PREDICTOR OF LONG-TERM NORMOTENSION IN SUBJECTS SCREENED FOR STAGE 1 HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e73.
    PubMed     Text format     Abstract available


  852. GIJSBERS L, Dower JI, Schalkwijk CG, Kusters YH, et al
    5D.06: EFFECTS OF SODIUM AND POTASSIUM SUPPLEMENTATION ON ENDOTHELIAL FUNCTION AND INFLAMMATION IN UNTREATED (PRE)HYPERTENSIVES: A FULLY CONTROLLED DIETARY INTERVENTION STUDY.
    J Hypertens. 2015;33 Suppl 1:e72.
    PubMed     Text format     Abstract available


  853. POLONIA J, Monteiro J, Almeida J, Silva J, et al
    5D.03: HIGH SALT INTAKE IS INDEPENDENTLY ASSOCIATED WITH A HIGHER RISK OF CARDIOVASCULAR EVENTS. A 12 YEARS EVALUATION OF A HYPERTENSIVE COHORT.
    J Hypertens. 2015;33 Suppl 1:e71.
    PubMed     Text format     Abstract available


  854. OKA M, Kaneda M, Sasabe S, Yamamoto M, et al
    5D.02: WHY DOES WAKAYAMA PREFECTURE HAVE THE HIGHEST RATES OF HYPERTENSION IN JAPAN? CONSIDERATION ON EXERCISE INCORPORATED INTO EVERYDAY LIFE.
    J Hypertens. 2015;33 Suppl 1:e71.
    PubMed     Text format     Abstract available


  855. GIRERD X, Villeneuve F, Gury C, Giral P, et al
    5D.01: DECREASE IN EXCESS SALT CONSUMPTION FOR HYPERTENSIVE SUBJECTS LIVING IN THE PARIS AREA.
    J Hypertens. 2015;33 Suppl 1:e71.
    PubMed     Text format     Abstract available


  856. KANG Y, Li Y, Huang QF, Song J, et al
    1B.09: ACCURACY OF HOME VERSUS AMBULATORY BLOOD PRESSURE MONITORING IN THE DIAGNOSIS OF WHITE-COAT AND MASKED HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e7.
    PubMed     Text format     Abstract available


  857. DESTRO M, Dognini GP, Pozzi A, Cagnoni F, et al
    5C.06: HYPERTENSION AND CARDIOVASCULAR RISK FACTORS: A SHOT ON NORTHERN ITALY POPULATION IN REAL LIFE SETTING.
    J Hypertens. 2015;33 Suppl 1:e69.
    PubMed     Text format     Abstract available


  858. RISSE J, Lauriere E, Iraqi M, Fay R, et al
    5C.04: SCREENING FOR HYPERTENSION IN THE BARBERSHOP: A FRANCO-MOROCCAN FEASIBILITY STUDY (THE "DECOIFFA" STUDY).
    J Hypertens. 2015;33 Suppl 1:e69.
    PubMed     Text format     Abstract available


  859. GERSHINSKY Y, Bursztyn M, Ein-Mor E, Stessman J, et al
    2C.03: HYPERTENSION IS NOT ASSOCIATED WITH SURVIVAL IN 90 YEARS OLD: THE JERUSALEM LONGITUDINAL STUDY.
    J Hypertens. 2015;33 Suppl 1:e68.
    PubMed     Text format     Abstract available


  860. TORLASCO C, Calvanese C, Faini A, Santini F, et al
    5C.02: PREVALENCE OF HYPERTENSION AND OTHER CARDIOVASCULAR RISK FACTORS IN PARTICIPANTS IN THE 2014 HYPERTENSION WORLD DAY CAMPAIGN IN ITALY.
    J Hypertens. 2015;33 Suppl 1:e68.
    PubMed     Text format     Abstract available


  861. PIETRI P, Vlachopoulos C, Ioakeimidis N, Aggelis A, et al
    5B.06: ASSOCIATION OF PLASMA TESTOSTERONE WITH CENTRAL HAEMODYNAMICS IN HYPERTENSIVE MEN.
    J Hypertens. 2015;33 Suppl 1:e67.
    PubMed     Text format     Abstract available


  862. FACONTI L, Bruno R, Buralli S, Barzacchi M, et al
    5B.03: ARTERIAL-VENTRICULAR COUPLING AND PARAMETERS OF VASCULAR STIFFNESS IN HYPERTENSIVE PATIENTS: ROLE OF GENDER.
    J Hypertens. 2015;33 Suppl 1:e66.
    PubMed     Text format     Abstract available


  863. MUIESAN ML, Salvetti M, Paini A, Bertacchini F, et al
    5B.01: LONGITUDINAL AND RADIAL LEFT VENTRICLE SYSTOLIC FUNCTION ASSESSMENT IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e66.
    PubMed     Text format     Abstract available


  864. SZYMANSKI FM, Filipiak KJ, Platek AE, Kotkowski M, et al
    5A.07: PREVALENCE OF ARTERIAL HYPERTENSION IN PATIENTS WITH ATRIAL FIBRILLATION UNDERGOING ABLATION. A PROSPECTIVE, COHORT STUDY.
    J Hypertens. 2015;33 Suppl 1:e65.
    PubMed     Text format     Abstract available


  865. SHAVAROV A, Yusupov A, Kiyakbaev G, Moiseev V, et al
    5A.06: CORRELATION OF THROMBOEMBOLIC RISK WITH GLOBAL LEFT ATRIAL STRAIN IN HYPERTENSIVE PATIENTS WITH ATRIAL FIBRILLATION.
    J Hypertens. 2015;33 Suppl 1:e65.
    PubMed     Text format     Abstract available


  866. GOSSE P, Cremer A, Laine M, Papaioannou G, et al
    5A.05: INCREASED ARTERIAL STIFFNESS IS AN INDEPENDENT PREDICTOR OF FUTURE ATRIAL FIBRILLATION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e65.
    PubMed     Text format     Abstract available


  867. CONTI A, Angeli E, Trausi F, Grifoni C, et al
    5A.01: CORONARY ATHEROSCLEROSIS AND ADVERSE OUTCOME IN HYPERTENSIVE PATIENTS WITH RECENT-ONSET ATRIAL FIBRILLATION AND TROPONIN RISE.
    J Hypertens. 2015;33 Suppl 1:e64.
    PubMed     Text format     Abstract available


  868. RODILLA SALA E, Millasseau S, Escriva M, Garcia J, et al
    4D.10: CHANGES IN PWV IN PREVIOUSLY UNTREATED MILD HYPERTENSIVES ARE RELATED TO REDUCTION OF BLOOD PRESSURE BY TREATMENT.
    J Hypertens. 2015;33 Suppl 1:e63.
    PubMed     Text format     Abstract available


  869. BRUNO R, Barzacchi M, Cartoni G, Antonelli M, et al
    4D.06: PROGRESSION OF CAROTID ARTERY REMODELING AND STIFFNESS IN HYPERTENSIVE PATIENTS: A PROSPECTIVE COHORT STUDY.
    J Hypertens. 2015;33 Suppl 1:e62.
    PubMed     Text format     Abstract available


  870. SMIRNOVA M, Britov AN, Platonova EM, Gorbunov VM, et al
    1B.06: MASKED HYPERTENSION PREVALENCE AND ITS MARKERS IN ORGANIZED COHORT.
    J Hypertens. 2015;33 Suppl 1:e6.
    PubMed     Text format     Abstract available


  871. SOUSA F, Neves J, Ferreira R, Polonia J, et al
    1B.05: IN HYPERTENSION THE CHANGE FROM A NON-DIPPER TO A DIPPER PATTERN IS ASSOCIATED WITH A BETTER CARDIOVASCULAR PROGNOSIS THAN THE PERSISTENCE WITHIN THE NON-DIPPER PATTERN.
    J Hypertens. 2015;33 Suppl 1:e6.
    PubMed     Text format     Abstract available


  872. CORREIA M, Santos WB, Matoso JD, Goncalves TR, et al
    4C.10: LOWER COGNITIVE PERFORMANCE IS NOT CORRELATED WITH VASCULAR STIFFNESS IN ELDERLY TREATED HYPERTENSIVES.
    J Hypertens. 2015;33 Suppl 1:e58-9.
    PubMed     Text format     Abstract available


  873. WIESMANN M, Zerbi V, Roelofs M, Van Der Lugt R, et al
    4C.09: EFFECT OF ANGII-INDUCED HYPERTENSION AND ANTIHYPERTENSIVE TREATMENT ON PATHOLOGICAL CHANGES IN A MOUSE MODEL FOR ALZHEIMER'S DISEASE.
    J Hypertens. 2015;33 Suppl 1:e58.
    PubMed     Text format     Abstract available


  874. CEREZO GH, Del Sueldo M, Zilberman J, Pawluk M, et al
    4C.06: COGNITIVE STATUS IN HYPERTENSIVE PATIENTS. HEART AND BRAIN STUDY IN ARGENTINE.
    J Hypertens. 2015;33 Suppl 1:e57-8.
    PubMed     Text format     Abstract available


  875. FOULQUIER S, Namsolleck P, Recarti C, Van Hagen BT, et al
    4C.02: PROLONGED ANGIOTENSIN II-INDUCED HYPERTENSION IMPAIRS SHORT-TERM MEMORY IN ADULT MICE.
    J Hypertens. 2015;33 Suppl 1:e56.
    PubMed     Text format     Abstract available


  876. TANG J, Tavintharan S, Sum C, Lim S, et al
    4B.10: 24 HOUR URINE FREE CORTISOL TO CORTISONE RATIO IS A NOVEL BIOMARKER FOR INCREASED LEFT VENTRICULAR MASS IN DIABETIC HYPERTENSIVES.
    J Hypertens. 2015;33 Suppl 1:e55.
    PubMed     Text format     Abstract available


  877. TASIC I, Kostic S, Djordjevic D, Lovic D, et al
    4B.09: DIABETES MELLITUS AND ORGAN DAMAGE, CARDIOVASCULAR DISEASE AND MORTALITY IN HYPERTENSIVE PATIENTS: FOLLOW-UP STUDY.
    J Hypertens. 2015;33 Suppl 1:e55.
    PubMed     Text format     Abstract available


  878. DIMAS G, Iliadis F, Tegos T, Spiroglou S, et al
    4B.08: SERUM LEVELS OF TIMP-1 AND IL-6 ARE ASSOCIATED WITH HYPERTENSION AND ATHEROSCLEROSIS IN PATIENTS WITH EARLY STAGES OF CHRONIC KIDNEY DISEASE AND TYPE 2 DIABETIC NEPHROPATHY.
    J Hypertens. 2015;33 Suppl 1:e55.
    PubMed     Text format     Abstract available


  879. VASILKOVA V, Mokhort T, Naumenko E, Filipcova N, et al
    4B.06: EFFECT OF CHRONIC KIDNEY DISEASE, DYSLIPIDEMIA AND HYPERTENSION ON CAROTID ATHEROSCLEROSIS IN ELDERLY PATIENTS WITH TYPE 2 DIABETES.
    J Hypertens. 2015;33 Suppl 1:e54.
    PubMed     Text format     Abstract available


  880. CHOWDHURY E, Ademi Z, Moss J, Wing L, et al
    4B.04: COST-UTILITY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR COMPARED TO THIAZIDE DIURETIC -BASED TREATMENT FOR HYPERTENSION IN ELDERLY AUSTRALIANS CONSIDERING DIABETES AS COMORBIDITY.
    J Hypertens. 2015;33 Suppl 1:e53-7.
    PubMed     Text format     Abstract available


  881. CHILTON R, Tikkanen I, Crowe S, Johansen OE, et al
    4B.03: EMPAGLIFLOZIN REDUCES SYSTOLIC BLOOD PRESSURE IN DIPPER AND NON-DIPPER PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e53.
    PubMed     Text format     Abstract available


  882. CHERNEY D, Cooper M, Tikkanen I, Crowe S, et al
    4B.01: CONTRASTING INFLUENCES OF RENAL FUNCTION ON BLOOD PRESSURE AND HBA1C REDUCTIONS WITH EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES AND HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e53.
    PubMed     Text format     Abstract available


  883. KARIO K, Bakris GL, Bhatt D
    4A.10: PREFERENTIAL REDUCTION IN MORNING/NOCTURNAL HYPERTENSION BY RENAL DENERVATION FOR DRUG- RESISTANT HYPERTENSION: A NEW ABPM ANALYSIS OF SYMPLICITY HTN-3 AND HTN-JAPAN.
    J Hypertens. 2015;33 Suppl 1:e52.
    PubMed     Text format     Abstract available


  884. LOBO M, Saxena M, Jain AJ, Walters D, et al
    4A.09: SAFETY AND PERFORMANCE OF THE ENLIGHTN RENAL DENERVATION SYSTEM IN PATIENTS WITH SEVERE UNCONTROLLED HYPERTENSION: 12 MONTH RESULTS FROM THE ENLIGHTN II STUDY.
    J Hypertens. 2015;33 Suppl 1:e51.
    PubMed     Text format     Abstract available


  885. OGNA VF, Pereira E, Sapoval M, Azizi M, et al
    4A.07: PREVALENCE AND RISK FACTORS FOR REFRACTORY HYPERTENSION IN THE DENERHTN STUDY.
    J Hypertens. 2015;33 Suppl 1:e51.
    PubMed     Text format     Abstract available


  886. KOUCHAKI Z, Butlin M, Lovett E, Avolio AP, et al
    4A.06: ARTERIAL AND RENAL HEMODYNAMICS AND BARORECEPTOR FUNCTION IN NORMOTENSIVE AND HYPERTENSIVE RATS DURING FIELD STIMULATION OF CAROTID BARORECEPTORS.
    J Hypertens. 2015;33 Suppl 1:e50-1.
    PubMed     Text format     Abstract available


  887. DIMAS G, Iliadis F, Tegos T, Spiroglou S, et al
    4A.05: CIRCULATING FGF-23 AS AN INDEPENDENT CORRELATE OF HYPERTENSION AND ATHEROSCLEROSIS IN EARLY STAGES OF CKD.
    J Hypertens. 2015;33 Suppl 1:e50.
    PubMed     Text format     Abstract available


  888. SERAVALLE G, Dell'Oro R, Trevano FQ, Spaziani D, et al
    4A.04: EFFECTS OF RENAL DENERVATION ON ASYMMETRIC DIMETHYLARGININE AND SYMPATHETIC NERVE TRAFFIC IN RESISTANT HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e50.
    PubMed     Text format     Abstract available


  889. SIVEN S, Niiranen T, Kantola I, Jula A, et al
    1B.03: WHITE-COAT AND MASKED HYPERTENSION AS RISK FACTORS FOR PROGRESSION TO SUSTAINED HYPERTENSION: THE FINN-HOME STUDY.
    J Hypertens. 2015;33 Suppl 1:e5-6.
    PubMed     Text format     Abstract available


  890. VARRENTI M, Meani P, Giupponi L, Vallerio P, et al
    1B.01: 24 HOUR MODULATION OF PERIPHERAL AND CENTRAL BLOOD PRESSURE, HEART RATE AND ARTERIAL STIFFNESS IN HEART TRANSPLANT HYPERTENSIVE INDIVIDUALS.
    J Hypertens. 2015;33 Suppl 1:e5.
    PubMed     Text format     Abstract available


  891. TSIOUFIS C, Papademetriou V, Dimitriadis K, Kasiakogias A, et al
    4A.03: CATHETER-BASED RENAL DENERVATION FOR RESISTANT HYPERTENSION: 24 MONTH RESULTS OF THE ENLIGHTN I STUDY USING A MULTIELECTRODE ABLATION SYSTEM.
    J Hypertens. 2015;33 Suppl 1:e49-50.
    PubMed     Text format     Abstract available


  892. MANCIA G, Mahfoud F, Narkiewicz K, Ruilope LM, et al
    4A.01: LONG-TERM EFFECTS OF RENAL ARTERY DENERVATION IN REAL WORLD PATIENTS WITH UNCONTROLLED HYPERTENSION FROM THE GLOBAL SYMPLICITY REGISTRY.
    J Hypertens. 2015;33 Suppl 1:e49.
    PubMed     Text format     Abstract available


  893. CAMELLI S, Bobrie G, Postel-Vinay N, Azizi M, et al
    LB01.11: PREVALENCE OF SECONDARY HYPERTENSION IN YOUNG HYPERTENSIVE ADULTS.
    J Hypertens. 2015;33 Suppl 1:e47.
    PubMed     Text format     Abstract available


  894. HOFFMANN-PETERSEN N, Lauritzen T, Bech JN, Pedersen EB, et al
    LB01.08: TREATMENT OF HYPERTENSION USING TELEMEDICAL HOME BLOOD PRESSURE MEASUREMENTS.
    J Hypertens. 2015;33 Suppl 1:e46-7.
    PubMed     Text format     Abstract available


  895. LIP S, Carlin C, McCallum L, Touyz RH, et al
    LB01.03: INCIDENCE AND PROGNOSIS OF CANCER ASSOCIATED WITH DIGOXIN AND COMMON ANTIHYPERTENSIVE DRUGS.
    J Hypertens. 2015;33 Suppl 1:e45.
    PubMed     Text format     Abstract available


  896. KARIO K, Saito I, Kushiro T, Teramukai S, et al
    LB01.02: MORNING HOME BLOOD PRESSURE IS A STRONG PREDICTOR OF CORONARY ARTERY DISEASE EVENTS AS WELL AS STROKE EVENTS IN HYPERTENSIVE PATIENTS ON ANTIHYPERTENSIVE TREATMENT. THE HONEST STUDY.
    J Hypertens. 2015;33 Suppl 1:e45.
    PubMed     Text format     Abstract available


  897. CLARK C, Smith L, Cloutier L, Glynn L, et al
    LB01.01: ALLIED HEALTH PROFESSIONAL-LED INTERVENTIONS FOR IMPROVING CONTROL OF BLOOD PRESSURE IN PATIENTS WITH HYPERTENSION: A COCHRANE SYSTEMATIC REVIEW AND META-ANALYSIS.
    J Hypertens. 2015;33 Suppl 1:e44.
    PubMed     Text format     Abstract available


  898. KANETA M, Miyai N, Yamamoto M, Oka M, et al
    3D.08: ARTERIAL STIFFNESS AND AUTONOMIC NERVOUS FUNCTION ON ORTHOSTATIC BLOOD PRESSURE-ELEVATION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e42.
    PubMed     Text format     Abstract available


  899. OMBONI S, Posokhov IN, Rogoza AN
    3D.05: RELATIONSHIP BETWEEN 24-HOUR BLOOD PRESSURE VARIABILITY AND 24-HOUR AORTIC PRESSURE AND STIFFNESS IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e41-2.
    PubMed     Text format     Abstract available


  900. GOROSTIDI M, Sarafidis P, Sierra Ade L, Banegas JR, et al
    3D.02: BLOOD PRESSURE VARIABILITY INCREASES WITH ADVANCING CHRONIC KIDNEY DISEASE STAGE. A CROSS-SECTIONAL ANALYSIS OF 14,382 HYPERTENSIVE PATIENTS FROM SPAIN.
    J Hypertens. 2015;33 Suppl 1:e40.
    PubMed     Text format     Abstract available


  901. FARIA RA, Brandao AA, Pozzan R, Paiva AG, et al
    3C.08: 24H CENTRAL BLOOD PRESSURE AND PULSE WAVE VELOCITY MONITORING IN NORMOTENSIVE, HYPERTENSIVE, WHITE COAT HYPERTENSION AND MASKED HYPERTENSION YOUNG ADULTS.
    J Hypertens. 2015;33 Suppl 1:e39.
    PubMed     Text format     Abstract available


  902. SUBLET ML, Courand PY, Bally S, Krummel T, et al
    3C.07: ARE THE PHYSICIANS RELUCTANT TO PRACTICE TELEMEDICINE IN HYPERTENSION?
    J Hypertens. 2015;33 Suppl 1:e38-9.
    PubMed     Text format     Abstract available


  903. ANDREEVA G, Gorbunov V, Lyusin D
    3C.06: EMOTIONAL INTELLIGENCE AND PSYCHOLOGICAL STATUS WERE RELATED WITH WHITE COAT EFFECT AND MEAN AMBULATORY BLOOD PRESSURE LEVELS IN PATIENTS WITH ARTERIAL HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e38.
    PubMed     Text format     Abstract available


  904. NTINERI A, Nasothimiou E, Kollias A, Roussias L, et al
    3C.05: DIAGNOSTIC AGREEMENT OF THE EUROPEAN SOCIETY OF HYPERTENSION HOME BLOOD MONITORING SCHEDULE WITH AMBULATORY BLOOD PRESSURE MONITORING IN UNTREATED AND TREATED SUBJECTS.
    J Hypertens. 2015;33 Suppl 1:e38.
    PubMed     Text format     Abstract available


  905. KIM J, Lee MY, Kim J, Namgung J, et al
    3C.03: OPTIMAL DURATION OF HOME BLOOD PRESSURE MEASUREMENTS FOR THE DIAGNOSIS OF ARTERIAL HYPERTENSION: A PROSPECTIVE MULTICENTER STUDY.
    J Hypertens. 2015;33 Suppl 1:e37.
    PubMed     Text format     Abstract available


  906. POLONIA J, Monteiro J, Almeida J, Faria J, et al
    3C.02: IN WHITE COAT HYPERTENSIVES CENTRAL PRESSURE AND HEMODYNAMIC VALUES ARE MORE CLOSE TO NORMOTENSIVES THAN TO TREATED HYPERTENSIVES FOR SIMILAR AGE, 24-H AND NIGHTTIME PRESSURES.
    J Hypertens. 2015;33 Suppl 1:e37.
    PubMed     Text format     Abstract available


  907. BOMBELLI M, Seravalle G, Dell'Oro R, Trevano FQ, et al
    3C.01: ADVERSE PROGNOSTIC VALUE OF PERSISTENT OFFICE BLOOD PRESSURE ELEVATION IN WHITE COAT HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e37.
    PubMed     Text format     Abstract available


  908. DEREZINSKI T, Wolf J, Szyndler A, Wasikowska B, et al
    3B.05: COMPARISON OF INCIDENT HYPERTENSION, OVERWEIGHT AND OBESITY IN A REPRESENTATIVE POLISH JUNIOR HIGH-SCHOOL POPULATION IN 2005 VS. 2014.
    J Hypertens. 2015;33 Suppl 1:e35.
    PubMed     Text format     Abstract available


  909. BLOETZER C, Bovet P, Chiolero A
    3B.01: PERFORMANCE OF TARGETED SCREENING FOR THE IDENTIFICATION OF HYPERTENSION IN CHILDREN.
    J Hypertens. 2015;33 Suppl 1:e34.
    PubMed     Text format     Abstract available


  910. PALATINI P, Mos L, Fania C, Benetti E, et al
    3A.07: NIGHT-TIME HEART RATE IS A LONG-TERM PREDICTOR OF MICROALBUMINURIA IN SUBJECTS SCREENED FOR STAGE 1 HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e33.
    PubMed     Text format     Abstract available


  911. HOFFMANN-PETERSEN N, Lauritzen T, Bech JN, Pedersen EB, et al
    3A.06: LESS THAN HALF OF CITIZENS, AGED 55-64 YEARS, HAD A NORMAL BLOOD PRESSURE IN A DANISH POPULATION. PREVALENCE OF HYPERTENSION USING TELEMEDICALLY TRANSMITTED HOME BLOOD PRESSURE.
    J Hypertens. 2015;33 Suppl 1:e33.
    PubMed     Text format     Abstract available


  912. TELLEZ-PLAZA M, Orozco-Beltran D, Gil-Guillen V, Navarro-Perez J, et al
    3A.05: HYPERTENSION AND RISK OF EVENTS ASSOCIATED TO REDUCED EGFR. THE ESCARVAL-RISK STUDY.
    J Hypertens. 2015;33 Suppl 1:e32-3.
    PubMed     Text format     Abstract available


  913. MOURAD JJ
    3A.04: OBJECTIVE FOR 2015: 70% OF TREATED AND CONTROLLED HYPERTENSIVE PATIENTS. HOW FAR FROM THIS GOAL WAS FRANCE IN 2014?
    J Hypertens. 2015;33 Suppl 1:e32.
    PubMed     Text format     Abstract available


  914. ADAMCZAK M, Gazda M, Gojowy D, Dudzicz S, et al
    3A.03: HYPERTENSION IN PATIENTS AFTER LIVER TRANSPLANTATION.
    J Hypertens. 2015;33 Suppl 1:e32.
    PubMed     Text format     Abstract available


  915. SOWEMIMO I, Ajayi I, Akpa O, Ossai E, et al
    3A.02: PREVALENCE OF HYPERTENSION AND ASSOCIATED FACTORS AMONG RESIDENTS OF IBADAN-NORTH LOCAL GOVERNMENT AREA OF OYO STATE, NIGERIA.
    J Hypertens. 2015;33 Suppl 1:e31.
    PubMed     Text format     Abstract available


  916. CONTI A, Bianchi S, Trausi F, Grifoni C, et al
    2D.06: IN HYPERTENSIVE PATIENTS WITH CHEST PAIN AND NORMAL RESTING ECG THE LOW-COST EXERCISE HIGH-FREQUENCY QRS-ANALYSIS IS COMPARABLE TO THE EXERCISE ECHO.
    J Hypertens. 2015;33 Suppl 1:e29.
    PubMed     Text format     Abstract available


  917. CONTI A, Bianchi S, Grifoni C, Trausi F, et al
    2D.03: IMPROVING DIAGNOSTIC STRATEGY IN PATIENTS WITH LONG-STANDING HYPERTENSION, CHEST PAIN AND NORMAL RESTING ECG: VALUE OF THE EXERCISE HIGH-FREQUENCY QRS VERSUS ST-SEGMENT ANALYSIS.
    J Hypertens. 2015;33 Suppl 1:e28-9.
    PubMed     Text format     Abstract available


  918. PIOTROWICZ K, Prejbisz A, Klocek M, Topor-Madry R, et al
    2C.06: BLOOD PRESSURE CONTROL IN THE CONTEXT OF SCREENING FOR COGNITIVE AND MOOD IMPAIRMENTS IN THE OCTOGENARIAN AND OLDER HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e26.
    PubMed     Text format     Abstract available


  919. ZUIN M, Schiavon L, Ramazzina E, Mazza A, et al
    2C.03: INDEPENDENT PREDICTORS OF NOCTURNAL HYPERTENSION IN ELDERLY SUBJECTS FROM GENERAL POPULATION: THE RISK OF VASCULAR COMPLICATION, IMPACT OF GENETIC IN OLD PEOPLE (ROVIGO) STUDY.
    J Hypertens. 2015;33 Suppl 1:e25.
    PubMed     Text format     Abstract available


  920. STEVANOVIC A, Dekleva M
    2B.05: SUBCLINICAL MYOCARDIAL DYSFUNCTION IN HYPERTENSIVE PATIENTS WITH HYPERURICEMIA.
    J Hypertens. 2015;33 Suppl 1:e23.
    PubMed     Text format     Abstract available


  921. YAO X, Li NF, Shao L, Zhang DL, et al
    2B.03: URIC ACID LEVELS RELATED TO OBSTRUCTIVE SLEEP APNEA SYNDROME IN PATIENTS WITH HYPERTENSION FROM XINJIANG OF CHINA.
    J Hypertens. 2015;33 Suppl 1:e22-3.
    PubMed     Text format     Abstract available


  922. SERAVALLE G, Trevano FQ, Boggioni I, Buzzi S, et al
    2B.01: IRON OVERLOAD EXERTS SYMPATHOEXCITATORY EFFECTS IN MEN WITH ESSENTIAL HYPERTENSION: MICRONEUROGRAPHIC EVIDENCE.
    J Hypertens. 2015;33 Suppl 1:e22.
    PubMed     Text format     Abstract available


  923. STEWART S, Carrington M
    2A.07: IMPACT OF STRUCTURED AND INTENSIVE PRIMARY CARE MANAGEMENT AT PROGRESSIVELY HIGHER BLOOD PRESSURE LEVELS IN INDIVIDUALS WITH PERSISTENT HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e21.
    PubMed     Text format     Abstract available


  924. SOBHY M, Saleh MA, Hamid MA
    2A.05: EFFICACY OF COMBINATION PERINDOPRIL/AMLODIPINE WITH OR WITHOUT DIURETICS IN EGYPTIAN PATIENTS WITH UNCONTROLLED HYPERTENSION: THE CONTROL STUDY.
    J Hypertens. 2015;33 Suppl 1:e20.
    PubMed     Text format     Abstract available


  925. YU J, Cai Y, Liu Y, Yang Y, et al
    1A.07: GENOME-WIDE PROFILING OF LONG NONCODING RNA EXPRESSION PATTERNS IN THORACIC AORTA FROM SPONTANEOUSLY HYPERTENSIVE RATS.
    J Hypertens. 2015;33 Suppl 1:e2.
    PubMed     Text format     Abstract available


  926. CHI C, Tai C, Wang J, Protogerou A, et al
    2A.04: WHETHER ACE INHIBITOR/ARB COMBINED WITH CCB IS SUPERIOR TO OTHER COMBINATIONS? A META-ANALYSIS IN 20,669 HYPERTENSIVES.
    J Hypertens. 2015;33 Suppl 1:e19-20.
    PubMed     Text format     Abstract available


  927. KORNEEVA O, Drapkina O
    2A.03: DIASTOLIC FUNCTION IN OBESE HYPERTENSIVE PATIENTS USING DIFFERENT FIXED COMBINATION WITH ACE INHIBITOR AND ANTAGONIST CALCIUM.
    J Hypertens. 2015;33 Suppl 1:e19.
    PubMed     Text format     Abstract available


  928. RIVERO MA, Ramos N, Torres I, Moreso F, et al
    1D.12: THE CONTRIBUTION OF INFLAMMATION AND ATHEROSCLEROSIS TO HYPERTENSION IN KIDNEY TRANSPLANTS.
    J Hypertens. 2015;33 Suppl 1:e18.
    PubMed     Text format     Abstract available


  929. MULE G, Nardi E, Morrcale M, D'Amico S, et al
    1D.04: INVERSE RELATIONSHIP BETWEEN AORTIC ROOT DIAMETER AND RENAL FUNCTION IN HYPERTENSIVE SUBJECTS.
    J Hypertens. 2015;33 Suppl 1:e15.
    PubMed     Text format     Abstract available


  930. VAKILZADEH N, Muller M, Forni V, Milani B, et al
    1D.02: COMPARATIVE EFFECT OF A RENIN INHIBITOR AND A THIAZIDE DIURETIC ON RENAL TISSUE OXYGENATION IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e14.
    PubMed     Text format     Abstract available


  931. ZHANG X, Feldmam R, Wu Z, Zhang Y, et al
    LB03.09: THERAPEUTIC INERTIA IS A MAJOR DETERMINANT OF BP CONTROL RATES IN CHINA. A HYPERTENSION ATTITUDE PERSPECTIVES AND NEEDS (HAPPEN) STUDY REPORT.
    J Hypertens. 2015;33 Suppl 1:e128.
    PubMed     Text format     Abstract available


  932. ZHANG R, Witkowska K, Ng F, Caulfield MJ, et al
    LB03.08: HYPERTENSION RELATED VARIANT OF SOLUTE CARRIER FAMILY 39 MEMBER 8 GENE INFLUENCES CADMIUM UPTAKE AND CELL TOXICITY.
    J Hypertens. 2015;33 Suppl 1:e128.
    PubMed     Text format     Abstract available


  933. BOAL A, Smith D, Muir S, Touyz RM, et al
    LB03.07: ANTIHYPERTENSIVE THERAPY AND RISK OF ADMISSIONS FOR MOOD DISORDERS.
    J Hypertens. 2015;33 Suppl 1:e128.
    PubMed     Text format     Abstract available


  934. HOSHIDE S, Kario K, Yano Y, Haimoto H, et al
    LB03.01: MORNING HYPERTENSION IS AN IMPORTANT RISK FOR STROKE IN ASIAN POPULATION. FROM J-HOP STUDY.
    J Hypertens. 2015;33 Suppl 1:e126.
    PubMed     Text format     Abstract available


  935. VAKILZADEH N, Grouzmann E, Maillard M, Burnier M, et al
    9C.09: TREATMENT WITH CANDESARTAN UNMASKS HIGHER URINARY NOREPINEPHRINE EXCRETION IN WHITE COAT HYPERTENSIVE PATIENTS COMPARED TO HEALTHY NORMOTENSIVE PARTICIPANTS.
    J Hypertens. 2015;33 Suppl 1:e125.
    PubMed     Text format     Abstract available


  936. SERAVALLE G, Van Bortel L, Bombelli M, Dell'Oro R, et al
    9C.07: MULTICENTRE RANDOMISED, DOUBLE BLIND, EVALUATION OF NEBIVOLOL PLUS HCTZ AND IRBESARTAN PLUS HCTZ IN THE TREATMENT OF ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY: THE NEHIS STUDY.
    J Hypertens. 2015;33 Suppl 1:e124-5.
    PubMed     Text format     Abstract available


  937. WANG J, Song J, Huang QF, Li LH, et al
    9C.06: COMPARISON BETWEEN CARDIOLOGY AND ENDOCRINOLOGY PHYSICIANS IN THEIR MANAGEMENT OF HYPERTENSION AND DIABETES MELLITUS: A CHINA REGISTRY.
    J Hypertens. 2015;33 Suppl 1:e124.
    PubMed     Text format     Abstract available


  938. XU H, Wang Q, Yang M, Yu J, et al
    9C.05: META-ANALYSIS OF AMLODIPINE VERSUS ANGIOTENSIN RECEPTOR BLOCKERS ON BLOOD PRESSURE, SOME ECHOCARDIOGRAPHIC INDICATORS OF LEFT VENTRICULAR DAMAGE AND ADVERSE EVENTS IN PATIENTS WITH HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e124.
    PubMed     Text format     Abstract available


  939. WANG TD, Tan RS, Lee H, Ihm SH, et al
    9C.04: TREATMENT WITH LCZ696 COMPARED TO AT1-RECEPTOR BLOCKADE IS ASSOCIATED WITH NON-SUSTAINED INCREASES OF NATRIURESIS AND DIURESIS IN ASIAN PATIENTS WITH SALT-SENSITIVE HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e124.
    PubMed     Text format     Abstract available


  940. KRZESINSKI P, Gielerak G, Stanczyk A, Piotrowicz K, et al
    9C.03: THE BENEFIT FROM HEMODYNAMICALLY GUIDED ANTIHYPERTENSIVE THERAPY DEPENDS ON BASELINE BLOOD PRESSURE.
    J Hypertens. 2015;33 Suppl 1:e123-4.
    PubMed     Text format     Abstract available


  941. BARKER E, Desmukh H, Levin D, George J, et al
    9C.02: EFFECT OF DIFFERENT ANTIHYPERTENSIVE DRUG CLASSES ON SURVIVAL IN UNILATERAL AND BILATERAL RENAL ARTERY STENOSIS: A RETROSPECTIVE RECORD-LINKAGE STUDY.
    J Hypertens. 2015;33 Suppl 1:e123.
    PubMed     Text format     Abstract available


  942. BERTACCHINI F, Paini A, Salvetti M, Casella E, et al
    9B.08: CARDIAC AND VASCULAR DAMAGE IN PATIENTS WITH PRIMARY ALDOSTERONISM AND ESSENTIAL HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e122.
    PubMed     Text format     Abstract available


  943. BARIGOU M, Kang FA, Orloff E, Amar J, et al
    9B.07: EFFECT OF POSTURAL CHANGES ON ALDOSTERONE TO PLASMA RENIN RATIO IN PATIENTS WITH SUSPECTED SECONDARY HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e121-2.
    PubMed     Text format     Abstract available


  944. CATENA C, Colussi G, Brosolo G, Martinis F, et al
    1C.12: DIETARY SALT INTAKE AND ALDOSTERONE-RELATED ORGAN DAMAGE IN HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e12-3.
    PubMed     Text format     Abstract available


  945. CASTAGNA F, Wang J, Emit M, Wang G, et al
    9A.09: PROTECTION AGAINST COMPLEMENT ACTIVITY IS REDUCED IN ARTERIAL HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e119.
    PubMed     Text format     Abstract available


  946. HONCHAR O, Ashcheulova T, Kovalyova O
    9A.08: INTERLEUKINS 33 AND 1B SERUM LEVELS ARE CONNECTED TO COMMON CAROTID ARTERIES REMODELING IN HYPERTENSIVE PATIENTS WITH OBESITY.
    J Hypertens. 2015;33 Suppl 1:e119.
    PubMed     Text format     Abstract available


  947. GE Q, Ruan C, Gao P, Ma Y, et al
    9A.03: OSTEOPONTIN AND OSTEOPROTEGERIN ACTIVATE MONOCYTES INTO ANTI-INFLAMMATORY PROPERTIES IN THE PATIENTS WITH HYPERTENSION-RELATED VASCULAR CALCIFICATION.
    J Hypertens. 2015;33 Suppl 1:e117-8.
    PubMed     Text format     Abstract available


  948. RADENKOVIC S, Kocic G, Stojanovic D, Milojkovic B, et al
    9A.02: SODIUM SENSITIVE HYPERTENSION: CAN IT BE ASSESSED BY MEASURING URIC ACID LEVELS?
    J Hypertens. 2015;33 Suppl 1:e117.
    PubMed     Text format     Abstract available


  949. SAXENA M, Collier D, Jain A, Knight C, et al
    8C.09: A CENTRAL ILIAC ARTERIOVENOUS ANASTOMOSIS RESULTS IN DURABLE AND SUBSTANTIAL BLOOD PRESSURE REDUCTION IN A WOMAN WITH UNCONTROLLED HYPERTENSION AND MULTIPLE DRUG INTOLERANCES.
    J Hypertens. 2015;33 Suppl 1:e112.
    PubMed     Text format     Abstract available


  950. BAGUET JP, Sosner P, Delsart P, Jost S, et al
    8C.08: CONTINUOUS POSITIVE AIRWAY PRESSURE IS EFFICIENT TO DECREASE BLOOD PRESSURE IN PATIENTS WITH RESISTANT HYPERTENSION. RESULTS FROM THE RHOOSAS STUDY.
    J Hypertens. 2015;33 Suppl 1:e112.
    PubMed     Text format     Abstract available


  951. STAFYLAS P, Mavrodi A, Kourlaba G, Maniadakis N, et al
    8C.06: COST-EFFECTIVENESS OF TWO SINGLE-PILL TRIPLE ANTIHYPERTENSIVE THERAPIES BASED ON THE AMBULATORY BLOOD PRESSURE MEASUREMENTS.
    J Hypertens. 2015;33 Suppl 1:e111.
    PubMed     Text format     Abstract available


  952. VLAHAKOS DV, Dalamaga M, Marouga A, Bacharaki D, et al
    1C.09: SERUM RESISTIN AS AN INDEPENDENT BIOMARKER ASSOCIATED WITH ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN ELDERLY HYPERTENSIVE, NON-DIABETIC PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD).
    J Hypertens. 2015;33 Suppl 1:e11-2.
    PubMed     Text format     Abstract available


  953. ALNIMA T, Schutten M, de Leeuw PW, Kroon AA, et al
    8B.09: RIGHT-SIDED DOMINANCE OF CAROTID BARORECEPTOR REFLEXES IN PATIENTS WITH RESISTANT HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e109.
    PubMed     Text format     Abstract available


  954. TSIOUFIS C, Papademetriou V, Dimitriadis K, Kasiakogias A, et al
    8B.08: SUSTAINED BENEFICIAL EFFECTS OF MULTI-ELECTRODE RENAL DENERVATION ON CARDIAC ADAPTATIONS IN RESISTANT HYPERTENSION: A 24-MONTHS FOLLOW-UP STUDY.
    J Hypertens. 2015;33 Suppl 1:e109.
    PubMed     Text format     Abstract available


  955. DE LEEUW PW, Bakris GL, Nadim MK, Haller H, et al
    8B.06: BAROREFLEX ACTIVATION THERAPY CONSISTENTLY MAINTAINS BLOOD PRESSURE REDUCTION IN A LARGE RESISTANT HYPERTENSION COHORT FOR AT LEAST 6 YEARS.
    J Hypertens. 2015;33 Suppl 1:e108.
    PubMed     Text format     Abstract available


  956. MAHFOUD F, Linz D, Mancia G, Narkiewicz K, et al
    8B.04: RENAL ARTERY DENERVATION FOR TREATMENT OF HYPERTENSIVE PATIENTS WITH OR WITHOUT OBSTRUCTIVE SLEEP APNEA AND RESISTANT HYPERTENSION: RESULTS FROM THE GLOBAL SYMPLICITY REGISTRY.
    J Hypertens. 2015;33 Suppl 1:e108.
    PubMed     Text format     Abstract available


  957. ELMULA FF, Jin Y, Larstorp AC, Persu A, et al
    8B.01: META-ANALYSIS OF FIVE PROSPECTIVE AND RANDOMIZED CONTROLLED TRIALS OF RENAL SYMPATHETIC DENERVATION ON OFFICE AND AMBULATORY SYSTOLIC BLOOD PRESSURE IN TREATMENT RESISTANT HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e107.
    PubMed     Text format     Abstract available


  958. KINTIS K, Tsioufis C, Dimitriadis K, Kalos T, et al
    8A.07: NON-INVASIVE ASSESSMENT OF HAEMODYNAMICS IN RESISTANT HYPERTENSION: THE ROLE OF RENAL HAEMODYNAMICS.
    J Hypertens. 2015;33 Suppl 1:e106.
    PubMed     Text format     Abstract available


  959. CHO I, Kim MA, Shim WJ, Park SM, et al
    8A.06: DIFFERENTIAL IMPACT OF ANEMIA ON LEFT VENTRICULAR FILLING PRESSURE BETWEEN SUBJECTS WITH AND WITHOUT HYPERTENSION. RESULTS FROM A MULTICENTER, COHORT STUDY.
    J Hypertens. 2015;33 Suppl 1:e105-6.
    PubMed     Text format     Abstract available


  960. MATSUMOTO C, Tomiyama H, Kimura K, Odaira M, et al
    8A.01: INTERRELATIONSHIPS BETWEEN THE DEVELOPMENT OF HYPERTENSION AND LONGITUDINAL CHANGES OF ARTERIAL STIFFNESS/RENAL FUNCTION, AND PROPER BODY WEIGHT MAINTENANCE.
    J Hypertens. 2015;33 Suppl 1:e104.
    PubMed     Text format     Abstract available


  961. DOGOTAR O, Sopetik V, Kotovskaya Y
    7D.12: TELMISARTAN MONOTHERAPY EFFECTS ON MICROCIRCULATION IN PATIENTS WITH UNCOMPLICATED ARTERIAL HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e103.
    PubMed     Text format     Abstract available


  962. NAZZARO P, Schirosi G, De Benedittis L, Mezzapesa D, et al
    7D.09: REDUCED VIT D AND ELEVATED URICEMIA INDUCE CAPILLARY RAREFACTION BEFORE MACROVASCULAR DAMAGE IN PATIENTS WITH METABOLIC SYNDROME AT THE VERY EARLY STAGES OF HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:e102.
    PubMed     Text format     Abstract available


  963. TRIANTAFYLLOU A, Al-Diri B, Anyfanti P, Hunter A, et al
    7D.08: DETECTING HYPERTENSIVE RETINOPATHY USING RETINAL VASCULAR GEOMETRY.
    J Hypertens. 2015;33 Suppl 1:e102.
    PubMed     Text format     Abstract available


  964. DE CIUCEIS C, Rossini C, Rosei CA, Sarkar A, et al
    7D.03: RELATIONSHIP BETWEEN AGE AND STRUCTURAL ALTERATIONS IN SUBCUTANEOUS SMALL RESISTANCE ARTERIES IN HYPERTENSIVE PATIENTS.
    J Hypertens. 2015;33 Suppl 1:e100-1.
    PubMed     Text format     Abstract available


  965. MATTINA A, Rosenbaum D, Kanagasabapathy C, Koch E, et al
    7D.02: EFFECT OF A SHORT-TERM ANTIHYPERTENSIVE TREATMENT ON RETINAL ARTERIOLES EVALUATED WITH ADAPTIVE OPTICS RETINAL CAMERA.
    J Hypertens. 2015;33 Suppl 1:e100.
    PubMed     Text format     Abstract available


  966. BRUNO R, Duranti E, Taddei S, Virdis A, et al
    7D.01: ESSENTIAL HYPERTENSION INDUCES EARLY FUNCTIONAL AND STRUCTURAL VASCULAR AGEING IN SMALL RESISTANCE ARTERIES.
    J Hypertens. 2015;33 Suppl 1:e100.
    PubMed     Text format     Abstract available


  967. MOS L, Fania C, Benetti E, Bratti P, et al
    1C.04: COFFEE CONSUMPTION IS A PREDICTOR OF CARDIOVASCULAR EVENTS IN YOUNG AND MIDDLE AGED HYPERTENSIVE SUBJECTS.
    J Hypertens. 2015;33 Suppl 1:e10.
    PubMed     Text format     Abstract available


  968. JARDIM T, Neiva T, Rodrigues R, Arantes A, et al
    5C.05: DIFFERENCES IN PREVALENCE, AWARENESS, TREATMENT AND CONTROL RATES OF HYPERTENSION BETWEEN MALE AND FEMALE.
    J Hypertens. 2015;33 Suppl 1:69e.
    PubMed     Text format     Abstract available


  969. RATTO E, Viazzi F, Bonino B, Verzola D, et al
    7A.09: METABOLIC SYNDROME IS ASSOCIATED WITH LEFT VENTRICULAR DILATATION IN PRIMARY HYPERTENSION.
    J Hypertens. 2015;33 Suppl 1:91.
    PubMed     Text format     Abstract available


  970. MARTELL-CLAROS N, Abad-Cardiel M, Alvarez-Alvarez B, Garcia-Donaire JA, et al
    Primary aldosteronism and its various clinical scenarios.
    J Hypertens. 2015;33:1226-32.
    PubMed     Text format     Abstract available


  971. MOREO A, Gaibazzi N, Faggiano P, Mohammed M, et al
    Multiparametric carotid and cardiac ultrasound compared with clinical risk scores for the prediction of angiographic coronary artery disease: a multicenter prospective study.
    J Hypertens. 2015;33:1291-300.
    PubMed     Text format     Abstract available


  972. ANENI EC, Oni ET, Martin SS, Blaha MJ, et al
    Blood pressure is associated with the presence and severity of nonalcoholic fatty liver disease across the spectrum of cardiometabolic risk.
    J Hypertens. 2015;33:1207-14.
    PubMed     Text format     Abstract available


  973. TRACHSEL LD, Carlen F, Brugger N, Seiler C, et al
    Masked hypertension and cardiac remodeling in middle-aged endurance athletes.
    J Hypertens. 2015;33:1276-83.
    PubMed     Text format     Abstract available


  974. MENNI C
    Blood pressure pharmacogenomics: gazing into a misty crystal ball.
    J Hypertens. 2015;33:1142-3.
    PubMed     Text format    


  975. JORDAN J, Grassi G
    Natriuretic peptides in the cross-talk of human cardiovascular and metabolic regulation.
    J Hypertens. 2015;33:1139-41.
    PubMed     Text format    


  976. VAN HATEREN KJ, Hendriks SH, Groenier KH, Bakker SJ, et al
    Frailty and the relationship between blood pressure and mortality in elderly patients with type 2 diabetes (Zwolle Outpatient Diabetes project Integrating Available Care-34).
    J Hypertens. 2015;33:1162-6.
    PubMed     Text format     Abstract available


    May 2015
  977. CHO IJ, Chang HJ, Park HB, Heo R, et al
    Aortic calcification is associated with arterial stiffening, left ventricular hypertrophy, and diastolic dysfunction in elderly male patients with hypertension.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  978. TADIC M, Cuspidi C, Majstorovic A, Kocijancic V, et al
    The relationship between left ventricular deformation and different geometric patterns according to the updated classification: findings from the hypertensive population.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


    April 2015
  979. DRAMAN MS, Dolan E, van der Poel L, Tun TK, et al
    The importance of night-time systolic blood pressure in diabetic patients: Dublin Outcome Study.
    J Hypertens. 2015.
    PubMed     Text format     Abstract available


  980. PETRAMALA L, Violi F, Letizia C
    Response to 'Oxidative stress in patients affected by primary aldosteronism'.
    J Hypertens. 2015;33:884.
    PubMed     Text format    


  981. SAMBHI MP
    Oxidative stress in patients affected by primary aldosteronism.
    J Hypertens. 2015;33:883.
    PubMed     Text format    


    March 2015
  982. MILANI D, Pezzani L, Negri G, Gervasini C, et al
    Potential impact of fetal genotype on maternal blood pressure during pregnancy: the example of EP300.
    J Hypertens. 2015;33:664-5.
    PubMed     Text format    


    January 2015
  983. PARK HY, Kim JH, Bae S, Choi YY, et al
    Interaction effect of serum 25-hydroxyvitamin D levels and CYP1A1, CYP1B1 polymorphisms on blood pressure in an elderly population.
    J Hypertens. 2015;33:69-76.
    PubMed     Text format     Abstract available


  984. STABOULI S, Papakatsika S, Kotronis G, Papadopoulou-Legbelou K, et al
    Arterial stiffness and SBP variability in children and adolescents.
    J Hypertens. 2015;33:88-95.
    PubMed     Text format     Abstract available


  985. MACDONALD-WALLIS C, Silverwood RJ, Fraser A, Nelson SM, et al
    Gestational-age-specific reference ranges for blood pressure in pregnancy: findings from a prospective cohort.
    J Hypertens. 2015;33:96-105.
    PubMed     Text format     Abstract available


    October 2014
  986. VINYOLES E, Sierra Ade L, Roso A, Cruz JJ, et al
    Reply: contribution of the ABP-International study to the definition of night-time tachycardia.
    J Hypertens. 2014;32:2101.
    PubMed     Text format    


  987. PALATINI P, Reboldi G, Beilin LJ, Eguchi K, et al
    Contribution of the ABP-International study to the definition of night-time tachycardia.
    J Hypertens. 2014;32:2099-100.
    PubMed     Text format    


    September 2014
  988. SNIJDER M, Stronks K, Busschers W
    The role of body weight, fat distribution and weight change in ethnic differences: confounding factors.
    J Hypertens. 2014;32:1912.
    PubMed     Text format    


  989. SCHUH DS, Balsan GA, Pellanda LC
    The role of body weight, fat distribution and weight change in ethnic differences: confounding factors.
    J Hypertens. 2014;32:1911-2.
    PubMed     Text format    


  990. STEA F, Faita F, Bruno RM, Ghiadoni L, et al
    Reflections on vascular ageing and microvascular pulsatility.
    J Hypertens. 2014;32:1908-10.
    PubMed     Text format    


  991. MCDONNELL BJ, Pearson J, Cockcroft JR
    Reflections on vascular ageing and microvascular pulsatility.
    J Hypertens. 2014;32:1907-8.
    PubMed     Text format    


    July 2014
  992. FERNANDEZ-FERNANDEZ FJ
    Regulatory T cells and vascular dysfunction.
    J Hypertens. 2014;32:1542.
    PubMed     Text format    


  993. ZANCHETTI A
    Recommendations for practice and mechanistic investigations.
    J Hypertens. 2014;32:1357-8.
    PubMed     Text format    


  994. PERSU A, Giavarini A, Touze E, Januszewicz A, et al
    European consensus on the diagnosis and management of fibromuscular dysplasia.
    J Hypertens. 2014;32:1367-78.
    PubMed     Text format     Abstract available


  995. SALAZAR-VEGA JL, Levin G, Sanso G, Vieites A, et al
    Pheochromocytoma associated with pregnancy: unexpected favourable outcome in patients diagnosed after delivery.
    J Hypertens. 2014;32:1458-63.
    PubMed     Text format     Abstract available


  996. FUJIWARA A, Hirawa N, Fujita M, Kobayashi Y, et al
    Impaired nitric oxide production and increased blood pressure in systemic heterozygous ATP2B1 null mice.
    J Hypertens. 2014;32:1415-23.
    PubMed     Text format     Abstract available


  997. ROSSI GP, Cesari M, Letizia C, Seccia TM, et al
    KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism.
    J Hypertens. 2014;32:1514-21.
    PubMed     Text format     Abstract available


  998. BISSON M, Rheaume C, Bujold E, Tremblay A, et al
    Modulation of blood pressure response to exercise by physical activity and relationship with resting blood pressure during pregnancy.
    J Hypertens. 2014;32:1450-7.
    PubMed     Text format     Abstract available


    September 2013
  999. SALLES GF , Leite NC, Pereira BB, Nascimento EM, et al
    Prognostic impact of clinic and ambulatory blood pressure components in high-risk type 2 diabetic patients: the Rio de Janeiro Type 2 Diabetes Cohort Study.
    J Hypertens. 2013.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: